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The incorporation of nonviral vectors into biomaterial matrices has been 
employed to improve localization at the implant site and to protect from loss by clearance 
or extracellular barriers. However, several limitations such as detrimental crosslinking 
mechanisms, uncontrolled burst release require improved design of matrix-based gene 
delivery systems that provides sustained and controlled vector release as well as 
overcomes extracellular barriers to gene transfer in proximity to target cells. The long-
term objective of this dissertation project is to provide the basis for the eventual creation 
of tissue engineering scaffolds that combine structural and biologica  activity through the 
creation of composite materials consisting of polymeric fibers with hydrogel coatings 
encapsulating nonviral vectors for localized gene delivery. The primary focus of this 
dissertation was to develop hydrogels with suitable physical/chemi al properties for the 
localized, sustained gene delivery application; including variable degra ation rate for 
controlled release, mild crosslinking conditions compatible with vector encapsulation, 
and minimal swelling after crosslinking to maintain stability as a fiber coating. The 
hypothesis was that vector release from hydrogel coatings in intimate proximity with 
adherent cells will overcome extracellular barriers to gene transfer and increase 
transfection efficiency relative to conventional bolus delivery methods.  
In order to concentrate nonviral vectors for efficient hydrogel loading, several 
approaches to vector lyophilization were investigated. The inclusion of 10% sucrose as a 
cryoprotectant was shown to preserve DNA structural integrity and biological activity. In 
 iii  
addition, incubation of nonviral vectors with sodium tripolyphosphate was shown t 
effectively release DNA from nonviral gene complexes, which provides a basis for 
accurate measurement of vector/DNA release. To develop polymer-bas d gene 
encapsulation system for gene delivery, hydrolytically degradable hydrogels with various 
degradation-kinetics were developed and characterized. First, linear poly(ethylene 
glycol)(PEG) polymers were modified with ester bonds of varying susceptibility to 
hydrolytic degradation and crosslinkable acrylate groups. Hydrogels w re prepared by 
photopolymerization and shown to variable degradation rates and controlled release of a 
model macromolecule. Secondly, hydrogels crosslinked by Michael-typ  addition from 
various acrylate-terminated four-armed amphiphilic poloxamine (Ttronic®) were 
evaluated. It was shown that the physical properties of these gel  are attributable to both 
temperature-dependent noncovalent interactions and covalent crosslinking. Hydrogels 
prepared from Tetronic T904 did not experience significant swelling after crosslinking 
and were shown to form stable coatings on polymer fibers. Finally, lyophilized nonviral-
gene complexes were incorporated within T904-based hydrogels. DNA integrity and 
sustained release was observed although the kinetics was not considered optimal due to 
delayed release. Preliminary transfection experiments using an in vitro model with 
serum-containing medium demonstrated that released vectors could transfect surrounding 
cells, although the efficiency of transfection was limited and further improvements to the 
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The concept of gene delivery was introduced as an alternative to protein delivery 
or cell transplantation to overcome short half-life, low bioavailability, systemic toxicity, 
high cost of manufacturing, etc. [1-3] Systemic gene delivery or simple injection of 
naked plasmid DNA (pDNA) has been a common application in the pharmaceutic l area. 
However, the transfection efficiency of naked pDNA is relatively low and effective only 
at the injection site. In addition, even low-level gene expression is often sufficient to 
stimulate the immune system. [4] To improve the efficiency and stability of gene 
delivery, both viral and nonviral vectors were developed for gene transfer. To date, viral 
vectors have achieved much greater transfection efficiency. However, viruses can only 
accommodate transgene inserts of limited size and may be immunogenic and mutagenic. 
[5-7]. As an alternate method, nonviral vectors for gene delivery have been widely 
investigated. [8-12] One major concern of using nonviral vectors is their toxicity after 
systemic application and inability to achieve levels of transfection efficiency and duration 
of gene expression comparable to viral systems. [13-17] Successful re ults in tissue 
regeneration were limited to very few tissues such as bone and eve  though there have 
been a few reports of gene therapy for complex tissue regeneratio , most of promising 
studies were based on viral vectors. [18-20] One major limitation of systemic 
administration of nonviral gene delivery technology is the external barrier of efficient 
vector transport and concentration at the cell surface as well as the internal barriers of 
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endosomal escape and transgene delivery to the nucleus. The incorporation of nonviral 
vectors into biomaterial matrices protect vectors from extracellular 
degradation/clearance, increase their local concentration at the target site, and achieve 
localized expression of therapeutic genes. [21, 22] 
Biodegradable and biocompatible polymeric materials have been widely studied 
in tissue engineering as matrices to provide space for induced tissue development and 
delivery of cells and/or biologically active molecules to specific sites. The incorporation 
of pDNA into biomaterial matrices and subsequent transfection of endogeous or 
transplanted cells offers an attractive approach to localized, sustained delivery of 
therapeutic proteins such as growth factors because the major limitation of protein 
therapy was the difficulty in maintaining concentrations over sufficient time period to the 
desired therapeutic response. [23, 24] Matrix-based gene transfer can p ovide retention of 
pDNA which allows sustained expression of therapeutic protein within the target tissue. 
In addition, this local delivery system can overcome low levels of transfection following 
systemic plasmid injections as well as prompt degradation of naked DNA in the 
circulation. 
Matrix-based approaches to gene delivery have been categorized into two 
mechanisms: polymeric encapsulation and substrate-mediated delivery. [25] In 
encapsulation systems, vectors are generally homogeneously incorporated th oughout the 
3D structure of the matrix during fabrication. [19] Vector release is controlled by 
diffusion, hydrolytic/proteolytic degradation, or a combination of both mechanisms 
depending on the physical and chemical properties of the vector. In the substrate-
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mediated approach, vectors are immobilized to the surface of the matrix after fabrication. 
[17, 26] Both approaches have shown improved transfection efficiency, transgene 
expression, and therapeutic efficacy relative to bolus administration by simple injection 
without a supporting matrix.  
The long-term objective of this research project is to create complex scaffolds that 
provide structural support for cells as well as therapeutic protein expression via gene 
delivery through the creation of composite materials consisting of capillary channel 
polymer (CCP) fibers with hydrogel coatings encapsulating nonviral ectors for localized 
gene delivery. Mass transport of vectors to target cells and the potential for degradation 
during this process is one of the key barriers to successful gene transfer. Although this 
has been overcome by increasing vector concentrations, this approach commonly results 
in increased cytotoxicity and off-target effects. The approach in tis dissertation is based 
on the long-term hypothesis that vector release from hydrogel coatings in intimate 
proximity with adherent cells will overcome mass transport limitations and increase the 
probability of cell-DNA contact leading to increased transfection efficiency and sustained 
ectopic gene expression using relatively low vector concentrations. (Figure 1.1) Although 
CCP fibers with 8 micrometer scale surface grooves running parallel to the fiber axis 
have previously been shown to promote alignment of a variety of cell types by 
topographic guidance, the fabrication of PLLA-based fibers requires melt extrusion at 
elevated temperatures incompatible with the incorporation of biological molecules. 
Therefore, the main goal of this project is the development of materials suitable for the 
formation of thin hydrogel coatings that can be stably formed within the fiber grooves 
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and provide controlled degradation kinetics suitable for the delivery of nonviral vectors. 
In addition, while nonviral vectors have been incorporated into several types of 
structurally organized scaffolds, their distribution within the scaffold is typically 
homogeneous. [19, 25] Ultimately, the functional regeneration of complex tissues is 
likely to require the delivery of multiple bioactive molecules with variable temporal and 
spatial patterns. A unique, long-term capability of this approach is that, relative to other 
biomaterial fabrication technologies, individual fibers with distinct coating formulations 
can be easily integrated into a single heterogeneous scaffold using a variety of existing 
textile technologies, similar to the weaving of a multi-colored fabric. Through variation 
of the physicochemical properties of various hydrogel coatings, it will be possible to 
simultaneously deliver a variety of bioactive molecules including pharmaceuticals, 
neurotrophins, recombinant DNA, and therapeutic small RNAs from a single device with 
variable and independent control of dose and kinetics.  
 
Figure 1.1. Hypothesis; nonviral gene transfer from degradable hydrogel coating 
with various degradation rate on CCP fiber will provide transfection of targeting 
cells in the direct contact with the topographical support of hydrogel and CCP fiber 
 5
This dissertation mainly consists of three objectives as shown in Figure 1.2. The 
first objective was to develop effective methods for preparing lyophilized gene 
complexes without a change in DNA integrity and transfection effici ncy. The second 
objective was to develop hydrolytically degradable synthetic hydrogels, followed by the 
characterization of their properties including degradation kinetics and geometrical 
stability as hydrogel coating. Finally, the transfection efficacy of the selected hydrogel 
system encapsulating optimized gene complex in the presence of serum was investigated 
in the final research objective.  
 
Figure 1.2. Diagram of research outline in the dissertation 
 
The objectives of each chapter in this dissertation are summarized as follows: 
Chapter 2 reviews the concepts and fundamentals of gene delivery including 
strengths and weaknesses of various vector systems. Through this exten ive r view of 
gene delivery systems, this chapter identifies key issues for uccessful gene transfer that 
are necessary for the development of an ideal gene delivery system. 
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Chapter 3 reviews biomaterial matrix-based approaches to gene deliv ry. Two 
widely studied approaches, polymeric encapsulation and substrate-mediated delivery are 
described.  
Chapter 4 investigates two major requirements for the development of matrix-
based gene delivery. First, the feasibility of lyophilization is di cussed for the 
stabilization of nonviral-mediated gene delivery with various cryoprotectants. Second, 
various decomplexation methods are compared to measure plasmid DNA amount after 
condensation with nonviral vectors. In addition, a preliminary reverse gentra sfer 
approach is performed to predict the transfection efficacy of hydrogel-encapsulated 
nonviral vectors in the presence of serum as a pilot study. 
Chapter 5 describes the development of novel, degradable, and photocrosslinkable 
PEG-based hydrogels (adapted from Cho and others [27]). Synthesized using chemical 
intermediaries that form ester linkages with variable alkyl chain length, these macromers 
are shown to form hydrogels with variable degradation kinetics and co sistent physical 
properties. The resulting data demonstrates the suitability of these materials for controlled 
release of bioactive molecules. At the end of Chapter 5, the inability of these materials to 
form coatings on CCP firms is demonstrated and discussed.  
Chapter 6 characterizes Tetronic® based hydrogels that are composed of 
amphiphilic block copolymers. The current study evaluates various compositions of 
Tetronic® 1107 and 904 and shows that their physical properties are derived from both 
covalent and noncovalent crosslinking mechanisms. A formulation is identif ed that does 
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not undergo additional swelling at physiological temperature after crosslinking and this is 
shown to be capable of forming stable coatings on CCP fibers.  
Chapter 7 evaluates Tetronic® based hydrogels as a vector encapsulation gene 
delivery system. The incorporation efficiency, stability, and release kinetics of nonviral 
vector after Michael-type addition is investigated. Finally, the potential of this optimized 
hydrogel gene delivery system is addressed through cell transfection on the degradable, 
thin hydrogel. 
Chapter 8 outlines the major conclusions and recommendations for future studi s 





GENE THERAPY: APPROACHES AND CHALLENGES  
 
2.1.  Introduction 
Gene therapy has recently been defined as “a method to provide a patient’s 
somatic cells with the genetic information required for producing specific therapeutic 
proteins to correct or modulate disease”. [3]  Two primary applications of gene therapy 
are i) correction of genetically-based disease and ii) transient overexpression of a protein 
capable of initiating or altering a biological process such as angiogenesis or tissue 
regeneration. [2, 3, 5] Although some successful reports have suggested the use of naked 
DNA, long-term expression with efficient gene delivery has not been accomplished yet. 
[20] To improve the efficiency and stability of gene delivery, both viral and nonviral 
vectors have been developed for gene transfer. The objective of thischapter is to review 
the concepts and fundamentals of gene delivery including strengths and we knesses of 
various vector systems. 
2.1.1. General concept of gene therapy/delivery 
Gene therapy starts with the introduction of an appropriate vector either directly 
into the body (in situ delivery) or cultured cells prepared for transplantation (ex vivo 
delivery). In situ delivery may be achieved by systemic (intravascular 
injection/inhalation) or local routes (direct injection into the target tissue or implantation 
of a vector-loaded scaffold). Once the therapeutic transgene is i troduced to its target, it 
needs to be transcribed and the resulting mRNA needs to be transla ed into the 
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therapeutic protein. Most transgene products are soluble, secreted pro ins that bind to 
receptors on appropriate target cells to induce a biological effect, r sulting in a 
therapeutic outcome. [3] In the case of systemic delivery, however, there are two primary 
problems. One is the lack of specificity, and another is systemic toxi ity caused by viral 
vectors and/or the transgene. [4, 28] Systemic delivery to the nervous system is further 
limited by the poor penetration of vectors through the blood-brain or blood-spinal cord 
barriers. At present, to overcome these problems, two approaches to localized gene 
delivery have been investigated, ex vivo and in vivo. For ex vivo approach, cells are 
transfected in vitro before their transplantation to the target tissue. In the in vivo case, 
host cells are genetically modified via in situ vector delivery either by simple injection or 
implantation of gene-carrying materials. 
2.1.2. Vector-assisted delivery systems 
Delivery systems or vectors play a critical role in providing the ideal properties in 
the DNA delivery. Their properties should include high transfection efficiency, cell 
specificity, low immunogenicity or toxicity, stability with transgene formulation and 
biodegradability. [29] Currently available DNA vectors can be classified into viral and 
nonviral vectors. 
2.1.2.1. Viral vectors [30] 
Retrovirus 
Retroviruses are a family of viruses that store their genetic material in the form of 
RNA. When a retrovirus infects a host cell, its RNA produces a DNA copy via reverse 
transcription carried out by reverse transcriptase carried in the virus. This DNA copy is 
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integrated into the genome of the host cell with an integrase enzym  carried in the virus. 
The virus then replicates as part of the cell’s DNA. Retrovirus has been shown to achieve 
1-30% transduction efficiency. While integration into the host genome can provide long-
term gene expression, one problem is that the viral DNA is randomly inserted at an 
arbitrary position, possibly leading to mutagenesis if a gene ess ntial to cell cycle 
regulation is disrupted. Another problem is that most retroviruses generally infect only 
dividing cells. The cloning capacity of retroviral vectors inserting size is 9-12kb. 
Lentivirus 
One genus of retroviruses is lentiviruses. The lentiviral vectors typically used are 
derived from human immunodeficiency virus (HIV-1). This virus can be used to 
transduce both dividing and non-dividing cells such as neurons, distinguishing them from 
general retroviruses. Lentiviral vectors also insert transgenes into the host genome via the 
reverse transcriptase/integrase mechanism. The cloning capacity of lentirival vectors 
cloning capacity is 9-13.5kb. [31] Lentiviral vectors exhibited more suitable to deliver 
D15A transgene, a neutrotrophin with BDNF and NT-3 activities, than ade oviral and 
retroviral vectors in vitro and in vivo. [32] Due to their ability to transfect non-dividing 
and provide stable, long-term gene expression, lentiviruses have been pref rred vectors 
for neural applications. 
Adenovirus 
Adenoviruses store their genetic material in the form of double-stranded DNA 
and can accommodate transgenes of 4-5kb. When these viruses infect a host cell, the vira  
transgene is not incorporated into the genome of the host cell. The viral DNA is left free 
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in the nucleus of the host cell and is transcribed just like other genes. However, viral 
genes are not replicated when the cell undergoes cell division so the viral DNA cannot be 
transmitted to daughter cells. Therefore, adenovirus-mediated gene expr ssion is 
transient. Adenovirus has several advantages including high transduction efficiency, 
capability for infection of many cell types, and the ability to transfect non-dividing cells. 
However, adenovirus still carries the common problems induced by general viral vectors 
(the severe immune response including both the innate and adaptive immunity). [33]  
Adeno-associated virus (AAV) 
Adeno-associated viruses (AAVs) are small viruses with a genom  of single 
stranded DNA and a cloning capacity of 5 kb. These viruses can incorporate genetic 
material into the host genome and infect both dividing and non-dividing cells. As with 
lentiviruses, the ability to transfect postmitotic cells such as neurons has promoted the use 
of AAV in neural applications.  AAV has generally been found to be less pathogenic and 
immunogenic relative to adenoviruses. 
Herpes simplex virus (HSV)  
Herpes simplex virus (HSV), especially HSV type 1 (HSV-1), has been 
investigated as a vector for gene transfer to the nervous system. These viruses carry a 
linear double stranded DNA molecule of 152kb. 40-50 kb of foreign DNA can be 
accommodated within the virus. [34] These viruses infect a wide range of cell types. 
They have relatively prolonged expression compared to other viruses. However, due to 
complications of herpes infection such as encephalitis, it is difficult to develop as vectors 
for gene therapy.  
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2.1.2.2. Nonviral vectors 
Naked DNA 
Plasmid DNA (pDNA) is a circular form of double-stranded DNA carried by 
many bacteria that contains its own replication origin and typically an antibiotic-
resistance gene that allows for selective growth of bacterial carrying a plasmid of interest. 
Plasmids are typically several thousand kb and can be readily modified to include 
mammalian promoters and genes, usually in the form of open reading frames without 
introns created by reverse transcription of mRNA. [35] Direct pDNA 
injection/microinjection is the simplest of nonviral methods. This strategy is independent 
of the length and sequence of the DNA. Naked pDNA has been administered 
intramuscularly and expressed for up to 19 months. [36] However, since pDNA is a large 
and negatively charged molecule, it is difficult for it to interact with the negatively 
charged cell membrane and consequently internalize into cells for gene transfection. 
Consequently, extremely high doses are commonly required and generally very low 
transfection efficiencies have been observed in comparison to other methods. [37]  
Liposomes/cationic lipids 
Lipids with cationic head groups can bind and condense pDNA. Their 
hydrophobic lipid tail groups help in forming liposomes and can interact with cell 
membranes. As stated above, lipoplex achieve relatively low transfection efficiency 
compared to viral vectors. Because liposomes are taken up by cells by means of 
endocytosis, fuse with endosomes and inefficiently release DNA from endosomes unless 
an endosomolytic agent is added to the formulation, limited amounts of DNA are able to 
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reach the nucleus. [38, 39] To improve lipoplex transfection efficiency, current 
approaches have focused on the conjugation of pH-sensitive and membrane-active 
peptides, which destabilize the endosomal membrane and increase the releas  of pDNA 
into the cytoplasm prior to endosomal degradation. [40-42] 
Poly(L-lysine) (PLL) 
The positively charged primary ε-amines of PLL condense pDNA and form 
donuts/toroids of 25-50nm in diameter or short stem/rod structures of 40-80nm long in 
water. To form stable complexes with DNA, MW of PLL is required higher than 3000 in 
order to have sufficient number of primary amines in the PLL backbone. [2] One of the 
drawbacks of PLL-DNA complexes is aggregation and precipitation of complexes at high 
salt concentration or in physiological saline at all charge ratios of complexes. [43] 
Although PLL was an early material investigated for nonviral gene delivery, its current 
use is limited by several factors. In general, PLL-DNA complexes cause a relatively high 
level of cytotoxicity, which results in 40-60% cell viability after in vitro transfection. 
Relative to PEI (discussed below), PLL also exhibits relatively low transfection 
efficiency. This has been attributed to i) strong DNA binding to form inter-
polyelectrolyte complexes, hindering its release in the cytoplasm/nucleus, and ii) the 
higher pKa of its amines relative to PEI, hindering its ability to act as a proton sponge. 
[44] To increase the solubility of PLL-DNA complexes in aqueous media, PLL has been 
modified with hydrophilic dextran by a reductive amination reaction between ε-amino 
groups of PLL and the reductive ends of dextran, but dextran chains don’t considerably 
hinder the electrostatic interaction between DNA and PLL. [45] PLL-DNA complexes 
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with covalently linked PEG exhibited 30-fold higher transfection efficiency than PLL-
DNA complex in order to decrease both cytotoxicity and salt-induced aggregation. [46] 
The circulation of PLL-DNA complex depends on the molecular weight of PLL. Most of 
20kDa PLL-DNA complexes were localized in the liver (80%), kidney (0.8-1.9%), lung 
(1-2%) and aggregated in the blood through interaction with negativ ly charged serum 
protein in the blood. When using longer PLL chains such as 211kDa, PLL-DNA 
complexes had long blood circulation time and were localized in the liver (47%) and not 
aggregated. The merit of using PLL is that a targeting moiety can be easily coupled to 
PLL by chemical conjugation for targeted delivery.  
Polyethylenimine (PEI) 
There are two types of PEI, branched and linear form. Linear PEIs are already 
commercialized as transfection reagents such as ExGen 500. Branched PEIs are 
theoretically composed of 25% primary, 50% secondary, 25% tertiary amines. But, the 
branching degree of commercially available PEI actually shows 1:1:1 ratio. Primarily the 
PEIs larger than 10kDa have been used successfully in transfection studies. However, 
higher MW PEI (> ~48kDa) reduced transfection efficiency in vivo (the results are 
somewhat contradictory in vitro) and showed cytotoxicity. [47, 48] Among the various 
PEI forms studied, liner PEI (L-PEI) of 22kDa and branched PEI (B-PEI) of 25kDa are 
the most effective transfection vectors used in vitro and in vivo. PEI-DNA complexes 
exhibit a narrow particle size distribution, which presumably allows high cellular uptake 
of the plasmids leading to high transfection efficiency. PEIs have their own method of 
endosome disruption via the proton-sponge effect. Linear PEIs consist of almost entirely 
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secondary amines while branched forms are theoretically 75% secondary and tertiary 
amines. The overall protonation level is about 10-20% at pH7 and increases up to 40% at 
pH5. [49] Based on these properties, the amines present in the PEI become protonated in 
the low pH endosomes, which not only protects DNA from degradation, but also 
increases water uptake into the endosome and leads to endosomal rupture and release of 
DNA into the cytoplasm. [50] This proton sponge hypothesis has been supported by 
several studies, showing a decrease in acidification as well as an increase in chloride 
concentration and the relative volume in PEI-containing endosomes (140% increase). 
[51] Additionally, quarternization of amine groups present in PEIs decreased transfection 
efficiency by about 20-fold because of the removal of protonable amine groups. [52] 
Although the high cation density of PEI contributes to highly condensed PEI-DNA 
complexes and relatively good transfection efficiency in some cases, th  excessive 
amount of free amine groups in PEI polymers causes significant cyto oxicity and is 
highly dependent on MW of PEI. [48, 53] Furthermore, it is known that less than 30kDa 
of hydrophilic polymers can be eliminated by the kidney. Unless their size is less than 
30kDa or they are enzymatically degraded, high MW PEI is not recommended as 
delivery vectors. Even though low MW PEI was used, the ratio of nitrogen in PEI to 
phosphate group in DNA (N/P ratio), salt concentration and presence of s rum in the 
environment strongly influenced aggregation of complexes. [54, 55] For example, an 
increase of salt concentration (e.g. NaCl > 50mM) promoted aggregation of PEI-DNA 
complexes. [56, 57] Although N/P ratio that increases particle size i  still controversial, it 
affected a change in particle size. [54, 58] PEGylation via the primary amino groups in 
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PEI enhanced the water solubility and reduced the surface charge of complexes by PEG 
shielding effect and subsequently decreased polyplex self-aggregation and promoted 
polyplex stability in the presence of serum proteins. [38] Low MW PEI was covalently 
linked with degradable bonds, which increased the overall polymer hydrophilicity and 
MW without toxicity. [59] This degradable site can promote the clearance of the polymer 
after DNA release.  
Dendrimers/polyamidoamine (PAMAM) 
Dendritic PAMAM provides a low MW structure and a high density of positive 
surface charge. [60] The surface charge and diameter of any starbur  polyamidoamine 
(PAMAM) dendrimer can be easily controlled by the number of synthetic steps taken to 
produce it. For example, five steps of polymerization generate 5th-generation dendrimer. 
Dendrimers condense plasmids via electrostatic interactions of their terminal primary 
amines with the pDNA phosphate groups. The particle size, surface charge and gene 
transfer efficiency of complexes are influenced by the dendrimer concentration in the 
complexes. 
2.1.3. Barriers to gene delivery [37] 
Figure 2.1 is a schematic representation of the delivery, uptake and intracellular 
fate of gene delivery systems. The first inherent factors to efficient gene delivery can be 
the inefficient cellular uptake of naked DNA or gene complex. A combination of several 
factors such as charge, size, and poor stability in the extracellul r environment is 
considered as a potent barrier to cellular uptake. [29, 35, 61] For example, the negatively 
charged DNA causes inadequate cellular association due to its elec rostatic repulsion. 
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High MW DNA is often too big to internalize via endocytosis. Without any protection by 
vector, plasmids undergo a rapid degradation caused by nucleases following 
administration both intravenously and intramuscularly. Nucleases recognize the 
phosphodiester linkage in the DNA backbone, resulting in hydrolytic degradation.  
Upon endocytic internalization, delivered genes are trapped within endosomal 
vesicles, where DNA molecules are inactivated and eventually degra d due to acid 
hydrolysis activated by lysosomal enzymes at pH 5-6. Failure of DNA escape from these 
structures has been demonstrated as one of the major barriers to efficient gene delivery. If 
DNA safely escapes from the endosome, it enters the cytosol and should traverse the 
cytosol to enter the nucleus. However, large DNA molecules (>2000 base pair  in length) 
experiences a substantial diffusion barrier according to its low diffusion coefficient in the 
cytosol (<1% of the diffusion coefficient in water). [62] Although DNA can reach the 
nuclear membrane, transport of plasmid by nuclear pores is limited du  to the size of 
nuclear pores. Nuclear pores change their size from <9nm in diameter to <26nm 
depending on their closed and open states, respectively. [61] For example, if DNA is of 
size in 1000bp (660kDa), its size is approximately 3400 Å (=340nm; bp = base pair(s) 
one bp corresponds to circa 3.4 Å of length along the strand), which is onsiderably 
larger than nuclear pore size. [63] Finally, when delivered DNA overc mes all of these 
barriers, DNA is accessible to the transcriptional machinery and can produce the desired 
therapeutic protein. Although these various barriers to gene delivery contribute to 
inefficient gene delivery, it is not obvious that all the delivery systems are incapable of 
efficiently delivering genes to various tissues.  
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Figure 2.1. Schematic generalized representation of delivery of a DNA-based 
therapeutic using a viral or nonviral DNA delivery vector: (1) complexation and/or 
entrapment of DNA-based therapeutic with DNA delivery vector; (2) interaction of 
DNA-based therapeutic-vector complex with cell membrane; (3) cellular 
internalization via receptor- or non-receptor-mediated endocytotic pathways; (4) 
endosomal breakdown; (5) cytoplasmic release of DNA-based therapeutic-vector 
complex or DNA-based therapeutic alone (Cytoplasm is the site of action for 
antisense oligonucleotides, aptamer, ribozymes, DNAzymes, and cytoplasmic 
plasmid DNA expression systems); (6) dissociation of DNA-based therapeutic from 
vector; (7) nuclear translocation of viral vectors or DNA-based therapeutics. 
(Nucleus is the site of action for transgenes in plasmids for gene therapy, siRNA 
generating plasmids, and antigene oligonucleotides.) [29] 
[Reprinted from The AAPS Journal 7 (2005) E61-E77, Siddhesh D. Patil, David G. 
Rhodes, and Diane J. Burgess, DNA-based therapeutics and DNA delivery systems: 
A comprehensive review, Copyright (2005) with permission from The American 
Association of Pharmaceutical Scientists]  
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2.1.3.1.Barriers to viral gene delivery 
Application of viral vectors uses the natural ability of viruses to infect host cells. 
In brief, viruses bind to cell surface receptors on the cell membrane and internalize either 
by endocytosis or by fusion with the plasma membrane. The viral DNAthen escapes due 
to conformational changes or the disruption in viral coat proteins and trverses the 
cytoplasm to reach the nucleus by use of the cytoskeletal network, finally enters nucleus 
in size of 2.5-250kb DNA through nuclear pore complexes or during the breakdown of 
the nuclear membrane during mitosis. Viral vectors may be the most efficient vectors. 
70% of clinical trials utilized viral vectors including retrovirus, adenovirus, adeno-
associated virus, herpes simplex virus, etc. Unfortunately, viral vectors may provoke 
mutagenesis and carcinogenesis. [5] In addition, administration of a viral vector induces 
an immune response. In 2000, Marshall reported severe problems using viruses indicated 
by the sudden death of an 18-year-old patient. [6, 7] In the case of using viral vectors, 
especially adenoviral vectors, the severe innate or/and adaptive immune responses 
induced a significant problem including the patient’s death. [13, 33] Moreover, th  
immune response may eliminate both the vector and the transfected clls and reduce the 
gene transfer efficacy as well as the duration of transgenic protein expression. The 
intensity of the immune response depends on several variables such as the type of virus, 
dose, the administration route, the nature of transgene, etc. [33, 64] Additional 
disadvantages include limited DNA carrying capacity or limitation in the size of the 
transgene to be delivered, and lack of target specificity. 
2.1.3.2. Barriers to nonviral gene delivery 
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Considering these safety issues and disadvantages, nonviral vectors based on 
plasmid DNA (pDNA) offer an attractive alternative due to their relatively lower 
immunogenicity. While naked DNA is used in some applications, more commonly it is 
condensed by the formation of polyelectrolyte complexes with cationic lipids (lipoplex) 
or polymers (polyplex). In contrast to naked DNA that is repelled from the cell 
membrane due to its negative charge, lipoplex and polyplex formulations achieve a 
neutral or slightly positive charge that increase binding to the cell membrane. One 
advantage of nonviral vectors is greater control of their molecular composition for 
simplified manufacturing and analysis than viral vectors. The various size of the 
transgene can be delivered as well. However, nonviral methods showed l  levels of 
transfection and gene expression, potentially caused by toxicity and 
aggregation/instability of vectors. High molecular weight (MW) polycations delivered to 
cultured cells and in animals are significantly more toxic than low MW polycations. [47, 
53] In addition, highly charged particles rapidly aggregated in high ionic strength 
solutions due to the decrease in the protective electrostatic layer. [57] If there is a strong 
positive charge on the delivery systems, gene complexes non-specifically interact with 
ECM, cell surfaces and plasma proteins due to their negative charges. If there is a strong 
negative charge on the gene complexes, they are removed by phagocytosis via the 
macrophage polyanion receptor. Steric stabilization of nonviral complexes has been 
studied by creating a hydrophilic layer in the polymer chain or on the particles, which 
diminishes non-specific interactions with molecules from environment. After uptake of 
nonviral systems into the cells, gene complexes are fused with endosomes. Degradation 
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of the vector may occur in the lysosome unless the endosomal membrane is destabilized 
by pH-sensitive molecules or osmotic disruption by chloroquine afterion trapping after 
its protonation [65], which lowers the amount of DNA being delivered into nucleus. Even 
though some amounts of surviving complexes reach the nucleus, lipoplexes, polyplexes 
and pDNA all appear to be too large to enter the nucleus via the nuclear pore complexes. 
[5, 38] Therefore, nonviral gene delivery is highly dependent on cell division and nuclear 
membrane breakdown, resulting in a more space for those molecules to enter. 
2.1.4. Systemic gene delivery [30, 66] 
The most widely investigated application of systemic gene therapy h s been 
cancer treatment. When the target tissue cannot be reached directly, systemic delivery is 
conducted by the injection of viral or nonviral vector-DNA complexes into the 
bloodstream, thus distributing the complexes to tissues throughout the body. H wever, 
this approach has encountered limitations due to a low specificity of gene expression, in 
vivo instability, toxicity and low transfection efficiency. [67] Many gene therapy 
approaches involve the expression of growth/trophic factors that may have detrimental 
side-effects in non-target tissues. For systemic administration, delivery systems should be 
prepared at a high concentration sufficient to bear the loss that will occur in the 
bloodstream. PLL-DNA complexes were rapidly cleared from the bloodstream within 30 
min and accumulated in the liver. [17, 68, 69] While repeated injection might increase the 
period of gene expression, if a vector is based on the viral vector and gene therapy is 
repeatedly administered through its complex, the vector itself causes the severe problems 
to host cells, for instance, toxicity or immune responses. [70, 71] Circulating antibodies 
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and the complement system recognize viral vectors in the bloodstream as pathogens and 
neutralize them rapidly. In addition, other immune effectors can neutralize the viral 
vectors and cells which have been transduced as well. In the case of nonviral vector 
delivery, electrostatic interactions of cationic gene complexes with salts and anionic 
proteins in serum (e.g., albumin, fibronectin) results in rapid aggregation. One major 
concern of using nonviral vectors is their toxicity after the systemic application. For PEI 
complex, the electrostatic condensation method with PEI generated about 86% free 
residual PEI, which induced the cytotoxicity. [72, 73] When free 25kDa PEI was directly 
added to PC-3 cells, cell viability was significantly lower than the other complex groups 
such as PEI-DNA (N/P=10) and PLL-DNA complexes. Chollet reported that increasing 
the quantity of L-PEI complex induced liver necrosis and death of mice (4weeks, Swiss 
nude and C57/black6). In addition, older animals were more sensitive to this complex. 
[14] Moreover, the results after injection indicated that PEI alone or complexed with 
DNA can induce inflammatory and innate immune responses including an increase in the 
number of monocytes, granulocytes, natural killer cells, B lymphocytes and T killer cells. 
[14] Systemic administration of lipoplex also induces the rapid innate immune response. 
[69] A series of these reductions of gene complexes finally affect the transfection 
efficiency at target site. There are strategies for overcoming some of these barriers, 
including the use of certain immune cells such as macrophages, and T cells, transduced 
with viral vectors to encode therapeutic genes, and the modification of traditional 
nonviral vectors with hydrophilic polymers for their stability against salt and serum. [66, 
74] However, the application of systemic delivery is limited only to vascularly accessible 
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tissue or tissue that has the discontinuous endothelial wall such as liver, spleen, and bone 
marrow. [12]  Unless enhancing the vascular permeability, systemic administration may 
be inapplicable to many tissues. 
2.1.5. Local gene delivery 
2.1.5.1. Ex vivo gene therapy 
Localized therapeutic gene expression may be achieved by ex vivo and in situ 
delivery. For ex vivo, this approach requires the transplantation of cells that have been 
previously transfected in vitro. This method provides the ability to select successfully 
modified cell populations before in vivo transplantation and may provide long-term 
transgene expression if the cells are transfected using appropriate vi al vectors. Also, this 
approach can achieve immunocompatability if autologous cells are used. Th re are a 
couple of drawbacks including the time-consuming processes to identify, purify and 
expand the transfected cells, the lack of cell survival and bioactivity after transplantation, 
tumorigenesis by the implantation of genetically modified cells, the high cost associated 
with all the necessary procedures. [70] 
2.1.5.2. In vivo gene therapy  
In vivo gene therapy modifies host cells genetically by direct in situ vector 
delivery either by injection or implantation of materials that crry genetic materials. In 
vivo gene therapy is simple to apply to the body, requiring only the in vivo small volume 
injection, minimally invasive injection (e.g., several microliters) of a transgenic vector 
and avoiding the risk of introducing ex vivo transfected cells that have potential 
tumorigenicity. In addition, pDNA or a virus which is incorporated into a polymer 
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scaffold may enhance gene transfer at the implant site, providing sustained delivery, 
localized gene expression and extending opportunities for internalization. [75] Increasing 
the concentration of DNA in the local cellular microenvironment can increase 
transfection. [76, 77] However, transfection efficiency introduced by nonviral vectors via 
in vivo gene delivery is too low to be clinically useful. The nonspecific interaction of 
extracellular proteins with vectors can be one of reasons to reduce the number of active 
gene complexes.  
2.1.6. Current problems of nonviral-mediated local gene delivery 
2.1.6.1. Cellular responses 
In vivo gene therapy is an alternate approach to systemic gene deliv ry, used to 
reduce the chance of vectors to transfect nontargeting cell/tissue nonspecifically via 
circulation. However, similar to observations in systemic delivery applications, nonviral 
vectors, which are locally introduced, can cause cytotoxicity at the applied site. PEI-DNA 
complexes have a similar toxic effect where the cells adopt a rounded morphology, 
indicative of a loss of adherence. [78] Moghimi and colleagues demonstrated hat both B-
PEI (25kDa) and L-PEI (750kDa) induced membrane damage and apoptosis in various 
human cell lines. [15] A decrease in the level of free PEI in the transfection solution can 
be of benefit to cell survival and transfection. An ultrafiltration method proposed by 
Finsinger and others is one simple solution addressing the elimination of free PEI 
molecules. [72] This method removes about 30% of the free PEI. However, this method 
was attributed to stability of PEI-DNA complexes, resulting in a significant decrease of 
the surface charge. Any shear forces by centrifugation or homogenizing caused damage 
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to DNA. [79] Electrophoretic purification was also introduced as a simple and quick 
method for the purification of polyplexes. This method was able to purify about 60% of 
free PEI and PEI conjugates like PEGylated PEI independent of their siz  associated with 
N/P ratio. [80] Cationic liposomes induced the innate immune response a d tissue 
damages as well. Lipoplex triggered the innate immune response to unmethylated CpG 
motifs of pDNA via recognition by toll-like receptors (TLRs), leading to the production 
of inflammatory cytokines and interferons (IFNs). [13] To reduce inflammatory toxicity 
caused by lipoplexes, the sequential injection method (cationic liposome first, and then 
DNA injection) with an optimized interval time was effective in inhibiting the induction 
of inflammatory cytokines (e.g., TNF-α, IFN-γ, IL-12) except removal of CpG motif of 
pDNA. However, this method was only able to benefit certain types of liposome vectors 
such as DOTAP/Chol and DOTMA/Chol. [69] 
2.1.6.2.Environmental interactions 
For both in vitro and in vivo applications, gene complexes mediated by nonviral 
vectors interact with serum proteins in the cell culture media or the extracellular 
environment within the tissue before binding to the cell surface. In in vitro studies, the 
introduction of either lipoplex (e.g., Lipofectamine) or polyplex (e.g., polyethylenimine, 
PEI) resulted in only 20-50% internalization of initial pDNA. [81-84] Complexes 
between either lipoplexes or polyplexes and pDNA are typically prepared by electrostatic 
interactions between the positive charges of either the cationic l pid headgroups or the 
cationic polymers and the DNA phosphate groups. It has been accepted that slig tly 
positive lipoplexes and polyplexes achieved higher transfection efficiency because their 
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net positive charge allowed more efficient binding with the negatively charged cell 
surface. [12, 76, 77, 85] However, a positively charged complex is also likely to interact 
with extracellular proteins in the physiological fluid, which may induce the aggregation 
of complex itself or dissociation of the complexes. [17] These serum barriers may 
directly or indirectly reduce the number of gene complexes via either their electrostatic 
interaction with gene complex or subsequent gene complex self-aggreg tion neutralized 
by proteins, respectively, which was proposed as one of the reasons for lipoplexes or 
polyplexes exhibiting low transfection efficiency. Luo in 2000 tried to overcome low 
transfection efficiency by simply increasing a number of gene complexes at the surface of 
cell monolayer. Briefly, silica nanoparticles bound with gene complexes were settled 
over cellular membranes in gravity, which resulted in an increase in the concentration of 
DNA at the cell surface and gene expression. [76] In conclusion, an increase in the 
number of gene complexes at the cell surface increases the opportunity for cellular 
internalization and eventually transfection. Several studies attempted to enhance cellular 
internalization of gene complexes via the addition of receptor ligands to the vector, the 
modification of vectors with PEG groups, etc. [86] Alternatively, degradable biomaterials 
provided a continuous infusion of DNA or gene complexes into the targeting tissue and 
some of them resulted in significantly greater physiological responses compared with 
application of a bolus delivery. [19] Biomaterials can be fabricated in various forms, such 
as scaffolds, hydrogels, and nanospheres, and can potentially protect vectors and DNA 
from the extracellular serum barriers. 
2.2. Conclusions 
 27
Gene delivery provides new approaches for treating and controlling disease . The 
major barrier to the success of gene delivery is transfection efficiency. Although a greater 
efficiency of transgene expression has been achieved with viralectors, their 
immunogenicity and carrying capacity remain significant challenges. Due to the safety 
issue of viral vectors, nonviral vectors have been widely investigated as an alternative 
approach. However, their low transfection efficacy has limited the ability for clinical 
therapies. The successful in vivo application of nonviral vectors will depend on 
understanding and overcoming the environmental and intracellular barriers to gene 
delivery. Since it is difficult to fully control the intracellular mechanisms, the method to 
increase the concentration of gene complexes at the cell membrane to chieve increased 
internalization may be the most direct and practical approach. Encapsulation within 
biomaterials was developed to shield the vector from the extracellul r environment and 
localize DNA release. Sustained release systems facilitated by degradable biomaterials 
may provide a means of overcoming transient gene expression and low transfection 





BIOMATERIAL MATRICES FOR LOCALIZED GENE DELIVERY 
 
3.1. Introduction 
Biodegradable and biocompatible polymeric materials have been widely studied 
in tissue engineering as matrices to provide space for induced tissue development and 
delivery of cells and/or biologically active molecules to specific sites. [87, 88] The 
incorporation of pDNA into biomaterial matrices and subsequent transfection of 
endogenous or transplanted cells offers an attractive approach to localized, sustained 
delivery of therapeutic proteins such as growth factors because the major limitation of 
protein therapy has been the necessity to maintain therapeutic concentration sufficient to 
induce the desired therapeutic response for the desirable length of time. [23, 24] Matrix-
based gene transfer can provide retention of pDNA as well as therapeutic protein 
produced by delivered pDNA within the target tissue. In addition, this local delivery 
system can overcome low levels of transfection following systemic plasmid injections as 
well as prompt degradation of naked DNA in the circulation. 
Matrix-based approaches to gene delivery have been categorized into two 
mechanisms: polymeric encapsulation and substrate-mediated delivery. [25] In 
encapsulation systems, vectors are generally homogeneously incorporated th oughout the 
3D structure of the matrix during fabrication. [19] Vector release is controlled by 
diffusion, hydrolytic/proteolytic degradation, or a combination of both mechanisms 
depending on the physical and chemical properties of the vector. In the substrate-
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mediated approach, vectors are immobilized to the surface of the matrix after fabrication. 
[17, 26] Both approaches have shown improved transfection efficiency, transgene 
expression, and therapeutic efficacy relative bolus administration. However, combination 
strategy combining both methods should be considered for the ultimate application to 
create complex tissue structures.  
3.1.1. Vector encapsulation systems 
The main potential of encapsulation systems is the ability to provide continuous 
vector release and uptake by the target cells and to increase the local vector concentration 
retained within the target tissue relative to intravenous injection or bolus administration. 
[89] Biomaterial matrices for gene delivery can be divided into tw classes: hydrogels 
and porous sponges. Hydrogels are prepared in aqueous solution by physical, ioni or 
chemical crosslinking of hydrophilic polymers at ambient temperature for relatively short 
times, which allows pDNA or vector complexes to be homogeneously incorporated 
during gelation under physiological conditions. Hydrogel degradation may occur by 
cellular proteolytic activity or chemical hydrolysis. Due to the relatively large size of 
pDNA and lipoplex/polyplex vectors compared to the mesh size of mosthydrogels, 
degradation generally has a strong influence on the vector release kinetics and may be 
influenced by changes in network crosslinking density, polymer molecular weight, 
concentration, etc. Hydrogels have been particularly attractive for vector encapsulation 
based on their ability to be injected by minimally invasive methods and crosslinked in 
situ, allowing the matrix to conform to irregularly sized defects. 
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On the other hand, porous scaffolds fabricated from relatively hydrophobic 
degradable polyesters have also been considered as useful vector encapsulation ystems. 
These materials offer an increased range of mechanical properties and can support rapid 
colonization of endogenous cells throughout the 3D structure. [90-92] Although a variety 
of techniques are available for fabrication of porous sponges, the gas-foaming method 
developed by Mooney’s group that can be performed at room temperature without the use 
of organic solvents has been almost exclusively used for gene deliv ry applications. [93, 
94] 
3.1.1.1. Natural polymer hydrogels 
Natural polymer matrices formed by collagen, gelatin, alginate, or recombinant 
silk-elastinlike proteins have been of interest in the application of gene delivery because 
of their generation in mild crosslinking conditions and their intrinsic degradability by 
cellular proteolytic enzymes. [95] Bonadio and colleagues first describ d matrix-based 
gene delivery using collagen gels loaded with naked pDNA, terming these constructs 
gene activated matrices (GAMs). [18, 96] GAMs loaded with pDNA encoding bone-
growth promoting proteins such as bone morphogenetic protein-4 (BMP-4) and 
parathyroid hormone (PTH) were implanted in critical size defects in the adult rat femur 
and shown to promote significantly increased bone formation relative to control matrices 
without pDNA. This paradigm (naturally-derived hydrogel/naked pDNA) has been 
replicated and shown to be effective in several other in vivo models including dermal 
wounds, ischemic ulcers, and skeletal muscle injury. [97-99] Ochiya used PCR to 
demonstrate that pDNA injected intramuscularly with atelocollagen remained 
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predominantly localized at the site of administration and was only minimally detected in 
other tissues. [100] Although naked pDNA is essentially ineffective for in vitro 
transfection, GAMs using naked pDNA have been effective in this and other in vivo 
studies. However, it is important to note that relatively high (0.5-1mg/matrix) loading 
concentrations were required as shown in Table 3.1. Although prolonged transgene 
expression ranging from a few weeks to months has been achieved using GAMs, the 
release property of collagen-based GAMs has seldom been investigat d. So, it is unclear 
how their release kinetics influences the level and period of transgene expression. A few 
studies reported that 20% burst release of the initial, loaded DNA amount was observed 
within 30min in the case of collagen matrix at the low concentration. [98, 100, 101]  
To reduce the amount of DNA required within GAMs and optimize releas 
kinetics, several studies employed viral or nonviral vectors to protect naked pDNA from 
rapid degradation by nucleases as well as to provide sustained delivery of pDNA. The 
complexation with vectors was expected to reduce the initial loading quantity of DNA by 
increasing transfection efficiency. In fact,  those studies used relatively small amounts of 
pDNA, for example, using PLL as a nonviral vector enabled successful, localized 
transfection with DNA loading ranging from 2.5-7.5µg per matrix (1-2mg collagen). 
[102] However, a high initial burst (>50%) was still observed regardless of the effort to 




Table 3.1. Collagen GAMs applications 








BMP-4, PTHa 0.5-1mg 
Implantation into bone 
gaps [96] 
Type I bovine 
collagen 
 pMat-1b 1-100mg 











implantation [100, 103] 
Type I bovine 
collagen 
50µg collagen pPDGF A,Bc 1-3mg 
Subcutaneous 
Implantation [97] 








Matrix coating or 
impregnation into PVA 
sponge, followed by 
subcutaneous 
implantation [104] 
abone morphogenetic protein-4 and parathyroid hormone 
bplasmid DNA encoding hPTH1-34 peptide 
cplatelet-derived growth factor A or B 
dthrombospondin 2 
 
Gelatin, a type of natural polymer, has been tested as a gene carrier. Tabata’s 
group focused on cationized gelatin hydrogel as a controlled gene deliv ry system. [105-
108] The positively charged gelatin can electrostatically bind pDNA, and the in vivo 
degradation is mediated by proteolysis and its rate controlled by var ing the 
concentration of glutaraldehyde crosslinker. For example, less crosslinked gelatin 
hydrogel (denoted as hydrogels with 99.7 wt% water content) exhibited faster 
degradation than hydrogel with higher crosslinking density (denoted as hydrogels with 
96.4 wt% water content). [105] The in vivo degradation period of gelatin hydrogels was 
controlled over the time from 7 to 21 days. [105, 106] For cartilage regeneration, gelatin 
was blended with chitosan to improve its mechanical properties as well as provide a 
favorable environment to chondrocytes, then incorporated with pDNA encoding TGF-β1. 
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[109] According to the results of the release test, an initial burst release was observed 
within 3 days and then the DNA release decreased. This release profile probably 
influenced TGF-β1 expression, resulting in a peak value at 8 days of cell culture. Overall, 
pDNA release was well controlled by the degradation of the gelatin or gelatin-chitosan 
scaffold, but this system was only capable of achieving gene expression over a 2 week 
time period due to the rapid degradation of the matrix. 
pDNA has also been incorporated with recombinant silk-elastinlike polymers, 
made of silk-like (Gly-Ala-Gly-Ala-Gly-Ser) and elastin-like (Gly-Val-Gly-Val-Pro) 
blocks, that undergo an irreversible sol-to-gel transition with a ch nge in temperature 
from room temperature to 37°C. DNA release was controlled by varying the condition of 
preparing hydrogels including a change in cure time and polymer concentration. [110-
112] This hydrogel matrix showed controlled delivery of pDNA for over 28 days. In the 
case of hydrogel prepared with low concentration and short gelation time, burst release 
was observed so that less than 70% of initial loaded DNA was lost within 5 days and 
following DNA release was decreased. [110] Interestingly, the lev ls of transfection 
within the tumor were higher than skin transfection and release kinetics became more 
linear as increasing the polymer concentration and crosslinking time. [112] Although the 
silk-elastinlike polymer gels were capable of entrapping viral gene complex as well as 
localizing gene transfer, this type of genetically engineered biomaterial requires high cost 
for production. [112] 
An injectable, agarose-based carrier was able to deliver PLL-DNA complexes to 
skin for wound healing. Gene expression, following the injection of gene complexes in 
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solution, was detected for only 5-7 days, whereas one of the compacted DNAs from the 
agarose hydrogel was prolonged for at least 35 days. [113] Recently, fibrin-based gels 
were tested as delivery matrices in vitro. NIH 3T3 fibroblasts both encapsulated with 
gene complexes and cultured on the fibrin gels, showed prolonged transfection for at least
10 days. [114]  However, burst release still remained an issue, for example, an initial 
burst of 21% and 22% was observed after 4h for pDNA and lipoplexes, respectively. In 
contrast, Kong and colleagues reported well sustained pDNA delivery without an initial 
burst using biodegradable alginate hydrogels. [115] Three different calcium cross-linked 
alginate hydrogels were prepared with varying crosslinking segments of polymers, 
resulting from the introduction of oxidation into alginate chains. Oxidation opened the 
sugar ring of mannuronic acid to form acetal linkages, which were susceptible to 
hydrolysis, and led to a decrease in the MW of alginates. When oxidized alginate 
molecules of different MWs were calcium crosslinked, the resulting hydrogels were 
composed of crosslinks between guluronic acid blocks in the different lengh of alginate 
molecules. The resulting hydrogels contained various crosslinking densities and different 
swelling ratios, and exhibited various degradation rate related to the crosslinking density. 
The DNA release rate was related to the hydrogel degradation rate via concurrent 
physical dissociation via ion-exchange and degradation via hydrolysis. This study 
showed successful revascularization within the connective tissue and muscle in ischemic 
hindlimbs of mice using the most rapidly degradable alginate hydrogel that incorporated 
PEI-pDNA encoding VEGF. Overall, it should be noted that DNA release kinetics was 
well controlled by manipulating two different degradation processes of biomaterials and 
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in vivo gene expression was successful with a relatively small amount of pDNA (100µg 
pDNA/ml hydrogel).  
Hydrogels of naturally-derived polymers, with the exception of gelatin-based 
GAMs have demonstrated sustained gene delivery as gene-activated m trices and 
achieved long-term gene expression up to a few months. However, many of these studies 
resulted in an initial burst release and, when using naked DNA, required h gh loading 
amounts of DNA to induce the desired therapeutic response for the prolonged period. 
Also, due to the nature of the polymers, degradation of matrices composed of natural 
polymers is only mediated by proteolytic enzymes, which limits the ability to regulate the 
release profiles. 
3.1.1.2. Synthetic polymer hydrogels 
The fabrication of synthetic hydrogels has received much attention due to their 
reproducibility, availability, and ease of tailoring the hydrogel physical/chemical 
properties to desired applications. One common strategy for the creation of synthetic 
hydrogels has been the modification of water soluble polymers such as poly (ethylene 
glycol) (PEG) and poly (vinyl alcohol) (PVA) with vinyl end groups and their subsequent 
crosslinking by photo- or redox-initiated free radical polymerization. The degradation 
rate of these hydrogels was controlled by a change in variation crosslink density within 
network, polymer MW, the chemical composition, the degree of polymerization of the 
polyester blocks, and polymer concentration. As a result of hydrogel deradation, DNA 
release was sustained and controlled. [116, 117] Quick and Anseth first proposed the 
potential of a photopolymerized hydrogel as a gene carrier. [118-120] This hydrogel was 
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first introduced by Sawhney and Hubbell, which consisted of a hydrophilic PEG center 
block copolymerized with polylactic acid (PLA) or polyglycolic acid (PGA) and end-
capped with acrylate groups which provide crosslinkable residues. [93, 116] The control 
of DNA release was mediated by a change in polymer type, composition and MW. 
Unfortunately, the reactive free radicals generated by photocrosslinking process 
significantly damaged DNA under typical photoinitiating condition. (Figure 3.1) 
Protection of plasmid DNA from radical attack by condensation with nonviral vectors as 
well as addition of vitamin C as a radical scavenger was investigated. These treatments 
improved percent of DNA detected, especially in the case of DNA protected by either 
protamine sulfate or PEI in the presence of 0.85mM vitamin C. [118, 119] However, 
addition of a radical scavenger affected photopolymerization mechanism, re ulting in less 
crosslinking density within hydrogel network. So, the optimization of vitamin C 
concentration was an issue. 
 
Figure 3.1. Photograph of agarose gel electrophoresis showing conformations of 
plasmid DNA released from dimethacrylated poly(lactic acid)-b-poly(ethylene 
glycol)-b-poly(lactic acid) (PEG-PLA-DM) with 8.5 LA/PLA block  hydrogels in the 
absence of protective additives. First lane is non-encapsulated DNA in a solution of 
degraded polymer, second lane is the released, encapsulated DNA. 
[Reprinted from Journal of controlled release 96 (2004) 341-351, Deborah J. Quick, 
Kristi S. Anseth, DNA delivery from photocrosslinked PEG hydrogels: 
encapsulation efficiency, release profiles, and DNA quality, Copyright (2004) with 
permission from Elsevier B.V.] 
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 Hydrogels photocrosslinked with methacrylated hyaluronic acid (HA) and 
acrylated PEG-derivatives were also investigated. [121, 122] These hydrogels allowed 
release of nonviral gene complexes with various degradation rates influenced by 
hydrolysis and enzymatic degradation (hyaluronidase). DNA releas  showed a burst 
release up to 80% within 2 days, and then dramatically decreased. Chun and colleagues 
increased UV curing time to reduce this event. However, a long exposure to UV 
irradiation damaged DNA, resulting in a change in DNA conformation. [122] In contrast 
to naked pDNA, PEI-DNA complexes incorporated into these hydrogels wre retained 
within the hydrogel during release test. However, the quantity of released DNA reached 
only 14% of the initial loaded DNA at most, while the activity of the complexes was still 
maintained to transfect MCF-7/WS8 cells in vitro. [121] (Figure 3.2) It was assumed that 
there was non-specific interaction of PEI-DNA complexes with the hydrogel. However, 




Figure 3.2. Representative release profiles for cumulative release of DNA complexes 
from HA-PEG gels. Release studies performed in the presence of PBS (a) or 
150U/ml HAase (b). The percentages of PEG and HA in the hydrogel are; 
PEG6:HA1(■), and PEG8:HA1(▲) for mechanically stable gels and PEG2:HA1 (□), 
PEG4:HA2(○), and PEG4:HA4 (∆) for fully degradable gels 
[Reprinted from Journal of controlled release 120 (2007) 233-241, Julie A. Wieland, 
Tiffany L. Houchin-Ray, Lonnie D. Shea, Non-viral vector delivery from PEG-
hyaluronic acid hydrogels, Copyright (2004) with permission from Elsevier B.V.] 
 
Mikos’s group has developed a number of synthetic materials based on fumaric 
acid. [123, 124] These biodegradable materials include poly(propylene fumarate-co-
ethylene glycol) (p(PF-co-EG)), and oligo(poly(ethylene glyco ) fumarate) (OPF), either 
one of which can be applied as an injectable liquid and crosslinked i  situ to form a 
crosslinked network using radical initiators with a poly(ethylene glycol) diacrylate 
(PEGDA) crosslinker. [125, 126] Kasper and others tested DNA release from OPF 
synthesized with the different MW of PEG, 3.5K or 10K. It was found that 80-81% 
dsDNA out of the total loaded DNA was released in a sustained, linear fashion over 45-
62 days in vitro, depending on the degradation kinetics of hydrogels. [127] It was noted 
that degradation kinetics of OPF was the mechanism controlling DNA release kinetics 
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because the molecular size of pDNA is much larger than hydrogel mesh size (e.g., 
~13.6nm for OPF 10K hydrogel). 
In conclusion, the kinetics of DNA release and transfection of intact released 
DNA can be controlled temporarily depending on the degradation properties of 
hydrogels. Controlled release of DNA from degradable polymer matrix over the 
prolonged times can protect DNA from degradation as well as provide consistent or 
elevated levels of DNA within the extracellular environment. However, 
photopolymerization process was detrimental to DNA structural and functional integrity 
and an initial burst was uncontrollable. Using nonviral vectors may be the solution to 
protect DNA from UV exposure and change incorporation mechanism of DNAwithin 
hydrogel network. However, unfavorable interaction of vectors with hydrogel during 
crosslinking was problematic. 
3.1.1.3. Scaffolds 
Relative to hydrogels, porous scaffolds support increased cellular co onization 
throughout the 3D structure and can provide increased mechanical properties required for 
certain applications. Scaffolds offer the structural and functional replacement of damaged 
tissues. In addition to these merits, the delivery of pDNA through localized polymeric 
scaffolds may be an attractive approach to provide an opportunity to control l cal gene 
expression directly in the tissue. Mooney’s group has incorporated pDNA alone or 
polyplex into poly(lactic-co-glycolic acid) (PLGA) scaffolds, which were formed by gas 
foaming techniques, in order to provide the sustained delivery of pDNA over a p iod 
ranging from days to a month. [19, 128] In comparison to the delivery of uncondensed 
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DNA encapsulated into scaffolds, implantation of PLGA scaffolds incorporating 
condensed pDNA (β-galactosidase) via PEI into the subcutaneous tissue of rats resulted 
in a high level of gene expression for the entire 15-week duration of the experiment. In 
comparison to the highest expression level resulting from bolus delivery (direct injection) 
of condensed DNA at the 2-week time point, the results from scaffolds incorporating 
condensed gene complex clearly indicated the importance of a scaffold for sustained 
delivery of condensed DNA with intensified and extended expression of transferred 
genes. [128] Porous multiple channel bridges made from PLGA by the gas foaming 
method, allowed cells to infiltrate through multiple channels as well as to be transfected 
by release of incorporated DNA following bridge implantation when bridge loaded with 
plasmid was implanted into rat spinal cord lateral hemisection. However, in vitro DNA 
release study showed substantial burst release with approximately 75% of DNA within 
the bridge was released during the first day. [129] Furthermore, Shea’s group coated this 
porous multiple channelled PLGA scaffold with ECM components, for example, co lagen 
I, fibronectin and laminin I in order to improve cell adhesion andsubsequent transgene 
expression. [130] In this study, lipoplexes with Transfast were applied and incubated on 
ECM-coated PLG surfaces, in contrast to the previous DNA encapsulation method. 
Although higher levels of transgene expression overall were reported aft r spinal cord 
implantation due to an increase in the number of cells adhered to the scaffold, the fast 
release within an hour in a burst stage (about 69.3% release of lipoplexes) was still 
observed and transgene expression lowered after one week. In fact, the release kinetics 
for poly(α-hydroxy acids)-based scaffolds displayed an initial burst releas and the acidic 
 
environment during scaffold degradation caused plasmid conformation change from the 
supercoiled form to nicked and linear conformations ver time. (Figure 3.3) 
Figure 3.3. In vitro DNA release kinetics and agarose gel electrophoresis. (A) 
Cumulative DNA release from scaffolds loaded with 200, 400, or 800µg of plasmid 
(n=4 per dose) (B) Image of an agarose gel containing DNA released 
at different times. Lane 1: molecular weight marker, Lane 2: unincorporated 
plasmid, Lane 3-7: DNA released at days 1, 3, 7, 14 and 21, respectively.
[Reprinted from Biomaterials 30 (2009) 394
Rieux, Marina Zelivyanskaya, Stuart R. Stock, William L. Lowe, Jr., Lonnie D. 
Shea, Layered PLG scaffolds for 
permission from Elsevier Ltd.]
 
3.1.2. Substrate-mediated delivery
Substrate-mediated gene delivery or reverse transfection immobilizes pDNA or a 
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transgene to target cells that adhere to thesubstrate. [132] This delivery system can avoid 
mass transfer limitations of bolus administrations. Novel cDNA microarrays for high-
throughput transfection of adherent cells have been described based on this concept. 
[133] There are two methods to immobilize gene complexes. One isspecific 
immobilization and the other is nonspecific immobilization. [86, 134] Specific 
immobilization was employed through the reaction between antigen and antibody or 
biotin and avidin. Levy and colleagues investigated localized gene transduction from 
collagen gels within a 50µm surrounding zone by use of the binding affinity between 
avidin and biotin. [75] Basically, collagen gel was incorporated with avidin (avidin-
collagen gel) and adenoviral vector was incubated with biotinylated antihexon IgG, and 
then two solutions were combined to produce the localized viral gene delivery system. 
Although there is still a risk of viral vector use, this study addressed site-specific 
localization and localized transgene expression in comparison to the bolus administration 
which caused distal side-effects. [75] Not only binding of viral complexes but also 
nonviral DNA complexes was developed, based on specific immobilization. Both 
biotinylated polylysine and PEI formed complexes with plasmid encoding for luciferase, 
and then they were tethered to the Neutravidin (NA)-containing surface. The 
immobilization varied with the number of biotin residues per either vectors or complexes. 
For polylysine complex, increasing the number of biotin groups present on polylysine 
increased luciferase activity. [135] Furthermore, using spatially p tterned NA-bound HA-
collagen hydrogel with topographic features allowed binding of biotinylated complexes 
as well as oriented cell growth. [56, 136] However, increasing the number of biotin 
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residues on the complex induced strong avidin-biotin binding between the complex and 
the surface, which interfered with gene complex release from the atrix, which lowered 
transfection efficiency. [135]  
In studies based on nonspecific immobilization, either lipoplexes or polyplexes 
were immobilized by surface adsorption. The main issue with this appro ch is the affinity 
of the DNA complex for the substrate that achieves a delicate balance between 
immobilization and release. Shea’s group is one of the major groups to have focused on 
DNA delivery via a substrate-mediated approach. To enhance cell attachment and DNA 
cellular internalization, various serum and adhesive molecules such as fetal bovine serum 
(FBS), bovine serum albumin (BSA), fibronectin, collagen and laminin were applied to 
the polystyrene culture plate surface. [23, 134, 137] Substrate binding of DNA was 
independent of the type of proteins except for laminin; however, fibronectin coating 
supported the best cellular internalization and gene expression. [23] The type of gene 
complex and molecular interactions between the complex and substrate also affect 
transgene expression. For example, polyplexes with PEI increased gen  expression on 
serum-coated substrates, while lipoplex delivery with Lipofectamine exhibited equivalent 
quantities delivered from the control group (no serum modification). These differences 
may result from the different properties of vectors such as zeta-potential, size, chemical 
composition, etc. [137] As continuing studies, the substrate-mediated delivery approach 
via nonspecific complex immobilization and adhesive proteins coating was extended to 
biomaterial scaffolds such as PLG. [138] Especially, patterned PLG substrates, which 
were prepared with 50% FBS and pNGF-PEI complex immobilization, were employed to 
 44
lead neurite extension (dorsal root ganglia) by co-culture over HEK293T cells transfected 
on the PLG substrates. [139] In conclusion, DNA or gene complex-immobilized substrate 
served to increase transfection efficiency and the number of transfected cells with a 
relatively small amount of DNA required. Especially, the result of spatially patterned 
surfaces suggested the selective transfection of cells adhered on the substrate which is 
aligned along the patterns. However, in some cases, burst release was still observed 
within a few hours. [138] In addition, although there was no significant difference in 
quantities of DNA binding onto either hydrophilic or hydrophobic substrates, transfection 
efficiency was significantly increased at the hydrophilic surfaces. [140, 141] Finally, the 
substrate-mediated approach has not been widely studied in vivo, where exposure of 
superficial DNA/gene complexes to enzymes in biological fluids may significantly affect 
their activity. 
3.2. Conclusions 
The incorporation of DNA into biomaterial matrices may provide an improved 
alternative to bolus gene delivery. Both vector encapsulation systems and substrate-
mediated systems have been developed to improve the transgene expression. Figure 3.4 
summarizes the approach of two types of biomaterial matrices for localized gene 
delivery. As vector encapsulation systems, hydrogels and porous scaffolds were 
evaluated for their release kinetics and localization of gene expression. Overall, 
encapsulation systems exhibit temporal control of DNA release kinetics depending on the 
degradation properties of hydrogels whereas the initial burst release still remains an issue 
to be solved. In natural polymer case, despite successful in vivo results, it still required 
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high loading amounts of DNA to induce the desired therapeutic response for prolonged 
periods. Also, enzymatic degradation can be another limitation to control DNA release 
kinetics. On the other hand, synthetic polymer-based hydrogels can be prepared with 
various types of polymerization/crosslinking in the presence of DNA, resulting in various 
release profiles. However, DNA integrity can be damaged depending on the crosslinking 
mechanism. Although poly(α-hydroxy acids)-based scaffolds are made of materials such 
as PLGA already used in FDA-approved clinical applications and their preparation and 
modification have been well known, the initial burst release and the acidic environment 











Figure 3.4. Schematic representation of biomaterial matrices for localized gene 
delivery of DNA-based therapeutics using a nonviral DNA delivery vector: (a) 
Vector encapsulation systems and (b) Substrate-mediated delivery 
 
Following the substrate-mediated delivery mechanism, direct contact of DNA or 
gene complex with cells adhered to the gene transfer substrate significantly improved cell 
transfection by use of the small quantities of DNA, resulting from the elimination of the 
undesirable interactions with ECM and serum proteins. Especially, the selective 
transfection of cells adhered on the substrate which is aligned along the pattern suggests 
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the potential of spatially controlled gene delivery. However, DNA release in the studies 
to date was uncontrolled. Especially in the case of adsorption of DNA onto PLG scaffold-
based substrate, the porous scaffold-induced burst release observed within a few hours. 
And it seemed that only 2D patterned structure has been studied. Taken together, gene 
delivery system requires several factors including material composition and fabrication 
compatible with pDNA, easily controllable degradation profiles avoiding the initial burst 
release, and direct contact with targeting cell/tissue to remov  the environmental barrier 
to delivered DNA. The application of biomaterial matrices can potentially regulate the 
time period of gene expression by manipulating the degradation rate of biomaterials. In 
addition, this application can target tissue and organ sites to be transfected where the 
biodegradable polymer matrix is implanted or injected. Furthermore, spatial patterning 
combined with hydrogel controlled gene delivery system may be useful in regenerating 





METHODS FOR GENE COMPLEX STABILIZATION DURING 
LYOPHILIZATION AND pDNA QUANTITATION  
 
Abstract 
The investigation of matrix-based gene delivery requires effective methods for: 1) 
concentrating gene complexes without causing DNA damage or reducing transfection 
efficiency and 2) measuring the concentration of pDNA after polyplex/lipoplex 
formation. The first set of studies reported in this chapter examined the effects of varying 
polyethyleneimine (PEI) N/P ratio, sucrose/glucose cryoprotectants, and sugar/DNA 
mass ratio on the transfection efficiency of PEI (polyplex) and XtremeGene (XG, 
lipoplex) nonviral vectors after lyophilization. In order to measure pDNA release from 
hydrogel matrices, it was essential to develop a decomplexation method that enabled 
recovery of DNA condensed by nonviral vectors. The efficacy of various decomplexation 
reagents such as pH12 TE buffer or 120mg/ml sodium tripolyphosphate (STP) was 
investigated. STP treatment was shown to provide the highest pDNA detection levels 
(relative to non-complexed controls) from both PEI and XG complexes. Finally, a reverse 
transfection study was performed to provide initial proof of principle for the transfection 
efficacy of hydrogel-encapsulated nonviral vectors in the presence of serum. 
 
Keywords: cryoprotectant, decomplexation, lyophilization, N/P ratio, reverse 




Since the capability of lipoplexes and polyplexes for DNA delivery has attracted 
attention, one major concern is to maintain their long-term physical tability because 
these nonviral vectors readily aggregate in liquid, resulting in reduced transfection 
efficacy. [142, 143] Early studies in systemic gene delivery demonstrated that unless the 
injection was performed immediately after the complex preparation, it was necessary to 
develop a stabilization method, maintaining transfection efficiency after long-term 
storage. When biomaterial matrices such as hydrogels incorporate or encapsulate DNA or 
a gene complex, the gene complexes must be concentrated in order to obtain suitable 
loading amounts. A lyophilization process was developed to provide the prolonged 
stability of DNA or DNA complex. [144, 145] The process is an economical approach to 
maintain the efficacy of DNA-based therapeutic products during transportation and 
storage. The lyophilization process involves freezing and drying stresses that may cause 
damage to DNA. Naked DNA, without protection by cationic lipid or p lymer vectors, 
was degraded upon freezing, called cryolysis, resulting in DNA strand breaks. [146] 
Condensation of DNA with cationic lipid or polymer seemed to maintain the complex 
stability better than naked DNA during a rapid cooling process, for example, snap-
freezing in liquid nitrogen or ethanol and dry ice. However, DNA strand breakage was 
still observed as well as an increase in size of complexes due to aggregation, which 
resulted in a decrease in transfection efficiency. [147] Therefore, the addition of a 
stabilizing component or cryoprotectant, for instance, sugars, was investigat d to prevent 
aggregation during freezing and to provide protection during dehydration. [148]  
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Sugar protection can be explained by three mechanisms; glassy mtrix formation, 
particle isolation during the freezing process, and water replacment by sugars. [144, 145] 
As a cooling process lowers the temperature, sugars readily form a glassy structure able 
to immobilize complexes within this matrix and eventually prevent complex aggregation. 
The glass transition temperatures (Tg) of various sugar types showed that sugars 
possessed high Tg values in the range of approximately 60 °C to 78°C except for glucose, 
which explained the glassy state during freeze drying. (Table 4.1) [149] However, 
glucose fully protected transfection activity and size even though it is in therubb ry state. 
Also, a change in the disaccharide concentration affected the preservation of transfection 
activity, despite both samples maintaining the glassy state. So, glassy matrix formation 
alone was not sufficient to explain the protective mechanism. Since transfection 
efficiency is related to complex particle size, the prevention of aggregation is critical 
during the lyophilization process. Aggregation can happen during freezing because gene 
complexes are concentrated into the unfrozen fraction of a solution. It may be essential to 
isolate different components within a sugar matrix. [150] For example, although PEG 
does not have a measurable Tg [149] and is known to crystallize during lyophilization, 5% 
PEG (MW8000) was shown to preserve relatively small gene complex siz s and high 
transfection efficiency among the tested conditions. (Table 4.1) [149] The effect of PEG 
on the particle size was extended to the study of PEGylation effects on the complexes. 
[151] The water replacement mechanism can be explained by hydrogen bond formation 
between sugars and lipoplexes. The water replacement hypothesis was tudied by John 
and Lois Crowe over more than two decades; demonstrating that sugars serve a  a 
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substitute for structural water associated with lipoplex surfaces during dehydration. [148, 
152, 153] Regardless of the relative contributions of these mechanisms, evidence to date 
suggests that lyophilization with an optimal amount of cryoprotectant might be applicable 
to the stable concentration of gene complexes. However, the choice of cryoprotectants 
would be critical due to the different protection properties. Furthermore, it was found that 
the sugar/DNA ratio appeared to be the critical factor and an isotonic sugar solution 
should be prepared at the concentration only sufficient to protect, for examples, 5% 
glucose, 5% dextrose, 10% sucrose, etc. [150] Hydrogel compositions for gene delivery 
in this study is based on matrix-based gene delivery, which requires the effective method 
to concentrate the desirable amount of DNA without damage to DNA as well as a change 
in transfection efficiency. Since lyophilization with 5% glucose or 10% sucrose showed 
the potential to stabilize gene complexes for a long-term period, the influence of those 
cryoprotectants on the transfection efficiency and DNA stability of initial nonviral gene 
complexes should be considered before the investigation of transfection fficacy of genes 
mediated by a hydrogel matrix. Therefore, the first objectiv  of these studies was the 
development of a lyophilization method for PEI (polyplex) or X-tremeGene (lipoplex) 
vectors incorporating a plasmid encoding green fluorescent protein (pGFP) as an easily 
assayed gene product. The condensation of DNA during complexation with cationi  
materials also substantially reduces its accessibility to DNA binding dyes required for 
pDNA quantitation. In fact, signal reduction from DNA-binding dyes hascommonly 
been used in the gene therapy literature as an assay for the efficacy of complex formation. 
In order to effectively measure concentrations of nonviral gene complexes (particularly 
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following release from matrices), various strategies for decomplexation were investigated 
including treatment with heparin, addition of sodium tripolyphosphate or SDS. [118, 154] 
The PicoGreen DNA-binding dye that exhibits fluorescence enhancemet selectively 
after binding double stranded DNA was used to measure the efficacy of decomplexation 
relative to naked DNA controls. Finally, as proof of principle, a preliminary “reverse 
transfection” experiment was performed in which the transfection efficiency of PEI-based 
polyplexes lyophilized on the culture substrate was compared to conventional bolus 
addition of vector to the culture medium in the presence of serum.  
Table 4.1. Glass transition and crystal melt temperatures for DMRIE-C-DNA 




Tg (°C) Tm (°C) 
PEG 8000 
1 - 55.0 
5 - 55.7 
Hydroxyethyl starch 
1 75.2 - 
5 71.2 - 
Mannitol 
1 - 161.8 
5 - 162.4 
Sucrose 
1 59.9 - 
5 61.8 - 
Trehalose 
1 67.1 - 
5 69.5 - 
Lactose 
1 67.1 - 
5 77.5 - 
Glucose 
1 2.2 - 
5 7.0 - 
[Reprinted from Journal of pharmaceutical sciences 89 (2000) 682-691, S. D. Allison, 
T. J. Anchordoquy, Mechanisms of protection of cationic lipid-DNA complexes 
during lyophilization, Copyright (2000) with permission from Wiley-Liss, Inc. and 
the American pharmaceutical association]  
 
4.2. Materials and methods 
4.2.1. Materials 
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Branched PEI (b-PEI; Aldrich, MW 25kDa), fibronectin (0.1% solution from 
bovine plasma), and paraformaldehyde and antibiotics (10000I.U. penicillin- 10000µg/ml 
streptomycin solution) were purchased from Sigma-Aldrich Co (St. Louis, MO). b-PEI 
was diluted in water and syringe-filtered. Tryptone, yeast extract, agar, D(+)-sucrose 
(biochemical grade), D(+)-glucose (anhydrous), ethidium bromide (EtBr), and water 
(DNase-, RNase- and Protease-free) were obtained from Acros Organics (NJ, USA). 
Sodium chloride, sodium tripolyphosphate (STP) and sodium dodecyl sulfate (SDS) were 
from Fisher Scientific (NJ, USA). A plasmid vector encoding Monster Green Fluorescent 
Protein under a CMV enhancer promoter and an ampicillin resistance gen  (pGFP), 
Triton® X-100 (molecular biology grade), agarose (LE, analytical grde), blue-orange 6x 
loading dye, and 1kb DNA ladder were purchased from Promega Corp (Madison, WI). 
DMEM/F12 (50/50, 1x) and 10000I.U. penicillin/10000µg/ml streptomycin stock 
solution were obtained from Mediatech. Bovine growth serum (BGS) was from Hyclone 
(Logan, UT). Opti-MEM (Gibco®), fluorescein diacetate (FDA), pro idium iodide (PI) 
and 4'-6-Diamidino-2-phenylindole (DAPI), and DH5αTM chemically competent E. coli 
were obtained from Invitrogen Corp. EndoFree plasmid Maxi and Mega kits were 
purchased from Qiagen. (Valencia, CA) X-tremeGene (XG) was donated by Roche 
molecular biochemicals (IN, USA) and served as a model cationic l pid. XG is designed 
and optimized for transfection and high-level protein expression in HeLa, NIH 3T3, Hek 
293 cells, or other mammalian cells.  
4.2.2. Transformation of plasmid into chemically competent E. coli and DNA 
purification 
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pGFP was transformed into DH5α chemically competent E. coli by heat shock 
according to the manufacturer’s protocol. Transformed E. coli was spread on pre-warmed 
LB-agar plates (15g/l agar) containing 100µg/ml ampicillin (LB media: 1% Tryptone, 
0.5% yeast extract, and 1% sodium chloride, autoclaved) by use of a metal spreading bar 
that was cleaned with ethanol and flame-sterilized between each use. As a control , non-
transformed E. coli were also plated on LB-agar plates without ampicillin to ensure that 
only transformed cells grew in the ampicillin environment. After overnight incubation in 
a 37°C incubator, a single colony was picked from a freshly streaked sel ctive plate and 
inoculated in a 4ml or 8ml LB starter culture containing the 100µg/ml a picillin for 
EndoFree plasmid Maxi or Mega kits, respectively. Larger scale ultures were inoculated 
and plasmid purified using either EndoFree plasmid Maxi or Mega kits according to the 
manufacturer’s instructions depending on the required yield of purified DNA. DNA 
concentration was quantified by UV absorbance (Beckman, DU®640B 
spectrophotometer) at 260 nm. Agarose gel electrophoresis and the A260/280 ratio were 
used to verify DNA purity and quality. 
4.2.3. Optimization of conventional transfection 
To determine the optimal condition for gene complex formation, the transfection 
efficiency of freshly prepared complexes of pGFP with either b-PEI or XG was 
investigated. For PEI complexes, transfection efficiency was compared between 
complexes prepared at N/P ratios of 5 and 7.5. For conventional bolus transfection, PEI 
was gently mixed with 2µg pGFP, in sterile, deionized water (70µl total volume) at 
nitrogen-to-phosphate (N/P) ratios of 5 and 7.5. The calculation of N/P ratio is described 
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in Appendix A. After mixing, the complex solution was incubated for 30 min at room 
temperature. XG served as a model cationic lipid. It was used for transfection according 
to manufacturer’s protocol. Briefly, two separate suspensions of XG reagent and 2µg of 
pGFP were prepared in Opti-MEM and then mixed together. The massratio of XG 
reagent to DNA was kept at 5:1. NIH 3T3 fibroblasts were routinely cultivated in 
DMEM/F12 with 10% bovine growth serum (BGS) and 1% antibiotics. 1×105 cells per 
well of NIH 3T3 fibroblasts were seeded in 12-well plates one day before the transfection 
experiment to achieve the optimal cell density (50-70 % confluence) for transfection. 
Serum-containing culture medium was replaced with fresh serum-free media, after two 
rinses with serum-free media. After addition of each complex, the plat s were incubated 
for 6 hours, then the medium exchanged with serum-containing culture mediu . At 24 
and 48 hours post-transfection, the cells were fixed with 4% paraformaldehyde and 
stained with DAPI to identify all cell nuclei. Digital fluorescent image analysis was 
performed to quantify transfection efficiency as the ratio of GFP+ to total cells.. Freshly 
prepared complexes with PEI and XG were designated FC PEI and FC XG, respectiv ly. 
4.2.4. Effect of various cryoprotectants on the in vitro transfection efficiency  
Both 10% w/v sucrose and 5% w/v glucose were evaluated as cryoprotectants in 
this study and the volume of cryoprotectant to be added was fixed to 10% v/v of total 
complex volume. Briefly, PEI (N/P=5 and 7.5) was mixed with 2µg pGFP in sterile, 
deionized water (90% of total volume=63µl) and incubated at 37°C for 25 minutes. After 
complexation, 7µl of cryoprotectant solution was added (total volume=70µl) and 
incubated at 37°C for 5 minutes. In this case, either 7mg sucrose or 3.5mg glucose were 
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added to each complex, respectively. Since XG complexes were prepared in different 
volume from PEI complexes, two different addition methods were compared; one method 
was the addition of cryoprotectant at the same sugar/DNA ratio as used for PEI/pGFP 
complexes. That is, either 7mg sucrose or 3.5mg glucose were added to each complex. 
On the other hand, either 10% w/v sucrose or 5% w/v glucose were evaluated, for 
example, either 20mg sucrose or 10mg glucose were added to each complex sine the total 
volume of XG complex was 200µl. Complexes were rapidly frozen in dry ice/ethanol and 
immediately lyophilized. For transfection experiments, lyophilized complexes 
(designated LC PEI and LC XG) were resuspended in the same volume of sterile, 
deionized water for PEI complex and Opti-MEM for XG complex as before drying and 
used to transfect fibroblast cultures as described above. Complexes lyophilized without 
the addition of a cryoprotectant were prepared as negative controls. Transfection 
efficiency was analyzed as described above.  
4.2.5. Gel retardation assay 
To demonstrate efficient and stable complexation, a gel retardation ssay was 
performed. The complexes were electrophoresed on a 1% (w/v) agarose el containing 
0.5µg/ml of EtBr. DNA was visualized with a UV illuminator (Alpha Innotech 
FluorChemTMSP) and Alpha Ease FC software (version 4.1). 
4.2.6. Decomplexation of gene complex 
The condensation of DNA with nonviral vectors blocks interactions with DNA-
binding dyes and interferes with quantifying the amount of DNA. Since there was no 
optimal decomplexing method, various reagents such as pH12 TE buffer, and STP 
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(120mg/ml) were compared to dissociate DNA from either PEI or XG complexes. In 
addition, 0.2mM, 20mM, 34.7mM (1%) and 1M SDS and 0.1% Triton X-100 were 
evaluated as decomplexing agents only for the XG complexes. Increasing pH causes 
deprotonation of nonviral vectors and their dissociation from DNA. [55] Excessive 
amounts of STP and SDS electrostatically interact with cationic vectors, which results in 
the dissociation of DNA. Triton X-100 is a well known detergent and lysis buffer, which 
solubilizes lipids. A volume of 50 µl of gene complex solution and each de omplexing 
solution were mixed and incubated at room temperature for 30 minutes. Th  amount of 
DNA was measured by PicoGreen assay. 
4.2.7. PicoGreen quantification of DNA 
PicoGreen® is a fluorochrome that selectively binds dsDNA and allows efficient 
DNA quantitation with high sensitivity.  A standard curve encompassing the range of 
expected sample concentrations was prepared from a stock solution of naked pGFP. 
Standards and decomplexed samples were assayed according the manufacturer’s protocol. 
Briefly, 100µl samples of pDNA/decomplexation agent were mixed with 100µl 
PicoGreen working stock and analyzed with a Bio-TEK synergy HT multimode 
microplate reader with KC4 software using 480 nm excitation and 520 nm emission 
wavelengths. Duplicate or triplicate samples were averaged and normalized for 
background readings obtained from samples without pDNA.  
4.2.8. Reverse transfection in the presence of serum 
Transfection complexes containing PEI (N/P 7.5) or XG with 2µg pGFP were 
prepared in the same manner as the lyophilized complex. The resulting complexes were 
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pipetted onto the fibronectin (25µg/ml)-coated or uncoated lab-made wells (about 24well 
size) on the Petri dish for bacteria culture. After addition of complexes, the Petri dish was 
snap-frozen with dry ice and ethanol bath and freeze-dried overnight. After lyophilization, 
NIH 3T3 fibroblasts were seeded on the wells on the Petri dish (1×105 cells/well) and 
transfection was carried out in the presence of 10% BGS without any reatments nor 
medium renewals. Two days after transfection, samples were stained with 1 µM 
fluorescein diacetate/2.5 µM propidium iodide (FDA/PI), rinsed with PBS, visualized by 
fluorescence microscopy (Zeiss Axiovert 200), and digitally imaged to assess cell 
viability and morphology. Transfection efficiency was compared with conventional 
transfection performed by the direct addition of resuspended lyophilized complexes to 
pre-seeded cells in the presence of serum. 
4.2.9. Statistical analysis 
Statistical analysis was performed by single factor ANOVA using Tukey's HSD 
method for post hoc comparisons, where p values <0.05 were considered to be 
statistically significant. All results were expressed as mean ± standard deviation. 
4.3. Results 
4.3.1. Optimization of transfection condition 
Figure 4.1 shows the transfection efficiency of of freshly prepared nd lyophilized 
complexes of pGFP with b-PEI.  Overall, PEI complexes prepared at N/P 7.5 exhibited 
significantly better transfection than at N/P 5, resulting in more than threefold increase in 
the percentage of GFP+ cells. Relative to freshly prepared complexes at both N/P ratios, 
lyophilization caused a significant decrease in transfection for all conditions, resulting in 
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3.14% (±1.9), 9.47% (±3.44) and 9.99% (±3.54) for N/P5 PEI, N/P7.5 PEI and XG 
complexes at 10% w/v sucrose condition. Although there was no significant difference in 
transfection efficiency of LC PEI at N/P 7.5 prepared with 5% glucose and 10% sucrose, 
lyophilized complex with 10% w/v sucrose exhibited higher average values of 
transfection efficiency. 
 
Figure 4.1. Comparison of transfection efficiency of PEI-pGFP complexes at various 
N/P ratios; freshly prepared complex (= FC), lyophilized complex with 5% w/v 
glucose (= LC, 5% glucose), lyophilized complex with 10% w/v sucrose (= LC, 10% 
sucrose), p<0.05, letters represent the significant difference between groups 
 
The transfection efficiency of XG complexes under two conditions wa  shown in 
Figure 4.2. In one condition, maintaining constant sugar:DNA mass ratio was maintained, 
while in the other condition a final sugar concentration comparable to the conditions used 
for PEI-based complexes was used. Lyophilization had no significant influence on the 
transfection efficiency of XG complexes. As a result, although freshly prepared PEI 
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complexes at 7.5 N/P ratio provided significantly higher transfection of 16.54% (±3.55) 
than XG (10.34±3.42%), XG-based complexes achieved similar transfection fficiencies 
after lyophilization to freshly prepared one. 
 
Figure 4.2. Transfection efficiency of XG-based complexes with various preparation 
conditions; freshly prepared XG-pGFP complex (= FC XG), lyophilized XG-pGFP 
complex with 3.5mg glucose (= LC XG, 3.5mg glucose), LC XG with 5% w/v glucose 
(10mg) (= LC XG, 5% glucose), LC XG with 7mg sucrose (= LC XG, 7mg sucrose), 




Figure 4.3. Relative transfection efficiency of lyophilized complexes over freshly 
prepared complexes, p<0.05, * represents significant difference in comparison with 
freshly prepared complex 
Under our conditions, N/P=7.5 PEI complexes and XG complexes lyophilized 
with 10% w/v sucrose exhibited the closest transfection efficiency relative to freshly 
prepared complexes. However, LC PEI retained only 57.26% of FC PEI transfection 
efficiency and was not as efficient as LC XG in fibroblast transfection. (Figure 4.3) 
Representative photomicrographs of fibroblasts transfected with these polyplexes and 
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 (g)      (h) 
Figure 4.4. Transfection of NIH 3T3 fibroblasts after administration of freshly 
prepared (a, b) PEI-pGFP complex and (c, d) XG-pGFP complex, and lyophilized 
(e, f) PEI –pGFP complex and (g, h) XG-pGFP complex with 10% w/v sucrose; 
Green fluorescent images of pGFP transfected fibroblasts on the left and blue 
fluorescent images of DAPI nucleic acid stained fibroblasts on the right 
 
4.3.2. Decomplexation of gene complex 
The result of the efficacy of pH12 TE buffer and 120mg/ml STP for 
decomplexation is shown in Figure 4.5. When assayed in pH 7.4 TE buffer without 
decomplexation, less than 10% of the original amount of DNA could be detected in both 
PEI and XG complexes. Following exposure to pH12 TE, 77.74 % (±8.44) and 77.94 % 
(±8.30) of initial DNA was measured from FC PEI and LC PEI, respectively. However, 
in the XG complex case, 44.33 % (±5.99) and 40.92 % (±3.37) of initial DNA was 
detected from FC XG and LC XG, respectively. In comparison with pH12 TE treatment, 
120mg/ml STP treatment exhibited significantly better decomplexation, especially, 93.03 % 
(±2.06) and 92.65 % (±0.41) detected amount from FC PEI and LC PEI, respectively. 
Although there was significant improvement in decomplexing DNA from XG complexes, 
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DNA amounts detected were still lower than the amounts from PEI complexes, 66.18 % 
(±4.64) and 55.14 % (±1.09) of initial DNA from FC XG and LC XG, respectively. 
 
Figure 4.5. The percent amount of DNA measured over the naked DNA at pH7.4 as 
control after the various decomplexation treatment, 30 min incubation for 
decomplexation, p<0.05, * and # represent significant difference of each complex 
between pH12 TE treatment and 120mg/ml STP treatment, and significant 
difference between complexes treated with 120mg/ml STP, respectively 
 
The results of agarose gel electrophoresis are shown in Figure 4.6. When the 
complexes were treated with pH12 TE, no appearance of retarded DNA bands was 
observed. In the case of STP treatment, DNA dissociated from both PEI and XG 
complexes still remained in the supercoiled conformation. However, th  majority of 
DNA dissociated from both FC PEI and LC PEI was retained in or near the gel w ll and a 
very small portion of the supercoiled conformation was detected. Although PEI 
effectively transfected NIH 3T3 fibroblasts in Figure 4.4, LC PEI exhibited 57.26% of 
FC PEI transfection efficiency in Figure 4.3.  
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(a)      (b) 
Figure 4.6. Images of an agarose gel electrophoresis to show stability of plasmid 
DNA before and after decomplexation with (1) pH12 TE treatment for 30min-
incubation and (2) 120mg/ml STP treatment for 4 hour-incubation; Decomplexation 
of (a) PEI-pGFP complexes and (b) XG-pGFP complexes, Lane 1: 1kb DNA ladder 
 
To improve the decomplexation method and recover more DNA dissociated from 
XG complex, the decomplexing efficacy of various concentrations of SDS and 0.1% 
Triton X-100 were investigated. (Figure 4.7) Unfortunately, neither method worked as 
efficiently as 120mg/ml STP solution. DNA was able to be detected only when 0.2mM 




Figure 4.7. The efficiency of various decomplexation methods for XG-mediated 
complexes, 30 min incubation for decomplexation, p<0.05, letters represent the 
significant difference between treatments 
 
 As shown in Figure 4.7, under our experimental condition, 120mg/ml STP was 
the most efficient decomplexation method while the detected DNA amounts were only 
about 66% and 55% for FC XG and LC XG, respectively. To improve its decomplexation 
efficacy, various incubation times were employed. As shown in Figure 4.8, increasing 
incubation time helped to dissociate DNA and increased DNA amount detected by 
PicoGreen assay. Especially, almost 90% DNA were recovered from both FC XG and LC 
XG at 4 hour incubation of XG complexes.   
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Figure 4.8. The effect of incubation time on decomplexation of XG-mediated 
complex with 120mg/ml STP, p<0.05, * and # represent significant difference 
relative to 0.5 hr incubation FC XG and LC XG, respectively 
 
4.3.3. Reverse transfection 
In reverse transfection with LC PEI, transfection and GFP expression  was 
observed even in the presence of 10% serum whereas conventional bolus addition of 
complexes to the culture medium achieve minimal transfection or GFP expression. Cells 
cultured over LC PEI adsorbed dish showed transfection for one day while the 
conventional delivery of LC PEI exhibited almost zero transfection. Transfected cell 




(a)      (b) 
Figure 4.9. NIH 3T3 fibroblasts transfected by PEI complex (a) in the conventional 
delivery method and (b) in the reverse transfection method in the pres nce of 10% 
bovine growth serum, cells were cultured on the substrate without fibronectin 
 
In reverse transfection with XG complex, fibronectin coating was applied to the 
Petri dish surface to ensure consistent cell attachment. Uncoated substrate was studied at 
the same time. Relative transfection efficiency of both conventional bolus transfection 
and reverse transfection is shown in Figure 4.10. Without fibronectin coating, slight 
increased cell transfection values were shown in reverse transfection despite no 
significant difference. The presence of fibronectin improved cell attachment to the 
surface and significantly affected transfection efficiency. Reverse transfection of LC XG 
achieved a fourfold increase in the percentage of GFP+ cells on fibronectin-coated 




Figure 4.10. Comparison of the transfection efficiency between conventional bolus 
method and reverse transfection method, performed in the presence of 10% BGS, 
p<0.05, * represents significant difference in comparison with conventional bolus 
transfection with fibronectin (FN) coating on the Petri dish surface 
 
4.4. Discussions 
In these studies, two different N/P ratios of PEI complexes were compared and 
the higher ratio (7.5) found to yield significantly higher transfection efficiency. (Figure 
4.1) The N/P ratio is well known as a critical factor influencing both transfection 
efficiency and cell cytotoxicity. Ratios ranging from 5 to 13.5 have been presented in the 
literature, although the optimal ratio commonly differs among investigators and 
applications. Ferrari and others reported better transfection efficiency in vitro by use of 
linear PEI (ExGen 500) at a 5 ratio that resulted in neutral particle charge, while Boussif 
and colleagues indicated maximal transfection efficiency in the range of 9 to 13.5 ratios. 
[155-157] Overall, when PEI complexes were prepared at higher ratios nd with 
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increasing positive charge, greater levels of cytotoxicity were observed. In the present 
studies, increasing the N/P ratio to 10 resulted in severe cytotoxicity (data not shown).  
Overall, the choice of cryoprotectant did not significantly affect the transfection 
efficiency of lyophilized N/P 7.5 PEI complexes and XG complexes. (Figure 4.1 and 4.2)  
Various studies have investigated the feasibility of lyophilizaton o physically stabilize 
nonviral vectors. [158, 159] Lyophilization requires the addition of cryoprotectants and 
sucrose has been the most widely studied cryoprotectant in the literature. [144, 145, 147, 
149, 150] The addition of sucrose to nonviral gene complexes such as PEI-DNA gene 
complex and various lipoplexes prevented complex aggregation and helped to main ain 
transfection. However, lyophilization process induced the activity loss of each complex 
even in the presence of cryoprotectants in this study. While cryoprotection effectively 
preserved XG complex bioactivity, the transfection efficiency of PEI-based complexes 
was significantly reduced by lyophilization under all conditions. As shown in Figure 4.6, 
reduced amount of supercoiled conformation might affect transfection efficiency of LC 
PEI. 
The protective mechanism of cryoprotectants is still unclear and the preservation 
of transfection is controversially discussed in the literature. Some studies have reported 
an increase or preservation in transfection efficiency after lyophilization, while more than 
30% of transfection activity was lost following simple dehydration. [147, 149] Allison 
and others investigated mechanisms of cryoprotection of nonviral complexes during 
lyophilization. [149] Although glucose had low Tg values (Table 4.1) and complexes 
dried with glucose seemed to be collapsed during drying, their results showed that the 
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particle size and transfection efficiency were well preserved. However, the lowest 
transfection activity with 5% w/v glucose was observed in the present tudies. The 
sugar/DNA ratio has been discussed as a critical parameter. [159] Figure 4.2 showed that 
the transfection efficiency after lyophilization slightly increased with an increasing 
amount of cryoprotectant, although the changes were not statistically significant. This is 
inconsistent with the outcome reported by Brus and others that smaller amounts of 
cryoprotectant were required to maintain the particle size and fully recover transfection 
efficiency. [159] Also, Anchordoquy and others reported 1% w/v of disaccharide to the 
complexes reduced particle aggregation and helped preserve transfection. [145] In 
contrast, Molina and colleagues reported that sucrose/DNA mass ratios of 7500 
effectively preserved particle size of PEI complexes despit  lowering transfection 
efficiency. [158] On the other hand, Talsma and others used higher mass ratio (10000) of 
sucrose to DNA and showed well preserved transfection efficiency. [160] Again, the 
protection mechanism of cryoprotectants is still unclear and is requires further study.  
Decomplexation is an important step for gene delivery analysis. In these studies, 
120mg/ml STP was the most effective method to decomplex DNA from nonviral vectors, 
which indicated that interaction of negatively charged small molecules with positively 
charged PEI or XG was more effective for dissociation of DNA than vector 
deprotonation by alteration of buffer pH. (Figure 4.5) The result of agarose gel 
electrophoresis as shown in Figure 4.6 supported a choice of STP treatment for 
decomplexation because there was no appearance of DNA bands after pH12 TE treatmen  
although the reason for this outcome is unclear. In order to attempt to improve DNA 
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detection, EtBr was also added directly to the samples in the loading buffer rather the 
incorporation within the gel. Unfortunately, this method did not help to improve DNA 
detection (data not shown). Although several other agents were investigat d for XG 
decomplexation, none was as effective as STP. It was finally discovered that the 
incubation time of samples with STP solution was the critical factor. (Figure 4.8) As 
composition of XG is not provided by the manufacturer due to confidentiality, we can 
only guess that long nonpolar tails of lipids may act as steric barrier to the approach of 
STP molecules.  
As expected, a “reverse transfection” strategy in which vectors were localized on 
the substrate surface and thereby concentrated near the cell surface achieved a dramatic 
increase in transfection efficiency in the presence of 10% serum relative to conventional 
bolus vector delivery for which transfection was very low. (Figure 4.9 and 4.10) Relative 
gene expression of LC XG in reverse transfection was fourfold higher than in bolus 
transfection. The same experiments were conducted with LC PEI without fibronectin 
coating and reverse gene delivery method improved gene expression as well. Ho ver, 
we were unable to calculate transfection efficiency from this experiment due to cell 
detachment. Although it was reported that PEI complex itself was sufficient for cell 
immobilization at regular tissue culture polystyrene (TCPS) plates, this did not appear to 
be the case for bacterial Petri dish. [161] Under out experimenetal conditions, excess PEI 
charge helped cell adhesion in comparison to without complex at the surface only for one 
day. Reinisalo and others performed the similar studies, employing reverse transfection 
with various MW PEI complexes on the PLL/laminin treated 48-well plates. [161] They 
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compared the data from conventional transfection with serum-free media with reverse 
transfection in the presence of serum. Reverse transfection exhibitd 80-100% of 
transfection via conventional transfection. Furthermore, the reverse transfection-based 
system provided the long-term stability of transfection activities.  
4.5. Conclusions 
In these preliminary studies, factors critical to effective lyophilization and 
decomplexation were evaluated and optimized. All XG formulations and N/P 7.5 PEI 
complex lyophilized with 10% sucrose exhibited similar transfection efficiencies 
following lyophilization. Because XG is a proprietary material of undisclosed 
composition, N/P 7.5 PEI was selected for future studies (Chapter 7) 120 mg/ml STP 
treatment was identified as the most effective decomplexation solution and selected for 
use in future studies for measuring amounts of released PEI/pDNA complexes from 
hydrogels. As a pilot study, the dramatic improvement of transfection efficiency by 
reverse transfection in the presence of serum suggests that hydrogel-based delivery of 
nonviral vectors may concentrate vectors near the surface of adherent c lls in a similar 
manner and also achieve improved transfection efficiency. Relative to substrate-mediated 
reverse transfection approaches, it is expected that encapsulation of vectors within a 





A NOVEL SYNTHETIC ROUTE FOR THE PREPARATION OF 
HYDROLYTICALLY DEGRADABLE SYNTHETIC HYDROGELS 
 (Adapted from Journal of Biomedical Materials Research, Part A,  
2009. 90(4): p.1073-82) 
 
Abstract 
Synthetic hydrogels offer a number of advantages as matrices for gene delivery 
including reproducibility, tailoring of adhesive properties to target d sired cell 
populations, and the controlled variation of degradation rate and mechanical properties. 
These studies describe the development of a novel, two-step synthetic route for the 
preparation of hydrolytically degradable, crosslinkable PEG-based macro ers based on   
chemical intermediaries that form ester linkages with variable alkyl chain length. 
Through variation in the alkyl chain length of the chemical intermediary, variable 
degradation times ranging from weeks to months were achieved, while consistent 
swelling properties were maintained. Macromer solutions were coatd n CCP fibers and 
crosslinked by photo-initiated polymerization. However, the resulting hydrogel coatings 
were unstable and exhibited rapid delamination upon exposure to aqueous solutions.  
 
Keywords: controlled release, crosslinkable, hydrogel coating, hydrolytica ly degradable, 





Hydrogels have been widely investigated for biomedical applications, including 
drug/protein/DNA delivery systems and matrices for cell encapsul tion as well as 
transplantation. [162-164] Among their beneficial properties, aqueous solutions of 
monomers/macromers can be delivered by minimally invasive surgical techniques and be 
formed in-situ under relatively mild conditions.  The resulting hydrophilic, crosslinked 
structures form highly water swellable, yet insoluble polymer networks with similar 
physical properties to many soft tissues. Hydrogels can be formed from both biolgically-
derived and synthetic polymers. While biologically-derived hydrogels, such as chitosan, 
fibrin, collagen, and gelatin are intrinsically cell adhesive and degradable by cellular 
proteolytic enzymes, synthetic hydrogels offer advantages in reproducibility, availability, 
and tailoring of physical/chemical properties to desired applications. [107, 165-168] 
One common strategy for the creation of synthetic hydrogels has been the 
modification of water soluble polymers such as poly (ethylene glycol) (PEG) and poly 
(vinyl alcohol) (PVA) with vinyl end groups and their subsequent crosslinking by photo- 
or redox-initiated free radical polymerization.  Due to the non-degradable nature of the 
polymer backbone and the limited degradation of vinyl esters following free radical 
polymerization, considerable effort has been directed toward the modification of these 
polymers with hydrolytically degradable groups. Sawhney and Hubbell first describ d the 
synthesis of hydrolytically degradable, crosslinkable synthetic copolymers, which 
consisted of a hydrophilic PEG center block co-polymerized with poly(lactic acid) 
(PLA) or poly (glycolic acid) (PGA) and end-capped with acrylate groups. [116] They 
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showed that the hydrogel degradation properties could be controlled through variation of 
PEG molecular weight, and the chemical composition and degree of polymerization of 
the polyester blocks.  Later, Metters and colleagues developed a mathematical model that 
predicted the network mass loss of PLA-b-PEG-b-PLA based on several fundamental 
parameters, including the hydrolysis rate of the degradable linkages, polymer 
concentration, and the crosslink density.  [117] 
In recent years, a variety of alternative chemistries have been inv stigated for the 
creation of hydrolytically degradable, crosslinkable synthetic macromers.  Anseth and co-
workers developed degradable, crosslinkable PVA networks by grafting o  methacrylate-
terminated PLA oligomers and showed that degradation was controllable through 
variation of polymer molecular weight and degree of functionalization. [169-171]  Wang 
et. al. reported the modification of PEG with a hydrolytically degradable phosphoester 
linkage and terminal methacrylate groups. [172]  Mikos and co-workers synthesized 
novel oligo(PEG fumarate) (OPF) oligomers by the reaction of PEG with fumaryl 
chloride, generating multiple ester and double bonds in the polymer chains, which were 
crosslinked by photo- and redox-initiated radical polymerization. [124]  Variation of PEG 
molecular weight provided control of gel swelling, mechanical properties and 
degradation rate. [125, 126]  Hubbell and co-workers have recently described the 
crosslinking of acrylated multi-arm PEGs with multi-functional thiol compounds by 
Michael-type addition, yielding networks with varying rates of hydrolytic degradation as 
a function of polymer concentration and functionality. [173, 174] 
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Many of the methods described above achieve variable degradation through 
changes in macromer concentration, functionality, and molecular weight that produce 
corresponding changes in the network physical properties such as equilibrium swelling 
and elastic modulus.  Vyavahare and colleagues described the synthesis of a degradable 
hydrogel crosslinker, 2-hydroxyethyl glycolate dimethacrylate, by conjugating two 
hydroxylethyl methacrylate groups with a difunctional chemical intermediary, 
chloroacetyl chloride. [175]  These studies describe the adaptation and expansion of this 
method for the preparation of hydrolytically degradable as well as cro slinkable 
macromers based on water soluble, hydroxyl-terminated polymers such as PEG. In this 
chapter, hydrogels with consistent physical properties and variable degradation rates 
ranging from weeks to months were obtained through variation of the alkyl content of the 
chemical intermediary. The feasibility of fiber coating byuse of newly developed 
hydrogels was evaluated.  
5.2. Materials and Methods 
5.2.1. Materials 
Polyethylene glycol (PEG) and chloroacetyl chloride were purchased from Fluka 
(Buchs, Switzerland). 2-chloropropionyl chloride, 4-chlorobutyryl chloride, sodium 
acrylate, triethylamine (TEA), 4-methoxyphenol, poly(ethylene glycol) diacrylate 
(PEGDA, Mn258, inhibited with 100ppm MEHQ) and inhibitor remover column 
(disposable column for removing hydroquinone and MEHQ) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Inhibitor from PEGDA was removed by remover 
column and the filtered product was stored at 4°C, avoiding light. Anhydrous sodium 
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sulfate and ethyl ether were from Fisher scientific (NJ, USA). Irgacure 2959 (2-hydroxy-
1-[4-(hydroxyethoxy) phenyl]-2-methyl-1-propanone, I-2959) was obtained from Ciba® 
Specialty Chemicals (Basel, Switzerland) and prepared as a 10% stock solution in 70% 
ethanol. Dichloromethane (HPLC grade), anhydrous dimethylformamide (DMF), sodium 
bicarbonate and CDCl3 were obtained from Acros organics (NJ, USA). Dichloromethane 
was dried with calcium hydride and stored over molecular sieves (3A). All other 
chemicals were used as received. Adult normal human dermal fibroblasts (NHDF, CC-
2511) obtained from a 39-year-old female were purchased from Biowhitaker (Rockland, 
ME). DMEM F-12 50/50, 1x with L-glutamine, 15 mM HEPES/trypsin EDTA (0.05% 
trypsin/0.53 mM EDTA in HBSS), and 10000I.U. penicillin and 10000µg/ml 
streptomycin were obtained from Mediatech (VA, USA). Bovine growth serum was 
purchased from Hyclone (Logan, UT). The PLLA CCP fiber bundles were donated by 
Fiber Innovation Technologies and the cross-section of a single fiber was shown in 
Figure 5.1. Hexane and isopropanol were obtained from Fisher scientific. The fiber spin 
finishing was removed by serial washes with hexane and isopropanol. Brief y, a bundle 
of fiber was washed in order of 100% hexane, 50/50 hexane/isopropanol mixture and 
100% isopropanol for an hour at each step. Extra chemicals were rinsed off with water 
twice while sonicating. The final fibers were dried under vacuum. Dichloromethane was 
dried with calcium hydride and stored over molecular sieves (Grade 514, Type 4A). All 
other chemicals were used as received.   Loctite® 3311TM light cure adhesive were from 
Henkel Loctite Americas (SC, USA). Capillary tubes (I.D. 1.1- .2mm, wall 0.2±0.02mm, 
 
length 75mm) were from Chase 
frame for supporting fibers. 
Figure 5.1. Cross-section of a single PLLA 
 
5.2.2. Synthesis of photopolymerizable, degradable, and crosslinkable PEG 
macromers 
PEG-diacrylate macromers with hydrolytically degradable ester bonds were 
synthesized by a two-step reaction as shown in Figure 5.2.
Figure 5.2. Synthetic route for preparation of degradable, crosslinkable PEG
acrylate macromers 
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cientific glass Inc (TN, USA) and were used as a glass 
   






5.2.2.1. Preparation of PEG-bis-(chloroacetate), PEG-bis-(2-chloropropanoate), and 
PEG-bis-(4-chlorobutyrate) 
PEG-bis-chloroacetate was prepared by reaction of the PEG terminal hydroxyl 
groups with chloroacetyl chloride. All glassware was dried in a vacuum oven and fully 
purged with argon before use. 3.75 mmol PEG (MW 4000) was dissolved in 120mL of 
dry dichloromethane in a 250-mL round-bottom flask under an argon atmosphere. Once 
the PEG was completely dissolved, 6.75 mmol TEA was added and the reaction flask was 
cooled on an ice bath. Chloroacetyl chloride (15 mmol) in 30mL of dry dichloromethane 
was added dropwise with an addition funnel over 2 h. The ice bath was removed after 2 
h, and the reaction was allowed to continue at room temperature for 24 h. The reactant 
was filtered to remove TEA-HCl salt, and then concentrated by rotary evaporation (Buchi 
Rotavapor®, Switzerland) to reduce the solvent amount to 1/10th of its inital volume. 
The residue was precipitated in 200mL of cold ethyl ether (-20°C), recovered by 
filtration, and dried under vacuum for a few hours. The product was redissolved in dry 
dichloromethane (150mL) and washed repeatedly with 15mL of 10% sodium bicarbonate 
solution until the pH of the solution was neutral, followed by 3 washes with water (15mL 
each) and dried with anhydrous sodium sulfate. The solution was concentrated by rotary 
evaporation, the residue was precipitated in 200mL ethyl ether (-20°C), and was washed 
3 times with cold ethyl ether. The final product was recovered by filtration nd stored in a 
vacuum desiccator. 
PEG-bis-(2-chloropropanoate) and PEG-bis-(4-chlorobutyrate) were pr pared by 
the same procedures using 2-chloropropionyl chloride, 4-chlorobutyryl chloride, 
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respectively. The structure of all products was determined by 1H-NMR (Bruker Avance-
300 MHz) using CDCl3 solvent. Conversion efficiency was calculated based on the ratio 
of the integrals of the PEG back bone (δ = 3.5-3.7) and the terminal PEG methylene 
peaks (δ = 4.3). 
5.2.2.2. Preparation of PEG-bis-(acryloyloxy acetate)[PEG-bis- AA], PEG-bis-
(acryloyloxy propanoate) [PEG-bis-AP], and PEG-bis-(acryloyloxy 
butyrate)[PEG-bis-AB] 
PEG-bis-AA was prepared by the reaction of PEG-bis-chloroacetate and sodium 
acrylate. Dried PEG-bis-chloroacetate (2.5 mmol) was dissolved in 100mL DMF in a 
250mL 3-neck flask, with 0.01 g 4-methoxyphenol. Sodium acrylate (12.5 mmol) was 
added to the reaction flask under an argon atmosphere. The reaction proceeded for 30 h at 
50°C, and then the reactant was cooled to room temperature and filtered through a 
cellulose filter (Grades 4, Whatman®) to remove unreacted sodium acrylate. DMF was 
removed by rotary evaporation and the residue was precipitated and washed with 200mL 
of cold ethyl ether (-20°C) three times. The final product was recovered by filtration and 
stored in a vacuum desiccator. PEG-bis-AP and PEG-bis-AB were prepared by the same 
procedure under reflux at higher temperatures from PEG-bis-(2-chloropropanoate) (85°C) 
and PEG-bis-(4-chlorobutyrate) (100°C). The final structure of all products was 
determined by 1H-NMR (CDCl3 solvent). Product acrylation efficiency (%) was 
calculated based on the ratio of the integrals of the PEG back bone (δ = 3.5-3.7) and the 
acrylate peaks (δ = 6.4). 
5.2.3. Hydrogel preparation 
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Macromers were dissolved at varying concentration (% w/v) in de onized water 
with 0.1% I2959 (w/v) and syringe-filtered (0.2 µm, Nalgene®). These solutions were 
pipetted between two slide glasses, separated by 1 mm Teflon spacers and clamped 
together with binder clips. The photopolymerization was allowed to proceed for 5 min 
per each side under UV light (Model B 100 AP of Blak-ray®; wavelength: 365 nm; 
intensity: 15 mW/cm2). Gel discs were cut with a hole-punch (5/16 in.). 
5.2.4. Degree of gelation and swelling behavior 
After photopolymerization, the hydrogel discs were freeze-dried (FreeZone® 4.5 
Benchtop freeze dry systems of ©Labconco; RV5 rotary vane pump of BOC Edwards), 
weighed (Wd1), and then was allowed to swell in distilled water for 24 h to remove any 
uncrosslinked residual macromer. Excess water on the surface of gls was blotted 
moderately with a piece of Kimwipe paper and the wet weights of gels (Ww) were 
measured. The discs were completely dried under vacuum at 60°C for 3 days and 









The equilibrium water content (EWC) was calculated as: 
( )








5.2.5. Hydrogel degradation 
Photopolymerized hydrogel discs were swelled in water overnight to remove any 
unreacted macromer, freeze-dried, weighed (Wd0) and incubated in 4mL of PBS (pH 7.4) 
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at 37°C on a shaker plate. At specified time points, gel discs (n = 5/time point) were 
taken from each group, rinsed with water, and then freeze-dried to determine their final 













5.2.6. Cytocompatibility  
Acrylate-PEG-GRGDS was synthesized as described, [176] prepared as a stock 
solution in 1×PBS (10 µmol/ml), and sterile filtered. For hydrogel encapsulation studies, 
macromer solutions were prepared containing 10% w/v sterile filtered PEG-bis-AA in 
PBS, 2.5 µmol/ml acrylate-PEG-GRGDS, 0.1% I2959, and NHDF at 4×105 cells/ml. 
Sample volumes (100µL) were photopolymerized as described earlier and cultured in 
DMEM/F12 with 10% serum and 1% antibiotics in 12 well plates for 7 days. For surface 
seeding studies, 10% PEG-bis-AA solutions containing acrylate-PEG-GR DS and I-
2959 as above were photopolymerized, placed in 12 well plates with 2mL mediu , 
seeded with 8×104 NHDF, and cultured 5 days. To assess cell viability and morphology, 
samples were stained with 1 µM fluorescein diacetate/2.5 µM propidium iodide (FDA/PI), 
rinsed with PBS, visualized by fluorescence microscopy (Zeiss Axiovert 200), and 
digitally imaged. 
5.2.7. Controlled release of IgG 
40% w/v solutions of PEG-bis-AA, PEG-bis-AP, and PEG-bis-AB containing 2.5 
mg/ml human IgG were prepared in PBS. 100µL samples (250 µg initial protein content, 
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n = 4/group) were photopolymerized as described earlier and then incubated in 2.5mL of 
PBS (pH 7.4) at 37°C on an orbital shaker. At weekly intervals, the sample buffers were 
collected and replaced. IgG release was measured by fluorescamine ssay as previously 
described.[177] Briefly, 150µL samples were mixed with 50µL fluorescamine stock 
solution (3 mg/ml in acetone) and fluorescence was measured using a microplate reader 
(Spectramax GerminiEM, Molecular Devices, Sunnyvale, CA) at 395 nm excitation and 
475 nm emission wavelengths. IgG concentrations were calculated relative to a standard 
curve prepared from known IgG concentrations. 
5.2.8. Hydrogel coating 
The PLLA CCP fibers were cleaned by ultrasonication, completely dried under 
vacuum in advance, and then coiled around the glass frame. Both fiber ends w re glued 
to the glass frame by Loctite® 3311TM light cure adhesive via UV photocrosslinking. 
Fibers were dipped in hydrogel coating solution, 20% w/v PEG-bis-AA, PEG-bis-AP, 
and PEG-bis-AB with 0.1% I2959 (w/v) and then exposed to UV light (Model B 100 AP 
of Blak-ray®; wavelength: 365 nm; intensity: 15 mW/cm2) for photopolymerization. To 
obtain an air (or oxygen)-free environment, photopolymerization was also performed in a 
box filled with argon gas. 
5.2.9. Plasma surface modification 
 In order to improve hydrogel binding with fibers, plasma surface modification was 
applied. Plasma treatment technology is one of the most common ways to introduce 
chemically reactive groups on a material surface that can easily react with the contact 
material. [178] Its process is very simple and the cost is rather low relative to other 
 86
surface treatments such as chemical modification by oxidation. [179] In this study, 
oxygen plasma was applied by use of a Harrick plasma cleaner/sterilizer (PDC-001) to 
modify the CCP PLLA fiber surface chemistry through abstraction of hydrogens from the 
polymer chains, creating free radicals (peroxide groups). [180] Applied frequency was 
13.54MHz. The pressure in the plasma chamber was reduced to 30mtorr, follwed by 
introduction of oxygen gas into the plasma chamber at 300mtorr for 5 minutes. Right 
after plasma treatment, the modified fibers were dipped in low MWPEGDA for 30 
minutes. The extra PEGDA was rinsed with water several times. After removal of water, 
the resulting fibers were dipped in the hydrogel solution and then were mov d under the 
UV light. 
5.2.10. Statistical analysis 
Quantitative data for gel content, equilibrium water content, and mechanical 
properties were compared by ANOVA using Tukey's method for post hoc comparisons. p
values < 0.05 were considered to be statistically significant. All data are presented as 
mean±standard deviation. 
5.3. Results 
5.3.1. Synthesis of degradable, crosslinkable PEG-based macromers 
5.3.1.1. Preparation of PEG-bis-(chloroacetate), PEG-bis-(2-chloropropanoate), and 
PEG-bis-(4-chlorobutyrate) 
In the first step, the reaction between the PEG hydroxyl groups and the acid 
chloride groups of the various chemical intermediaries resulted in the formation of ester 
 87
bonds and terminal alkyl chloride groups separated by a variable alkyl spacer. 1H-NMR 
peaks detected and representative spectra from each material are shown below. 
PEG-bis-(chloroacetate) [Figure 5.3 (a)]: T= 3.5-3.7 (m, -(CH2CH2O)n-), 4.12 (s, 
-OC(=O)CH2Cl), 4.3-4.4 (t, -CCH2OC(=O)-) ppm. Conversion efficiency: ~96%. 
PEG-bis-(2-chloropropanoate) [Figure 5.3. (b)]: T= 1.65-1.75 (d, -CH3), 3.-3.7 
(m, -(CH2CH2O)n-), 4.3-4.4 (t, -CCH2OC(=O)-), 4.4-4.5 (q, -OC(=O)CH(C-)Cl) ppm. 
Conversion efficiency: ~94% 
PEG-bis-(4-chlorobutyrate) [Figure 5.3 (c)]: T= 1.96 (m, -CCH2C-), 2.5-2.6 (t, -
OC(=O)CH2C-), 3.5-3.7 (m, -(CH2CH2O)n-, -CCH2Cl), 4.2-4.3 (t, -CCH2OC(=O)-) 










Figure 5.3. Structure and 1H-NMR spectrum of (a) PEG-bis-(chloroacetate), (b) 
PEG-bis-(2-chloropropanoate) and (c) PEG-bis-(4-chlorobutyrate) 
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5.3.1.2. Preparation of PEG-bis-(acryloyloxy acetate)[PEG-bis- AA], PEG-bis-
(acryloyloxy propanoate) [PEG-bis-AP], and PEG-bis-(acryloyloxy 
butyrate)[PEG-bis-AB] 
Terminal acrylate esters were added to the intermediate products by nucleophilic 
substitution reaction between the terminal alkyl chloride groups and sodium acrylate. 
PEG-bis-(chloroacetate) also readily reacted with sodium methacrylate to produce 
terminal methacrylate groups (data not shown). 1H-NMR peaks detected and 
representative spectra from each material are shown below. 
PEG-bis-AA: T= 3.5-3.7 (m, -(CH2CH2O)n-), 4.3-4.4 (t, -CCH2OC(=O)-), 4.7-
4.8 (s, -OC(=O)CH2OC(=O)-), 5.9 and 6.4 (d, 2H, acrylic –CH2), 6.15 (q, 1H, acrylic –
CH) ppm. Acrylation efficiency: 95~98%. 
PEG-bis-AP: T= 1.45-1.55 (d, -CH3), 3.5-3.7 (m, -(CH2CH2O)n-), 4.3-4.4 (t, -
CCH2OC(=O)-), 5.1-5.25 (q, -OC(=O)CH(C-)OC(=O)-), 5.9 and 6.4 (d, 2H, acrylic –
CH2), 6.15 (q, 1H, acrylic –CH) ppm. Acrylation efficiency: 86~87%. 
PEG-bis-AB: T= 2.0 (m, -CCH2C-), 2.5-2.6 (t, -OC(=O)CH2C-), 3.5-3.7 (m, -
(CH2CH2O)n-), 4.15-4.25 (t, -CCH2OC(=O)-), 4.2-4.3 (t, -CCH2OC(=O)-), 5.9 and 6.4 











Figure 5.4. Structure and 1H-NMR spectrum of (a) PEG-bis-(acryloyloxy acetate), 
(b) PEG-bis-(acryloyloxy propanoate) and PEG-bis-(acryloyloxy butyrate) 
 
5.3.2. Gel content and swelling behavior 
Aqueous solutions of the various acrylated macromers were crosslinked by 
photopolymerization at 10 and 20% (w/v) concentration. The gel contents and the 
equilibrium water contents of various photopolymerized hydrogels are shown in Table 
5.1. Gel content was consistently high (around 95%) and not significantly ffected by 
variation in macromer chemical composition or concentration. Similarly, no significant 
differences were detected in equilibrium water content among hydrogels prepared from 
macromers of different chemical composition at fixed concentration. However, 
significantly lower equilibrium water content was observed in all hydrogels prepared at 
higher macromer concentration. 
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Table 5.1. Gel Content and Equilibrium Water Content 
 Gel Content (%) Equilibrium Water Content (%)  
 10% w/v 20% w/v 10% w/v 20% w/v 
PEG-bis-AA 95.89±4.3 96.74±1.52 91.78±0.26 86.37±0.23a 
PEG-bis-AP 94.61±4.5 95.86±3.26 92.47±0.55 87.64±0.38a 
PEG-bis-AB 96.59±2.86 94.74±1.77 92.17±0.29 87.44±0.28a 
arepresents the significant difference between two concentrations 
 
5.3.3. Hydrogel degradation 
Figure 5.5 shows an idealized schematic of hydrolytic degradation within the 
hydrogel network and the expected degradation products, which include PEG, polyacrylic 
acid (PA) and glycolic acid from PEG-bis-AA, lactic acid from PEG-bis-AP, 4-
hydroxybutanoic acid from PEG-bis-AB. The degradation characteristics of these gels 
were expected to be bulk hydrolysis and the degradation times varied from 21 days to 
months, depending on macromer concentration and the alkyl chain length of the chemical 
intermediary used for synthesis. 
 
Figure 5.5. Degradation mechanism of PEG-bis acrylates and expected products 
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5.3.3.1.Influence of macromer concentration on degradation 
First, the degradation behavior of hydrogels polymerized from solutions of 
constant macromer composition (PEG-bis-AA) at varying concentration (10, 20, and 40% 
w/v) was monitored (Figure 5.6). All of the hydrogels exhibited the small mass loss of 
about 20-40% within two weeks. After the initial 20% mass loss, however, th  rate of 
degradation increased sharply. The time required for complete degradation increased with 
increasing hydrogel macromer concentration. The 10% hydrogels completely degraded 
by 21 days, followed thereafter by the 20 and 40% gels, which exhibited to al mass loss 
after 35 days and 42 days, respectively.  
 
Figure 5.6. Mass loss of hydrogels polymerized from solutions containing different 
concentrations of PEG-bis-AA macromers; 10% w/v (▲), 20% w/v (■), and 40% 
w/v (♦) 
 
5.3.3.2.Influence of macromer chemical composition on degradation 
In a second set of experiments, the degradation of hydrogels prepared from the 
three different PEG-bis-acrylates was compared at fixed polymer concentration (10% 
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w/v). As the alkyl chain length of chemical intermediary used in the synthesis increased 
from chloroacetyl chloride through 2-chloropropionyl chloride to 4-chlorobutyryl 
chloride, the time required for hydrogel degradation increased (Figure 5.7). 10% PEG-
bis-AA hydrogels degraded by 3 weeks, whereas complete degradation of PEG-bis-AP 
and PEG-bis-AB hydrogels was observed by 5 weeks and 9 weeks, respectively.  
 
Figure 5.7. Mass loss of different PEG-bis-acrylate hydrogels at 10% w/v; PEG-bis-
AA (▲), PEG-bis-AP (□), and PEG-bis-AB (○) 
 
5.3.4. Cytocompatibility 
Cytocompatibility tests were performed using the most rapidly egrading 
hydrogel formulation, PEG-bis-AA. Encapsulated fibroblasts maintained a rounded 
morphology at both 1 and 7 days. (Figure 5.8(a) and (b)) At 1 day post-encapsulation, 
fibroblasts exhibited high viability with minimal cell death, whereas increased numbers 
of dead cells were observed by 7 days. Fibroblasts seeded on the surface of RGD-grafted 
hydrogels attached, spread, and proliferated to reach near confluence by 5 days. (Figure 
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5.8(c) and (d)) No evidence of cell death was observed in fibroblasts cultured on the 
hydrogel surface. 
  
(a)      (b) 
  
(c)      (d) 
Figure 5.8. Viability and morphology of human dermal fibroblasts encapsulated 
within PEG-bis-AA hydrogels after 1 day (a) and 7 days (b) in culture and cultured 
on the hydrogel surface for 1 day (c) and 5 days (d) (Scale bars = 100µm) 
 
5.3.5. Controlled release of IgG 
As a model high molecular weight solute, IgG release was compared among 
hydrogels prepared from three different PEG-bis-acrylate compositions at fixed polymer 
concentration (40% w/v). The release of IgG was primarily dependent on hydrogel 
degradation. (Figure 5.9) All materials exhibited slow release within the first two weeks. 
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Increased release from PEG-bis-AA, the most rapidly degrading formulation, occurred 
between 2 and 5 weeks prior to reverse gelation at 6 weeks. Total IgG recovered from 
PEG-bis-AA hydrogels was approximately 60% of the amount initially loaded. The 
slower degrading PEG-bis-AP and PEG-bis-AB hydrogels maintained steady, low-level 
release throughout the 6 weeks of the study.  
 
Figure 5.9. Release of human IgG from 40% w/v hydrogels crosslinked from 
macromers of varying chemical composition; PEG-bis-AA (▲), PEG-bis-AP (□), 
and PEG-bis-AB (○) 
 
5.3.6. Stability of hydrogel coating on the CCP fiber 
20% w/v hydrogel was photopolymerized on the CCP fiber and all the samples 
prepared with PEG-bis-AA, PEG-bis-AP and PEG-bis-AB were immersed in water. 
Unfortunately, all hydrogels detached and were released from the channels very quickly 
after exposure to water (Figure 5.10). Although fiber was modified by plasma treatment 
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and PEGDA grafting on its surface, this did not improve hydrogel fixation within the 




(b)      (c) 
Figure 5.10.  Hydrogel delamination from the capillary channel polymer (CCP) 
fiber; 20% w/v PEG-bis-AA was coated and images were taken (a) before and (b, c) 
after hydrogel swelling in water 
 
5.4. Discussions 
Acrylated linear PEG-based polymer via simple 2 step synthesis was developed 
for modifying hydroxyl-terminated polymers with discrete ester bonds and terminal 
acrylate esters based on the use of difunctional chemical intermediaries. This approach 
was based on the hypothesis that small changes in the alkyl spacer introduced through 
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various chemical intermediaries [-(CH2)-: chloroacetyl chloride; -C(CH3)H-: 2-
chloropropionyl chloride; -(CH2CH2CH2)-: 4-chlorobutyryl chloride] could provide 
significant changes in susceptibility to hydrolytic degradation while having minimal 
impact on the final network physical properties. The reaction mechanisms attained high 
degrees of conversion with final acrylation efficiencies of PEG-bis-AA and PEG-bis-AB 
exceeding 90%. The slight reduction in acrylation efficiency of PEG-bis-AP likely 
resulted from steric hindrance of the methyl group on 2-chloropropionyl chloride. A 
similar synthesis was also attempted using 3-chloropropionyl chloride [alkyl spacer -
(CH2CH2)-]. However, a stable intermediate product could not be maintained and 
converted to the desired final product by nucleophilic substitution due to a competing 
elimination reaction (data not shown). 
In general, hydrogel physical properties are highly dependent on the polymer 
backbone chemistry, degree of functionalization, and network crosslinking de sity. As 
shown in Table 5.1, the equilibrium water content of hydrogels crosslinked from the 
various macromers was independent of macromer chemical composition and decreased 
with increasing macromer concentration. These results suggest that he changes in 
macromer chemical composition and molecular weight introduced by the various 
chemical intermediaries are relatively small and the network physical properties are 
primarily attributable to the PEG backbone and macromer concentration. The reduction 
in equilibrium water content with increasing macromer concentration is consistent with 
increased crosslinking density resulting from the higher concentratio  of vinyl groups in 
the macromer solution. 
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To promote biocompatibility, the final degradation products of the hydrogel 
networks should consist of physiological metabolites and non-toxic water-soluble 
polymers. Hydrolytic or enzymatic cleavage of ester bonds within the hydrogel networks 
may be expected to yield PEG, polyacrylic acid, and various monomeric hydroxyl acids. 
PEG and polyacrylic acid are readily eliminated from the body by renal clearance. [181] 
The monomeric hydroxyl acids derived from the chemical intermediari s (glycolic acid, 
lactic acid, and 4-hydroxybutanoic acid) are all naturally occurring metabolites. Human 
fibroblasts encapsulated within or seeded on the surface of PEG-bis-AA hydrogels 
exhibited high initial viability. Encapsulated cell viability decrased by 7 days, while 
adherent cells proliferated and reached confluence. A recent studyreported similar 
observations of rounded fibroblast morphology and decreased viability following 
encapsulation within PEG-bis-AP hydrogels. [182] Incorporation of small amounts of 
native hyaluronic acid to form semi-interpenetrating networks resulted in increased cell 
spreading that was dependent on cellular hyaluronidase activity and significant 
proliferation over two weeks in culture. 
To further investigate the effect of varying macromer chemical composition on 
hydrogel degradation rate, two different experimental designs were examined. In the first 
set of studies, variation in the solution concentration of a single macro er (PEG-bis-AA) 
was shown to effectively vary hydrogel degradation rate, which decreased with 
increasing macromer concentration. These results are consistent wi h previous studies 
showing increasing macromer concentration increases polyacrylate chain length and 
crosslinking density and reduces macromer cyclization resulting in reduced water content 
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and kinetics of ester bond hydrolysis. [117, 183] It was noticed that increasing macromer 
concentration resulted in more continuous mass loss of the material over time. The 
degradation profile of 40% w/v PEG-bis-AA macromers appeared more cl se to surface 
degradation/erosion. According to an increase in crosslinking density at higher 
concentration, it can be explained that the in-diffusion of water within 40% w/v PEG-bis-
AA hydrogels was limited than the other groups, resulting in more susceptible to 
degradation at part of the matrix in proximity to the surface unlike ideal bulk hydrolysis. 
In the second set of studies, macromer concentration was held constant while chemical 
composition was varied using macromers incorporating various chemial intermediaries. 
Hydrogel degradation rate was found to decrease with increasing length of the alkyl 
spacer derived from the chemical intermediaries. Schoenmakers and colleagues recently 
reported a similar observation for the hydrolysis of drug-linked ester bonds. [184] 
Paclitaxel was conjugated to PEG through hydrolysable ester linkers (3-sulfanylpropionyl 
and 4-sulfanylbutyryl) containing two or three methylene groups, re pectively. Drug 
release kinetics decreased with increasing number of methylene groups in the linker. 
These results were attributed to a decrease in the atomic charge on the carbon atom of the 
ester carbonyl group with increasing number of methylene groups predicted by molecular 
modeling.  
Solute release from bulk degrading hydrogel networks such as those prepared in 
this study occurs by a combination of diffusion and degradation. The relative contribution 
of each mechanism is influenced by the size of the solute relative to the network mesh 
size. [185] Relatively rapid release (1-7 days) of low molecular weight proteins 
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comparable to growth factors that is primarily diffusion-mediated has been reported for 
several PEG-diacrylate hydrogels. [177, 186] In contrast, Quick and colleagues showed 
that release of high molecular weight solutes such as nonviral polyelectrolyte complexes 
of pDNA is primarily degradation-limited. [119] Kasper and colleagues also pointed out 
that DNA release kinetics from OPF-based hydrogel was controlled by hydrogel 
degradation and plasmid size. [127] In our study, preliminary experiments demonstrated 
>50% release of albumin and IgG from 10 and 20% PEG-bis-acrylate hydrogels within 
24-48 h (data not shown) due to their sufficiently small size (IgG=150kDa, 
albumin=65kDa) compared with hydrogel mesh size. Increasing the macro er 
concentration to 40% substantially reduced diffusive release and allowed sustained 
release of IgG as a function of macromer composition and degradation rate. The 
approximate 60% total recovery from PEG-bis-AA hydrogels is consistent with previous 
studies of protein release from photopolymerized networks and may be attri uted to free 
radical-mediated protein damage or crosslinking to the polymer network. [177] 
Unfortunately, hydrogel coatings within the grooves of CCP fibers were unstable 
in the aqueous environment. Although the fiber was modified by plasma treatment and 
subsequent PEGDA grafting at the surface, there was no improvement in hydrogel 
fixation within the grooves. Inefficient crosslinking may be considere  as the unfavorable 
factor to cause more swelling behavior in hydrogel. All free radical polymerizations are 
sensitive to oxygen inhibition and polymerization between microscope slid s that is a 
conventional technique to minimize this interference was not possible for fiber coatings. 
Although an argon box was used to attempt to eliminate the presence of oxygen, this 
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approach was also unsuccessful. The swelling behavior of linear PEG-based hydrogel 
caused by both the hydrogel itself property and less crosslinking desity resulted from 
incomplete photopolymerization severely led the problematic hydrogel fixation on the 
fiber. Another explanation is that heating during exposure to UV light may have resulted 
in partial dehydration during crosslinking, substantially increasing the driving force for 
swelling upon exposure to water. Although usually considered negligible in other studies 
using volumes greater than 100 ml and thickness in the 1 mm range, the potential 
consequences of dehydration to the micrometer scale coatings within channel grooves 
may have been significant. 
5.5. Conclusions 
Crosslinkable, hydrolytically degradable PEG-based macromers were 
successfully prepared with high conversion efficiency by a novel two-s ep synthetic route 
using difunctional chemical intermediaries. Through variation in the alkyl chain length of 
the chemical intermediary, significant variation in degradation rate was achieved, while 
consistent physical properties were maintained. The synthetic approach is readily 
applicable to other hydroxyl terminated multi-functional polymers such as poly (vinyl 
alcohol) and multi-arm PEG polymers and may be useful for the creation of 
polymer/drug conjugates with varying hydrolytic stability. However, the geometrical 
instability of these PEG-based hydrogels in the aqueous environment was unfavorable to 
continue this study in order to develop a controlled gene delivery matrix composed of 
hydrogel compositions with fibers. Future studies address alternative macromer 
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compositions and crosslinking mechanisms to reduce hydrogel swelling and avoid the 









Poloxamines or Tetronic®s are 4-arm amphiphilic AB block copolymers of 
polypropylene oxide (PPO) and polyethylene oxide (PEO). In aqueous s lutions, 
Tetronic®s exhibit thermosensitive properties including spontaneous aggregtion to form 
micelles consisting of hydrophobic polypropylene oxide (PPO) cores surrounded by 
hydrophilic polyethylene oxide (PEO) shells. [187, 188] If the temperature or the 
concentration is high enough, Tetronic® shows a reversible thermogelati n in the 
aqueous solution. [85, 187, 189-191] Two Tetronic®s (T1107, T904) with different 
molecular weight and hydrophilic/lipophilic balance were modified with acrylate groups, 
mixed at varying mass ratios, and crosslinked with dithiothreitol by Michael-type 
addition. Temperature-dependent analysis demonstrated that the resulting hydrogels 
exhibited physical properties derived from both covalent and noncovalent mechanisms. 
Various degradation profiles were obtained ranging from 18-36 days depen ing on 
Tetronic® composition. Hydrogels consisting entirely of T904 exhibited no significant 
change between initial and equilibrium swelling ratio and were shown t  form stable 
coatings on the surface of CCP fibers.  
 
Keywords: controlled release, hydrogel coating, micelle formation, Michael-type 
addition, physical gelation, Poloxamine, synthetic hydrogel, Tetronic®, thermosnsitivity 
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6.1. Introduction 
Poloxamines or Tetronic®s (BASF Corporation) are tetrafunctional AB block 
copolymers of polyethylene oxide (PEO) and polypropylene oxide (PPO) bonded to an 
ethylene diamine central group. Due to their amphiphilic polymeric structure, these 
copolymers spontaneously aggregate in an aqueous environment, forming micelles 
consisting of hydrophobic polypropylene oxide (PPO) cores surrounded by hydrop ilic 
polyethylene oxide (PEO) shells. [187, 188] Micellization, critical micellar concentration 
(CMC) and critical micellar temperature (CMT) vary depending upon the molecular 
weight and PEO/PPO balance of various Tetronic®s. Fernandez-Tarrio and colleagues 
characterized micellization behavior of three Tetronic®s and found that Tetronic® 
macromers of lower molecular weight required higher concentration to induce self-
association and formed micelles are easily destabilized by dilution. (Table 6.1) [189] The 
self-association of poloxamines to form micelles is strongly dependent on not only the 
concentration and the composition of the copolymer, but also the temperature, the pH and 
the ionic strength of the aqueous solution. (Table 6.2) [85, 187, 189-191] When the 
polymer concentration (≥ 20% w/v) and temperature (≥ room temperature) exceed the 
CMC and CMT, these micelles can rearrange to form liquid crystal phases (=lyotropic) 
and eventually become a “gel-like system”. (Figure 6.2) [192-194] 
Tetronic® polymers are very similar in their physical/chemical properties to the 
Pluronic family of PEO/PPO/PEO triblock copolymers. Several Pluronics (particularly 
F127) exhibit thermoreversible gelation and have been widely studied as matrices for 
drug and gene delivery (reference some reviews here). One limitation of these systems is 
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that implantation and exposure to biological fluids results in an effective dilution of the 
polymer concentration. Once the concentration drops below the CMC, rapid dissolution 
and release of entrapped biomolecules occurs. Therefore, additional covalent crosslinking 
is required to slow the dissolution kinetics and provide controlled releas  of an 
encapsulated molecule. 
 
Figure 6.1. Synthetic route for preparation of acrylated Tetronic® macromers 
 
Cellesi first described a “tandem” gelation process combining thermally-induced 
gelation and covalent crosslinking of Tetronic® 1107 for cell microencapsul tion. [193] 
Cells were suspended in a solution of acrylate-functionalized T1107, mixed with thiol-
functionalized T1107 at room temperature, rapidly dispensed as microsphee  t rough an 
encapsulator apparatus, and collected in a hardening bath at 37°C. This process allowed 
the microsphere structure to be immediately stabilized in the collection bath by 
thermally-induced gelation, while slower Michael-type addition reactions between the 
acrylates and thiols provided additional covalent crosslinking. The resulting microspheres 
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exhibited temperature-dependent swelling, indicating the final physical properties were 
derived from both physical and chemical crosslinking. 
 
Figure 6.2. Phase diagram of aqueous solutions of Tetronic® 908 [194] 
[Reprinted from Physical review E, 65 (2002) 041802, C. Perreur, J-P. Habas, J. 
François, and J. Peyrelasse, Determination of the structure of the organized phase 
of the block copolymer PEO-PPO-PEO in aqueous solutions under flow by small-
angle neutron scattering, Copyright (2002) with permission from the American 
Physical Society] 
 
It was hypothesized that this type of “tandem” crosslinking would significantly 
reduce hydrogel swelling at 37°C after application to CCP fibers. Michael-type addition 
is also insensitive to the presence of oxygen and does not require the g neration of free 
radicals that may be detrimental to incorporated DNA. In addition, Pluronics and 
Poloxamines (Tetronic®) have been widely investigated as drug/gene delivery agents due 
to their micelle formation with DNA or gene complex caused by their amphiphilic 
structure. [85, 187, 195, 196] 
The aim of these studies was to investigate the gelation and swelling of 
Tetronic®-based hydrogels. Various compositions of Tetronic® 1107 (T1107; MW15K, 
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HLB: 18-23) and 904 (T904; MW6.7K, HLB: 12-18) were prepared. T1107 was cho en 
as a macromer known to undergo thermoreversible gelation while T904 was included 
based its higher hydrophobic content that was expected to further reduce swelling. The 
hydrogels were covalently crosslinked via Michael-type addition and characterized in 
terms of their viscosity, gelation point, swelling behavior, hydrolytic degradation 
kinetics, and cytotoxicity. In addition, hydrogels were applied as coatings to CCP fibers 
and the stability of hydrogel coating within the grooves was chara terized. To improve 
fixation of hydrogel to the fiber, plasma treatment was performed on the surface of CCP 
fibers. 
Table 6.1. Structural properties and CMC at pH7.4 and 25°C [85] 
Tetronic® Mw HLB pKa1 pKa2 CMC (mM) 
304 1650 12-18 4.30 8.14 5 
904 6700 12-18 4.03 7.81 0.3 
1307 18000 >24 4.62 7.80 0.1 
[Modified from AAPS PharmSciTech, 9 (2008) 471-479, M. Fernandez-Tarrio, F. 
Yañex, K. Immesoete, C. Alvarez-Lorenzo and A. Concheiro, Pluronic and Tetronic 
Copolymers with Polyglycolyzed Oils as Self-Emulsifying Drug Delivery Systems, 
Copyright (2008) with permission from American Association of Pharmaceutical 
Scientists] 
 
Table 6.2. Tetronic® 1107 CMC values at four different pHs and 23°C±0.5°C [197] 





[Reprinted from European journal of pharmaceutics and biopharmaceutics, 69 
(2008) 535-545, D. A. Chiappetta, J. Degrossi, S. Teves, M. D’Aquino, C. Bregni, A. 
Sosnik, Triclosan-loaded poloxamine micelles for enhanced topical antibacterial 
activity against biofilm, Copyright (2007) with permission from Elsevier B.V.] 
 
6.2. Materials and Methods 
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6.2.1. Materials 
Tetronic® 1107 (T1107, MW15K) and 904 (T904, MW6.7K) were kindly 
donated by BASF corporation (USA). 4-arm PEG (MW10K) was purchased from Nektar 
(Huntsville, AL, USA). Acryloyl chloride, celite fine 500 and 4-methoxyphenol were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Toluene (HPLC grade), ethyl 
ether (anhydrous, BHT stabilized), hexanes (HPLC grade), and anhydrous sodium sulfate 
were purchased from Fisher scientific (NJ, USA). Dichloromethane (HPLC grade), 
triethylamine (TEA), dithiothreitol (DTT), sodium bicarbonate, calcium hydride and 
CDCl3 were obtained from Acros organics (NJ, USA). Dichloromethane was dried with 
calcium hydride and stored over molecular sieves (Grade 514, Type 4A). All other 
chemicals were used as received. Texas Red®-X goat anti-mouse IgG (H+L) was 
purchased from Invitrogen. 
6.2.2. Acrylation of Tetronic®  
6.2.2.1. Preparation of acrylated T1107 (Acryl-T1107) 
Acrylated T1107 or Acryl-T1107 prepared by reaction of the Tetronic® terminal 
hydroxyl groups with acryloyl chloride (Figure 6.1). All glassware was dried in a heating 
vacuum oven. 15g of T1107 (1 mmol) was dehydrated by azeotropic distillation with 
toluene over two hours, and the toluene was then removed by rotary evaporation (Buchi 
Rotavapor®, Switzerland) at 90°C. After cooling to room temperature, dehydrated T1107 
was dissolved in 120ml of dry dichloromethane in a 250ml round bottom flask under a  
argon atmosphere. Once the T1107 was completely dissolved, 4 mmol TEA was added 
and the reaction flask cooled on an ice bath. 8 mmol acryloyl chlorides in 30ml of dry 
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dichloromethane were dropwise-added with an addition funnel over two hours. The ice 
bath was removed after 2 hours and the reaction was allowed to continue a  room 
temperature for 24 hours. The reactant was filtered through celitefine 500 to remove 
TEA-HCl salt, and then concentrated by rotary evaporation to reduce the solvent amount 
to 1/10th of its initial volume. The residue was precipitated in 500ml of cold ethyl ether (-
20°C), recovered by filtration, and dried under vacuum for a few hours. The product was 
redissolved in dry dichloromethane (150ml), washed repeatedly with 15ml of 10% w/v 
sodium bicarbonate solution until the pH of the solution was neutral, followed by water 
washes (15ml each) until the pH of water was neutral, and then dri d with anhydrous 
sodium sulfate. The solution was concentrated by rotary evaporation, the residue 
precipitated in ethyl ether (-20°C), and washed 3 times with cold ethyl ether. The final 
product was recovered by filtration and dried in a vacuum desiccator. The final structure 
and acrylation efficiency were determined by 1H-NMR (Bruker Avance-300MHz) using 
CDCl3 solvent. 
6.2.2.2. Preparation of acrylated T904 (Acryl-T904) 
Acrylated T904 or Acryl-T904 was synthesized in a similar manner with minor 
changes to account for reduced thermal stability and different solubility properties.. 15g 
of azeotropically dried T904 (~2.24mmol) was reacted with 17.92mmol acryloyl 
chlorides in the presence of 8.96mmol TEA in 150ml of dry dichloromethane. This 
product was very sensitive to temperature, so the reaction was kept at 4°C in order to 
allow the reaction to continue for 24 hours. The reactant was filtered through celite fine 
500 to remove TEA-HCl salt, and then concentrated in the presence of 4-methoxyphenol 
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by rotary evaporation to reduce the solvent amount to 1/10th of its initial volume. The 
residue was precipitated in a total volume of 500ml of the cold hexane/ethyl ether (50/50 
volume ratio), kept at -20°C for a few hours, and the precipitating solution quickly 
decanted. The product was redissolved in dry dichloromethane (150ml), washed 
repeatedly with 15ml of 10% w/v sodium bicarbonate solution until the pH of the 
solution was neutral, followed by water washes (15ml each) until the pH of water was 
neutral, and then dried with anhydrous sodium sulfate. The solution was concentrated in 
the presence of 4-methoxyphenol by rotary evaporation, the residue precipitat d in a total 
volume of 500ml of 50/50 hexane/ethyl ether system, and washed 2 times w th cold ethyl 
ether. The final product was recovered by decantation of the precipitating solution and 
dried under vacuum within an ice chamber. Products were analyzed by 1H-NMR and 
acrylation efficiency (%) was calculated based on the ratio of the integrals of the PEG 
back bone (δ=3.5~3.7) and the acrylate peaks (δ=6.4). 
6.2.3. Gelation analysis 
This study investigated four different formulations of Tetronic® macromers 
prepared at varying T1107/T904 mass ratios (100/0, 75/25, 50/50, 0/100). Unmodified 
(reverse thermal gelation) or acrylated (covalent crosslinking) Tetronic® macromers 
were dissolved at a nominal concentration of 30% w/v in PBS (pH7.4, 50mM; 5.75g/l 
Na2HPO4, 0.88g/l NaH2PO4, and 4.8g/l NaCl). Due to the volume change of PBS solution 
by macromer dissolution, 1g of macromer was assumed to be equal to 1m . Table 6.3 
summarizes the composition of each group. A 4-arm PEG macromer was included as a 
control. The pH of all macromer solutions was adjusted to pH 7.2 at 23°C (±~1°C). 
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6.2.3.1. Reverse thermal gelation 
Thermally-induced noncovalent gelation was assessed using both the tube 
inversion method and rheometry. For the tube inversion test, 2 ml Tetronic® solutions in 
5 ml vials were placed in a temperature-controlled water bath at 4°C. The bath 
temperature was increased 1°C/5 minutes and at each time point the samples were 
removed and inverted. The gel point was recorded as the temperature at which the 
solution did not flow.  
Rheological analysis was performed using a Physica rheometer (Anton Paar, 
USA) and parallel plate geometry (50mm diameter). Tetronic® solutions (4°C) were 
pipetted onto the bottom plate (pre-cooled to 4°C) and the top plate was lowered to create 
a 0.2 mm gap. A temperature-sweep (1.2°C/min) from 4-40°C was perform d at constant 
frequency (0.1 Hz) and strain (0.01). The gel point was determined as the crossing point 
of the storage (G’) and loss (G”) moduli. The viscosity of the various Tetronic® solutions 
was characterized at 4°C, 24°C and 37°C. Samples were loaded and allowed 15 minutes 
to achieve uniform temperature. Viscosity was measured as a function of shear rate 
ranging from 0.01 to 1 s-1. 
6.2.3.2. Covalent crosslinking 
Acrylated Tetronic® macromers were covalently crosslinked using dithiothreitol 
(DTT) as a model thiol-containing compound. Crosslinking kinetics was analyzed by 
parallel plate rheology. Solutions of acrylated Tetronic® and DTT prepared at 4°C were 
mixed at a 1:1 thiol:acrylate molar ratio (30% w/v final Tetronic® concentration), 
quickly vortexed, centrifuged to remove air bubbles, and pipetted on the cent r of the 
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bottom plate pre-warmed to 37°C. The top plate was lowered to create a 0.2 mm gap and 
oscillatory shear immediately performed at constant frequency (0.1 Hz) and strain (0.01). 
Storage and loss moduli were recorded as a function of time. The gelation time was 
determined as the temperature at which the storage modulus exceeded the loss modulus.
Table 6.3. The formula for preparing Tetronic®-based hydrogel crosslinked via 
Michael-type addition  
















(50mM, pH 7.4) 
(µl) 




75/25 22.5 7.5 0.8 
50/50 15 15 1 
0/100 0 30 1.3 
aFor unmodified Tetronic® experiments, 10µl 50mM PBS was added instead of 
DTT solution 
 
6.2.4. Degree of gelation and swelling behavior 
Various T1107/T904 formulations (30% w/v) were covalently crosslinked with
DTT in 100µl sample volumes between glass coverslips separated by 1 mm Teflon 
spacers overnight at 37°C. The initial wet weight of polymerized hydrogel discs was 
measured right after polymerization (Wi), freeze-dried (FreeZone® 4.5 Benchtop freeze 
dry systems of ©Labconco Corp.; RV5 rotary vane pump of BOC Edwards), weighed 
(Wd1) and then allowed to swell in 37°C PBS (pH 7.4) for 24 hours to remove any 
uncrosslinked residual macromer. The discs were lyophilized and weighed (Wd2). The gel 









For the equilibrium swelling ratio, the dry hydrogel discs were immersed in PBS 
(pH 7.4) for 24 hours and allowed equilibrate. To investigate thermosensitivity of 
hydrogels, the hydrogel discs were swelled in 4°C and 37°C PBS (pH 7.4). Excess buffer 
solution on the surface of gels was blotted moderately with a piece of Kimwipe paper and 
the wet weights of gels both at 4°C (W4) and at 37°C (W37) were measured. The swelling 


















Here ρp is the density of the polymer (1.04 g/ml) and ρs is the density of the 
solvent (1g/ml for PBS). Values for Mw were considered as Wi for the initial wet weight 
of a gel disc right after Michael-type addition, W4 and W37 for the swollen disc weight at 
different temperature. 
6.2.5. Hydrogel degradation 
Hydrogel discs covalently crosslinked as described above were incubated in 37°C 
PBS (pH7.4) overnight to remove any unreacted macrome , freeze-dried, weighed (Wd0), 
and incubated in 4ml of PBS (pH 7.4) at 37°C on a shaker plate. At specified time points, 
gel discs (n=4 / time point) were collected, weighed wet, rinsed with water, and then 
freeze-dried to determine their final mass (Wdt). Hydrogel degradation was assessed by 












Hydrogel cytotoxicity was tested using NIH 3T3 fibro lasts by the direct contact 
method. NIH 3T3 cells were routinely cultured in DME /F-12 50/50 (1X) supplemented 
with 10% bovine growth serum (BGS) and 1% penicillin (10000I.U.)-streptomycin 
(10000µg/ml) and used between the 4th and 6th passage. Macromer solutions were mixed 
with DTT as described above, pipetted into the center of tissue culture wells (24-well 
plates), incubated at 37°C overnight, and seeded with 4.2×104 cells/well. After 1 and 4 
days in culture, cells were stained with 1mM fluoresc in diacetate (FDA) and 2.5mM 
propidium iodide (PI), rinsed with PBS, visualized by fluorescence microscopy (Zeiss 
Axiovert 200), and digitally imaged. 
6.2.7. Hydrogel coating 
PLLA CCP fibers were cleaned by ultrasonication and, dried under vacuum, and 
coiled around glass frames. Both fiber ends were glu d to the glass frame by Loctite® 
3311TM light cure adhesive via UV photocrosslinking under UV light (Model B 100 AP 
of Blak-ray®; wavelength: 365 nm; intensity: 15 mW/cm2). As hydrogel coating solution, 
both Acryl-T904 solution and DTT solution was prepared. For hydrogel coatings, the pH 
of T904 solution was adjusted from pH7.4 to pH7.2. Because a higher pH caused a 
quicker increase in viscosity, which shortened handling time to coat hydrogel over fiber. 
However, we did not want to change gel properties due to the alteration of pH, so pH7.2 
was chosen to avoid the property change as well as increase handling time. Immediately 
after mixing two solutions, fibers were dipped in the hydrogel coating solution. Fiber 
samples coated with Acryl-T904-based hydrogels were incubated at 37°C overnight for 
complete polymerization. 
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6.2.8. Plasma surface modification 
Although Tetronic®-based hydrogel ameliorates a change in hydrogel volume due 
to swelling in the aqueous solution, hydrogel anchorage only depends on its swelling 
property. As hydrogel is degraded over time, the physical tightness of hydrogel within 
fiber grooves will be changed and loosened. In order to improve hydrogel binding with 
fibers, plasma surface modification was applied. Plasma treatment technology is one of 
the common ways to introduce chemically reactive groups on a material surface that can 
easily react with the contact material. [178] Its process is very simple and the cost is 
rather low than other surface treatment such as chemi al modification by oxidation. [179] 
In this study, air plasma (20% oxygen) was applied by use of a basic plasma cleaner 
(Harrick plasma; PDC-32G) to modify the CCP PLLA fiber surface chemistry through 
abstraction of hydrogens from the polymer chains, creating free radicals (peroxide 
groups). [180] Applied frequency was 13.54MHz. The pr ssure in the plasma chamber 
was reduced to 80mtorr, followed by introduction of air into the plasma chamber at 
300mtorr for 5 minutes. Right after plasma treatment, the modified fibers was dipped in 
polyethlyene glycol diacrylate for 30 minutes. 
6.2.9. Characterization of hydrogel coating 
6.2.9.1.Quantification of hydrogel coating 
A Wyko Profilometer was used to measure a change in depth and width of 
grooves before and after hydrogel coating. Data wasanalyzed using Wyko vision 32 
software. Two or three grooves were observed on the det cted plane. Depth and width 
were calculated from the actual profilometer data. (See Appendix B) The range was 
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determined as increasing 2µm in size from minimum length. Percentage population was 
calculated by a ratio of the sample number, which had t e depth or width within a range, 
to total collected sample number. 
6.2.9.2.Visualization of hydrogel stability on the CCP fibers 
Hydrogel coatings within the grooves could not be readily distinguished under the 
microscope. Texas Red-conjugated IgG was mixed into hydrogel solution at 1% v/v ratio 
as a fluorescent labeling agent. Fibers were coated with macromer solutions with and 
without fluorescently labeled IgG and crosslinked overnight at 37°C in a humid 
environment. Fiber without hydrogel coating was used as a control group. An inverted 
microscope, Zeiss Axiovert 200 microscope (Carl Zeiss, Inc.) equipped with HAL 100 
and HBO 100 lamps powered by an ebq100 isolated power supply was used for 
investigation. Axiovision AC software was used for image collection. To observe 
samples in dry condition after polymerization, a 10×Ph1 objective lens was used. Since 
the CCP fiber itself exhibits some degree of autoflorescence, the light exposure time and 
light intensity were adjusted to the extent unable to detect a fiber in order to make a 
distinction between coated and uncoated fibers. The lig t exposure times of both halogen 
and fluorescent light sources, and fluorescent alone were 510ms and 3.5s, respectively. 
For wet condition right after contact of the hydrogel/fiber composite with water (37°C), 
the exposure time of only the fluorescent light source was changed to 5s. 
6.2.10. Statistical analysis 
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Quantitative data for gel content, equilibrium water content, and mechanical 
properties were compared by ANOVA using Tukey’s method for post-hoc comparisons.  
p values <0.05 were considered to be statistically significant. 
6.3. Results 
6.3.1. Tetronic® acrylation 
The reaction between the four terminal hydroxyl groups on T1107 or T904 and 
the acryloyl chloride resulted in the formation of ester bonds. (Figure 6.1) Representative 
NMR spectra of Acryl-T1107 and Acryl-T904 are shown in Figure 6.2. 
Acryl-T1107 and Acryl-T904: δ= 1.1 (m, PPO CH3), 3.4 (m, PPO CH), 3.54 (m, PPO 
CH2), 3.65 (m, PEO CH2), 4.32 (t, -CCH2OC(=O)-), 5.8 and 6.4 (d, 2H, acrylic –CH2), 
6.15 (q, 1H, acrylic –CH) ppm.  Acrylation efficiency: 94-100% for Acryl-T1107 and 84-
90% for Acryl-T904. 
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Figure 6.3. Tetronic® structure (T1107: n=60, m=19; T904: n=15, m=17) and 
representative 1H-NMR spectrum of Acryl-T1107 
 
6.3.2. Reverse thermal gelation 
Overall, the viscosity of Tetronic® solution exhibited a shear-thinning response 
as a function of shear rate ranging between 0.01 and 1s-1. At all shear rates, viscosity 
dramatically increased with increasing T1107 content and the temperature. (Figure 6.4) 
The value of viscosity was lower than 0.3Pa.s at all shear rates at 4°C. At 24°C, the 
viscosity of 75/25 and 100/0 groups dramatically increased to about 20kPa.s and 55kPa.s 
at 0.01 s-1 shear rate, respectively. At 37°C, the 50/50 group showed a large increase in 
viscosity to about 22kPa.s at 0.01 s-1 hear rate. Figure 6.5 shows the difference in 
viscosity between 4 and 37°C at a fixed shear rate of 0.1s-1. Again, viscosity at 4°C was 
very low in comparison with viscosity at 37°C and increased with increasing T1107 






Figure 6.4. The effect of temperature on the viscosity of Tetronic® solutions 
containing different composition of T1107 and T904 at 30% w/v; 100/0 (×), 75/25 (●), 




Figure 6.5. Viscosity of the Tetronic® solution containing different composition of 
T1107 and T904 (30% w/v) at 0.1s-1 shear rate 
 



















Gelation time at 37°C 
(sec) 
100/0 22 19.22±1.28 23.25±1.8 23.5±2.12 
75/25 26 20.95±1.77 17.74±3.16 24.17±5.58 
50/50 31 24.46±2.67 9.74±1.59 88.33±12.58 
0/100  - -  -  153.33±5.77 
aThermogelation was monitored in the range of temperature between 4°C and 40°C 
bPlateau storage modulus can be considered as a measure of the extent of hydrogel 
network formation or gel intensity 
 
Gelation points determined by the tube inversion method and rheometric 
temperature scans are shown in Table 6.4. First of all, 0/100 group or 100% T904 at a 
concentration of 30% w/v in PBS (50mM, pH7.4) did not exhibit thermal gelation 
behavior within the range of temperature between 4°C and 40°C. Gelation points of the 
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rest three groups decreased with increasing T1107 content, which was induced by the 
hydrophobic aggregation of T1107 molecules. The plateau storage modulus can be 
considered as a measure of the extent of hydrogel network formation or gel intensity. 
Consistently, increasing T1107 content caused gel-lik  phase transition, resulting in 
higher plateau storage modulus. 
6.3.3. Chemical gelation via Michael-type addition  
Gelation time during chemical crosslinking via Michael-type addition was 
rheologically analyzed. Chemical gelation times were l ss than 3 minutes for all groups. 
(Table 6.4) Increasing Acryl-T904 content increased chemical gelation time.  
6.3.4. Degree of gelation and swelling behavior 
The gel contents of 30% (w/v) hydrogels with various compositions are shown in 
Table 6.5. Gel content was consistently high (around 97%) and not significantly affected 
by variation in macromer composition. 
Table 6.5. Gel content of various acrylated Tetronic®-based hydrogels 
T1107/T904 composition 





4-arm PEGa 96.38±3.04 
a4-arm PEG was used as control, also crosslinked via Michael-type addition 
 
The swelling property of each hydrogels was characte ized by the volumetric 
swelling ratio. While the swelling ratio of 4-arm PEG-based hydrogels exhibited a 
fourfold increase, the volumetric swelling ratio of Tetronic®-based hydrogels increased 
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less than two times as high as the initial value. In the case of 0/100 group, no significant 
change in the volumetric swelling ratio was observed. (Figure 6.6) The effect of 
temperature on the swelling behavior is shown in Figure 6.7. At  4°C where hydrophobic 
interactions are reduced, 100/0 group hydrogel composed of only Acryl-T1107 showed 
the highest swelling ratio and 4-arm PEG-based hydrogel and hydrogel in 75/25 group 
exhibited similar swelling ratio, which might result from the similar mesh size between 4-
arm PEG acrylates (~MW10K) to one between Acryl-T904 (~MW6.7K) and Acryl-
T1107 (~MW15K). The groups with higher T904 content such as 50/50 and 
0/100showed lower swelling ratio than the other three groups. In comparison with the 
results at 4°C, when hydrogels were equilibrated in 37°C PBS, the higher temperature 
induced the hydrophobic interaction within crosslinked molecules and the volumetric 
swelling ratios of all groups decreased to half or less than half of that observed at 4°C, 





Figure 6.6. Volumetric swelling ratio of various Tetronic®-based hydrogels 
immediately following polymerization (initial) and at equilibr ium, p<0.05, * 
represents the significant difference between initial and equilibrium, letters 
represent significant difference between groups 
 
 
Figure 6.7. The effect of temperature on the volumetric swelling ratio of various 
Tetronic®-based hydrogels, p<0.05, * represents significant differnce between two 
temperatures, letters represent the significant difference between groups 
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6.3.5. Hydrogel degradation 
The degradation characteristics of hydrogels in this study were expected to be 
bulk hydrolysis and the degradation times varied from 18 days to 38 days, depending on 
the composition of Acryl-T1107 to Acryl-T904. Figure 6.8 shows the percent mass loss 
and the volumetric swelling ratio of Tetronic®-based hydrogels at varying composition 
of Acryl-T1107 and Acryl-T904. All of the hydrogels exhibited small mass loss of 20% 
or less within three weeks. After 20% mass loss, however, the rate of degradation 
increased sharply. The time required for complete dgradation increased with increasing 
Acryl-T904 content, consistent with increased crosslinking density. 100/0 group 
hydrogels completely degraded by 18 days, followed thereafter by 75/25, 50/50 and 
0/100 gels, which exhibited total mass loss after 24 days, 28 days, and 38 days, 
respectively. The volumetric swelling ratios of various hydrogels increased with 







Figure 6.8. Degradation (a) and swelling behavior (b) of various Tetronic®-based 




Representative fluorescent images of live (green) and dead (red) cells are shown 
in Figure 6.9. The hydrogel discs exhibited autoflurescence in the red wavelength. After 
1 day in culture, the cell clusters around the hydrogel disc showed a high uptake of FDA 
stain, indicating that the majority of cells were alive. Hydrogels including higher Acryl-
T904 content showed an increased number of dead cells. After 4 days in culture, although 







Figure 6.9. In vitro cytotoxicity determined by live/dead assay; (a) 1 day NIH 3T3 
fibroblasts culture and (b) 4 days culture around Tetronic®-based hydrogels (Scale 




6.3.7. Hydrogel coating characterization 
Due to the lack of a significant change in swelling between initial and equilibrium 
conditions of T904 at 37°C, hydrogel coatings on the CCP fiber were well maintained 
within the grooves. Various ranges of width and depth of a single CCP fiber were 
detected by a profilometer as shown in Table 6.6 and 6.7. Two or three grooves on the 
side were clearly detected by profilometer. None of treatments such as plasma treatment, 
PEGDA grafting and hydrogel coating influenced width, which indicated that the 
hydrogel coating was only filled within the grooves. (Table 6.6) In contrast, hydrogel 
coating with (100%) or without (~73%) PEGDA grafting reduced depth lower than 6µm. 
(Table 6.7)  
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Hydrogel coatings within the grooves could not be readily visualized. Figure 6.10 
shows that fluorescence within the hydrogel coatings could be readily visualized in both 





(a)      (b) 
  
(c)        (d) 
  
(e)        (f) 
Figure 6.10. Phase contrast (left column) and fluorescent (right column) images of  
hydrogel coatings on the capillary channel polymer (CCP) fiber; (a, b) images of 
only fiber without hydrogel coating (c, d) hydrogel-coated fiber before immersion in 
37°C water, (e, f) hydrogel-coated fiber immediately after immersion in 37°C water 




Thermosensitive sol-gel phase transition is an in situ crosslinking mechanism that 
has been widely studied. [198] However, there are some limitations of the application of 
noncovalent gelation including short residence time, high permeability, non-
biodegradability and limitation of molecular weight. [199] Tetronic® or poloxamer is a 
copolymer of 4-armed PPO-PEO that exhibits sensitivity to temperature, concentration 
and pH, resulting in micellization and liquid crystal phases beyond a certain level of 
those variables. Cellesi and others first described th  temperature-dependent swelling of 
T1107-based hydrogels, suggesting that their physical properties originate from both 
covalent and noncovalent crosslinking mechanisms. [193, 200] In this chapter, the 
preparation of acrylated Tetronic®-based hydrogels with differing Acryl-T1107 and 
Acryl-T904 contents was described with the goal of determining how changes in 
macromer composition affect the physical properties of the resulting hydrogels. 
Throughout these studies, experiments were performed at both physiological temperature 
and 4 C where noncovalent, hydrophobic interactions are minimized in order to 
determine the relative contribution of the different crosslinking mechanisms. It was seen 
that viscosity was related to the thermogelation behavior. Physical thermogelation 
occurred only in the hydrogels including Acryl-T1107 with an increase in the 
temperature, which was proved by viscosity data in the current study and previous 
reports. [193] (Figure 6.4 and 6.5, and Table 6.2) Both 100/0 and 75/25 groups exhibited 
a sol-gel transition around room temperature, which induced effective entanglements 
between the single molecule chains. This is consistent with the previous data reported by 
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Cellesi and colleagues [193, 201] Cellesi and colleagues also showed a gelation behavior 
of 30 wt% T1107 in water at 21°C. T904 at a concentration of 30% w/v did not show a 
thermogelation behavior in the temperature range between 4 and 40°C, while the physical 
gelation point of 10% T904 was reported at 62.4°C. [85] T904 predominantly forms the 
monoprotonated type in the pH range between 4.0 and 7.9. [187] The protonation occurs 
due to the proton association with the nitrogen atoms on the central ethylene diamine 
group, which interferes with PPO chain aggregation due to the coulombic repulsions 
among positive charges and the increased hydrophilicity of the macromolecules. [187] 
This coulombic repulsion and interference with micelle formation may be the reason that 
the T904 in pH7.4 PBS did not show physical gelation within the experimental 
temperature range. In fact, various Tetronic® polymers exhibited similar range of pKa 
caused by two tertiary amines as pKa(2H+ to H+) or pKa1 for the first amine and pKa(H+ 
to none) or pKa2 for the second amine are pH3.8-5.6 and pH6.2-8.2, respectively. This 
property indicates that these values are unlikely to correspond to the length of the PEO-
PPO blocks. (Table 6.8) [191, 195, 197] That is, T1107 supposedly undergoes resistance 
of the proton to micelle association. In this case, the factor of micellization can be 
considered not environmental features such as pH or temperature, but compositional 
parameters. Micellization is strongly dependent on the content number of propylene 
oxide (PO) groups in PPO blocks. [202] An increase in either PO groups or MW of 
copolymers with similar EO/PO ratios results in lower CMC and CMT values. [202-204] 
Higher number of PO groups lowered the CMC as shown in Table 6.1. Although T1107 
has the higher content of PEO than T904, T1107 has longer PPO chains and higher MW 
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than T904, which possibly induce lower CMC and CMT and stronger micelle formation. 
This result is consistent with the micellar formation of T1307 which has high MW (18K) 
and high HLB (>24, 70 wt % PEO). (Table 6.1 and 6.8)  [195] In addition to active 
micelle formation, T1107 eventually experienced “gel-like system” or crystalline phases. 
[194] The resulting gelation points showed some deviation depending on the testing 
method. The rheological gelation point indicates the crossing points between elastic or 
storage (G’) and viscous or loss (G”) shear modulus, whereas the tube inversion test can 
be less accurate to catch that crossing points and in fact, a viscous polymer solution still 
flowed until it completely became a gel. There was a point where G’ sharply increased 
after the gelation point, for example, 20.73±0.23°C for 100/0, 24.60±0.0°C for 75/25, and 
31.63±0.46°C. Interestingly, these values were comparable with the tube inversion point.  



















T304 Liquid 1650 3.7 4.3 12-18 4.3, 8.1 
T901 Liquid 4700 2.7 18.2 1-7 5.1, 7.6 
T904 Paste 6700 15 17 12-18 4.0, 7.8 
T908 Cast solid 25000 114 21 >24 5.2, 7.9 
T1107 Cast solid 15000 60 19-20 18-23 5.6, 7.9 
met-T1107a Powder 15030 60 20 - - 
T1301 Liquid 6800 4 26 1-7 4.1, 6.2 
T1307 Cast solid 18000 72 23 >24 4.6, 7.8 
T150R1 Liquid 7900 5 29 1-7 4.8, 7.5 
amethylated T1107 
[Modified from Langmuir, 24 (2008) 10688-10697, J. Gonzalez-Lopez, C. Alvarez-
Lorenzo, P. Taboada, A. Sosnik, I. Sandez-Macho, and A. Concheiro, Self-
Associative Behavior and Drug-Solubilizing Ability of Poloxamine (Tetronic) Block 
Copolymers, Copyright (2008) with permission from American Chemical Society] 
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The chemical gelation time exhibited the consistent dency with the physical 
gelation and the previous report of self-aggregation. [200] Acryl-T1107 readily 
aggregated to form a gel almost instantaneously when t se macromer solutions were 
exposed to temperatures higher than their gelation poi t (>22°C). Adding Acryl-T904 
into the system increased the gelation time or handling time. This is consistent with the 
fact that higher T1107 content induced a stronger gl-like phase transition within 
molecules, which may cause to reduce the polymerization time. 
Tetronic®-based hydrogels were further crosslinked by Michael-type addition and 
their physical properties examined. Crosslinking efficiencies or gel contents were 
achieved up to 99%, suggesting that these end-linked etworks are almost free of defects 
such as intramolecular non-crosslinking cycles or incomplete conversion of monomers. 
[174] Tetronic®-based hydrogels presented low equilibrium swelling compared to 4-arm 
based PEG at 37°C. Cellesi and others also reported T1107 swelling ratio at different 
temperatures as a function of time, resulting in significantly less swelling ratio at 37°C. 
[200] Immediately after all the hydrogel samples were crosslinked, the difference in 
swelling behavior was significant, but small. However, due to the absence of PPO chains 
in the polymer structure of 4-arm PEG, these hydrogels do not have the property of 
hydrophobic self-aggregation and resulted in large volumetric change when equilibrium 
swelling was achieved. The hydrogels containing higher Acryl-T1107 content swelled 
more due to their large MW and a consequent large mesh size as well as increased 
hydrophilicity due to longer PEO chains. When the hydrophobic effects were inhibited at 
4°C, swelling behavior was dependent only on the mesh size and chemical-crosslinking 
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density. [205] Therefore, the volumetric swelling ratios of Tetronic® based hydrogels 
exhibited a more than twofold increase relative to th se at 37°C. The resulting swelling 
ratio of 4-arm PEG was not significantly different from the 75/25 group at 4°C probably 
due to the similarity of the overall average molecuar weight between crosslinks and 
crosslinking density. Blending Acryl-T904 and Acryl-T1107 induced a change in 
polymer length between thiol linkers in comparison t  a hydrogel network composed of 
only Acryl-T1107 or Acryl-T904. [174]  
The degradation of Tetronic® based hydrogels ranged from 18 (2.6 weeks) to 38 
days (5.4 weeks) according to the formulation. Their mass was maintained higher than 
80% within 2-3 weeks corresponding to the ordinary time of wound healing, and then 
decreased quickly. An idealized schematic of hydrolytic degradation within the 
Tetronic® based hydrogel network and the expected degradation products is shown in 
Figure 6.11. Degradation rates commonly achieved through changes in macromer 
concentration and molecular weight result in corresponding changes in molecular weight 
between crosslinks, crosslink density, and mechanical properties.  The hydrogel of 100/0 
group degraded faster than other groups due to higher water uptake resulting from their 
large size or MW and long PEO chains,. In addition, the amount of reactive functional 
groups in the 100/0 group is smaller than those of the other groups at the same 
concentration solution, which influences the amount of the reaction between acrylate and 

























































The presence of hydrogels produced very minimal cytotoxicity and had no effect 
on the cell proliferation. The reason for the formation of cell clusters was that cells did 
not adhere to the surface of the hydrogel and becam concentrated on the culture plate 
adjacent to the gel. Although there was no or minimal indication of cytotoxicity, the main 
concern at this point is the use of DTT. DTT has been widely used in cell biology, 
biochemistry, and biomedical investigation as an antidote, a protector of SH groups 
against uncontrolled oxidation, a radioprotector an antioxidant, and so on, whereas in 
some cases DTT was involved in apoptosis, generated toxicity and reactive oxygen 
species in the presence of ions such as Fe and Cu and damaged the cells. [206] The 
previous study already proved the feasibility and i  vivo biocompatibility of PEG of 
which the terminal hydroxyl groups were modified with thiol groups. [207] Ultimately 
DTT will be replaced with thiol-modified PEG macromers. 
Tetronic®-based hydrogels, especially T904 based hydrogels, exhibited 
geometrical stability within the channels of CCP fibers because they did not take up 
additional water above the volume used in the initial crosslinking reaction. Profilometer 
data suggested that the proper coating of hydrogel n the CCP fiber was achieved; only 
filling in the grooves. The main drawback of using ewly developed liner PEG-based 
hydrogel in Chapter 5 was geometric instability in the aqueous environment. In contrast, 
T904 based hydrogels exhibited long-term stability n the 37°C water. This suggests the 
suitability of Tetronic® based hydrogels to further application in fiber/hydrogel 
composites for gene delivery. 
6.5. Conclusions 
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The physical properties of Tetronic®-based hydrogels have been examined to 
evaluate their suitability as a fiber coating for cntrolled gene delivery. The sensitivity of 
these gels to their environmental conditions such as temperature was investigated, and it 
was shown that noncovalent, hydrophobic interactions strongly influenced their 
properties, resulting in distinction from regular PEG-based hydrogels. Due to the 
different composition of polymeric chains in T1107 and T904 macromers, each 
Tetronic® based hydrogel had distinct properties. Hydrogels with higher T1107 content 
underwent more swelling and quicker degradation. Increasing T904 content reduced 
swelling and increased degradation time. Overall, degradation times varied from 2 to 5 
weeks. Cell cultures displayed minimal cytotoxicity of crosslinking Tetronic® based 
hydrogels and the presence of hydrogels did not affect cell proliferation. Their 
geometrical stability suggests that Tetronic®-based hy rogels are capable of performing 
composite materials as coatings on polymeric fibers. In conclusion, Acryl-T904 was 








The objective of these studies was to achieve nonviral ector-mediated direct 
gene transfer to target cells that adhere to thin degradable hydrogel coatings. In the 
previous chapters, the preparation conditions of lyphilized nonviral vector complexes 
with a cryoprotectant were optimized and hydrogel materials with variable degradation 
rates were developed. T904-based hydrogels formed by Michael-type addition were 
selected for these studies based on their limited swelling and suitability for fiber coating. 
In this chapter, the preparation conditions of Acryl-T904-based hydrogels incorporating 
lyophilized gene complexes with sucrose were optimized by the evaluation of DNA 
stability before and after exposure to hydrogel comp nents and crosslinking, in vitro 
release kinetics of pDNA, and the addition of adhesive ligands to support cell attachment. 
Finally, the potential of the hydrogel gene delivery system was addressed through cell 
transfection on the degradable, thin hydrogel. PEI-pGFP (16µg) complex was prepared in 
two different volumes with a different amount of sucrose and then incorporated into 
hydrogels prepared by Method I and II. Esterase was employed to accelerate hydrogel 
degradation rate. It appeared that groups containing i creased amounts of sucrose within 
the hydrogel exhibited transfection at early time point of hydrogel degradation during the 
course of this study. Although further study is required to determine the relationship of 
transfection efficiency with hydrogel degradation, the transfection in the presence of 
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serum at early time point of hydrogel degradation as well as the geometrical stability of 
Acryl-T904-based hydrogel showed the potential of hydrogel-mediated gene delivery 
system as well as topographic support for cells.   
 
Keywords: controlled release, gene complex incorporation with hydrogel, hydrogel 






The overall goal of matrix-based gene delivery is to achieve localized, sustained 
expression of a therapeutic molecule. One major limitation of nonviral gene delivery 
technology is the external barrier of efficient vector transport and concentration at the cell 
surface. The incorporation of nonviral gene complexes into scaffolds is expected to 
increase the localization of vectors to the implant site and protect genes from their loss by 
degradation or clearance, resulting in an increase in the amount of gene complex at the 
cell surface. [21, 22] In these studies, it was hypothesized that nonviral vector release in 
intimate spatial proximity with adherent cells would minimize the external barrier of 
vector transport to the cell surface and increase transfection efficiency relative to 
conventional bolus transfection techniques. Using hydrogels will provide the capability to 
achieve controlled release kinetics of DNA, which is expected to be primarily a function 
of hydrogel degradation due to the relatively large size of gene complexes compared to 
the mesh size of crosslinked hydrogel networks. Theapplication of hydrogels as thin 
coatings on CCP fibers will combine biochemical and structural stimuli for tissue 
regeneration. In addition, different groups of fibers can be coated with hydrogels 
providing distinct degradation profiles and including different biomolecules, which 
provide a basis for temporal and spatial patterning of ene expression.  
In the previous chapters, the preparation conditions f lyophilized nonviral vector 
complexes with a cryoprotectant were optimized and hy rogel materials with variable 
degradation rates were developed. In this chapter, lyophilized gene complexes were 
incorporated in Acryl-T904-based hydrogel and i  vitro vector release from the resulting 
 144
hydrogel was tested. Addition of cell adhesive molecul s such as fibronectin and 
acrylated RGD peptide was evaluated to support cell attachment and provide the optimal 
environment for DNA delivery in the direct contact mode. Finally, the potential of this 
optimized hydrogel gene delivery system was addressed through cell transfection on thin 
hydrogel films. 
7.2. Materials and Methods 
7.2.1. Gene complex incorporation within hydrogels 
Both LC PEI and LC XG were prepared with 10% w/v sucrose in advance and 
dried by lyophilization. 100µl sample volumes for hydrogel crosslinking were composed 
of 90µl of Acryl-T904 solution (30mg Acryl-T904) and 10µl DTT solution (130mg/ml). 
T904 and DTT were both prepared in 50 mM PBS, syringe-filtered with a 0.2 µm 
Nalgene® filter, and the pH of T904 solution adjusted o pH7.2 prior to use. In the first 
method (Method I), lyophilized gene complexes (2µg pGFP per hydrogel) were 
resuspended in 10µl DTT solution first and then mixed with the T904 solution. For the 
second method (Method II), lyophilized gene complexes were resuspended in 90µl 
Acryl-T904 solution and then mixed with the DTT solution. Crosslinking was performed 
overnight at 37°C. LC PEI incorporating hydrogel and LC XG incorporating hydrogel 
were termed LC PEI-T904 hydrogel and LC XG-T904 hydrogel, respectively. To assess 
whether lyophilized complexes remained intact or pDNA remained supercoiled after 
Michael-type addition, LC PEI was resuspended either in DTT solution or in Acryl-T904 
solution and hydrogel was prepared by Method I and II. Hydrogel was degraded by pH12 
TE, neutralized, and then treated with 120mg/ml STP solution for decomplexation. 
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Collected DNA was analyzed by agarose gel electrophoresis and naked DNA was used as 
a control.  
7.2.2. The effect of hydrogel degradation products on PicoGreen assay 
The products expected to result from degradation of Tetronic®-based hydrogels 
included original, hydroxyl-terminated Tetronic® polymers and a low molecular weight 
carboxylic-acid terminated form of DTT. To determine the interference of degradation 
products with the PicoGreen assay, the amount of DNA detectable by PicoGreen assay 
was measured both in the presence and absence of hydrogel degradation products. The 
planned conditions of the release study (100µl volume samples of 30% w/v crosslinked 
T904 incubated in 2.5 ml PBS) were calculated to theoretically result in a 1.2% w/v 
concentration of hydrogel degradation products, assuming complete degradation. 
Therefore, in this study, 1% w/v and 2% w/v degradation concentrations were 
investigated. According to the previous studies, pH12 TE and 120mg/ml STP were 
compared for decomplexation. Hydrogel discs were prepa ed, following the method in 
7.2.1, and quickly degraded in pH12 TE. For pH12 TEdecomplexation, a proper 
concentration of degradation solution in pH12 TE was used without further alteration. 
For 120mg/ml STP treatment, degraded gel solution was neutralized to pH7.4 and a 
proper amount of STP was added to make the final concentration of hydrogel degradation 
products 1% w/v and 2% w/v. An equal amount of gene complex solution and 
decomplexation solution including degradation products was mixed to a final volume of 
100µl and incubated at room temperature for 30 minutes. The samples were then 
analyzed by the PicoGreen assay as described above (section 4.2.7 in Chapter 4). 
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7.2.3. Interaction of hydrogel degradation product with released DNA 
In Chapter 6, the effect of pH changes on the charge of the two amine groups in 
the center of Tetronic® structure was described. This property can induce negatively 
charged plasmid DNAs to bind to positively charged nitrogens, resulting in lower amount 
of DNA measured by PicoGreen assay. To characterize th s interaction, 2µg of naked 
pGFP was mixed with 100µl of 30% w/v unmodified T904 solution in 50mM PBS 
adjusted to varying pH (pH 6.5, 7.2, and 8.0) and the resulting solution was incubated at 
37°C for 4 hours. After incubation, the DNA amount was determined by PicoGreen 
assay. These samples, which were a mixture of pGFP and unmodified T904 at different 
pH, were added to 2.5ml PBS (pH7.4) and incubated ov rnight. Again, the DNA amount 
was measured by the PicoGreen assay. The DNA amount of all samples was compared 
with 2µg of naked pGFP in pH7.4 PBS as a control grup. 
7.2.4. Determination of plasmid DNA incorporation efficiency 
The initial DNA amount loaded within hydrogels was measured by PicoGreen 
assay. pH12 TE and 120mg/ml STP were compared in their decomplexation function. 
First, hydrogels were prepared by Methods I and II as described in 7.2.1 except 
lyophilized naked pGFP with sucrose was added as a control group. The resulting gels 
were quickly degraded in pH12 TE and neutralized to pH7.4. To achieve a concentration 
of DNA within a range suitable for the PicoGreen assay, the proper volume of each 
sample was calculated to make a final concentration for the PicoGreen assay to 100ng/ml. 
The samples were mixed with each decomplexation solution at a 1:1 volume ratio and 
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incubated at room temperature for 30 minutes. The efficiency was calculated from the 
amount of DNA recovered after gelation over the initial loaded DNA amount. 
7.2.5. In vitro release of plasmid DNA 
To test controlled release of DNA from the degradable hydrogels, hydrogel was 
prepared by Methods I and II as described in 7.2.1. µg of pGFP was loaded to each 
hydrogel (100µl). After overnight polymerization at 37°C, each hydrogel was placed in a 
scintillation vial containing 2.5ml PBS (pH7.4) and incubated on a shaker plate at 37°C. 
At each time point, the buffer solutions were sampled and replaced. The collected 
samples were frozen until PicoGreen analysis. The release samples at each time points 
were mixed with either pH12 TE or 120mg/ml STP for decomplexation of DNA at a 1:1 
volume ratio and incubated at room temperature for 30 minutes. The amount of DNA 
from LC PEI was measured as the initial amount of DNA loaded to hydrogel, based on 
which the released DNA amount was calculated. The amount of release DNA was 
measured by the PicoGreen assay as described in Chapter 4 (4.2.7). 
7.2.6. Modification of hydrogels with adhesive ligands 
The favorable substrate for cells to attach and prolife ate is important for 
transfection in the direct contact mode. The Tetronic® based hydrogel itself used in this 
study is nonadhesive due to PEG-based repulsion of protein adsorption and the lack of 
specific adhesive ligands. Hydrogels were prepared s escribed above (7.2.1) with the 
addition of cell adhesive molecules such as fibronecti  or acrylated RGD peptide. 
Acrylated peptide was synthesized via aminolysis of the N-hydroxy succinimide ester of 
acrylate-PEG-NHS (Nektar, 3400 MW) by the α-amine terminus of the peptide sequence 
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(GRGDS, Bachem). [176] When using fibronectin, 30mg of Acryl-T904 was dissolved in 
60µl of 50mM PBS and its pH was adjusted to pH7.2. DTT solution was prepared at the 
concentration of 173mg/ml and 7.5µl of DTT solution was mixed for at least 5 minutes 
with 2.5µl of fibronectin stock (1mg/ml, Sigma). This 10µl solution was added to Acryl-
T904 solution to make a hydrogel. When using acrylated peptide, 30mg of Acryl-T904 
was dissolved in 50µl of 50mM PBS and its pH was adjusted to pH7.2. 10µl of acrylated 
peptide (10µmol/ml) was mixed in Acryl-T904 solution and then the final solution was 
mixed with 10µl of DTT solution (130mg/ml). 80µl ofhydrogel solution was pipetted 
onto a slide glass and another slide glass was placed over the drop, separated by 1mm 
Teflon spacers. Hydrogel discs were attached to tissue culture plates (24-well) using UV-
sterilized silicon grease. NIH 3T3 fibroblasts (1×104 cells/ml) were seeded on the 
hydrogel disc and their adhesion and proliferation was observed by FDA/PI staining. 
7.2.7. Cell transfection through hydrogel compositions 
In Chapter 4, the preparation method of N/P7.5 LC PEI containing 10% w/v 
sucrose with total complex volume of 70µl was optimized. Sucrose solubility in water is 
2.039 g/ml at 20 °C. As increasing the amount of pGFP, resuspension of lyophilized 
complex with small volume of hydrogel component soluti n can limit sucrose dissolution. 
In this chapter, two methods of complex preparation were compared for cell transfection. 
For the first method, total gene complex volume (70µl) and sucrose concentration (10% 
w/v) were fixed while the amount of pGFP and PEI was increased at the N/P ratio of 7.5, 
For the second method, the complex volume was proporti nally increased with an 
increase in pGFP amount as well as an increase in the amount of PEI and sucrose. 
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Although sucrose concentration was fixed to 10% w/v, its total amount was increased 
with an increase of total complex volume. Before performing cell transfection through 
hydrogel compositions, transfection efficacy of gene complexes prepared by both 
methods was tested using NIH 3T3 fibroblasts (1×105cells/ml, 12well-plate). Considering 
cytotoxicity due to its high amount of DNA (16µg pGFP) and PEI, each LC PEI was 
resuspended with 560µl deionized water and then 2µg DNA (70µl LC PEI) was added to 
each well. At 48 hours post-transfection, cells were fixed, stained with DAPI and the 
transfection efficiency determined based on the percentage of GFP+ cells. For cell 
transfection through hydrogel compositions, LC PEIs were from different solution 
volumes as described above. Each lyophilized complex was resuspended in either DTT 
solution (Method I) or Acryl-T904 solution (Method II), followed by mixing with either 
T904 solution or DTT solution, respectively. The pre ared solution was pipetted into a 
12well-plate and spread to make a very thin gel. Hydrogels were maintained with cell 
culture media with or without syringe-filtered esterase (15units/ml) and new media 
replaced at each time point (0, 1, 3, 7 and 10days). 1×105 cells/well of NIH 3T3 fibroblast 
suspension in 300µl media was added after a change in m dia at each time point. 
7.2.8. Statistical analysis 
Statistical analysis was performed by single factor ANOVA using Tukey's HSD 
method for post hoc comparisons. p values <0.05 were considered to be statistically 
significant. All results were expressed as mean ± standard deviation. 
7.3. Results 
7.3.1. The effect of hydrogel components on DNA stability 
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Figure 7.1 shows that neither hydrogel component solution affected the 
complexation between PEI and pGFP. pGFP of supercoil d form was maintained after 
the crosslinking process in either hydrogel preparation method in comparison with DNA 
bands of LC PEI in Figure 4.6(a) in Chapter 4. Light intensity of supercoiled form of 
DNAdecreased. However, there was no increase in relaxed or linear conformations of 
DNA. It was already seen that lyophilization process somehow reduced supercoiled form 
in the DNA conformation in the case of LC PEI and transfection efficiency. (Figure 4.3 
and 4.6 in Chapter 4) As same as shown in Figure 4.6(a) in Chapter 4, DNA dissociated 
from PEI complexes appeared as a dim line of supercoil d conformation due to some loss 
of supercoiled form by lyophilization process. The unusual traces moving from the well 
to cathode were observed only in samples containing Acryl-T904. (Figure 7.1(b))  
The electrophoretic behavior of T904 or Acryl-T904 is shown in Figure 7.2. 
Figure 7.2 shows that T904 itself had a tendency to move toward cathode and emit light 
under UV. A mass of polymers could be seen with the naked eye above the wells without 




Figure 7.1. The effect of Michael
gene complexes and released DNA following hydrogel preparation by 
or Method II (b). (a) Lane 1: 1kb DNA ladder, Lane 2: naked pGFP, Lane 3: naked 
pGFP + DTT solution, Lane 4: LC PEI + DTT solution without decomplexation, 
Lane 5: after crosslinking, decomplexation
DNA ladder, Lane 2: naked pGFP, Lane 3: naked pGFP + 
Lane 6: LC PEI without decomplexation, Lane 7: LC PEI + 




   
)         (b) 
-type addition polymerization on the stability of 
Method I (a) 
 with 120mg/ml STP. (b) Lane 1: 1kb 
Acryl- T904 solution, 
Acryl- T904 solution 





Figure 7.2. Electrophoretic behavior of T904; (a) Agarose gels containing EtBr; 
Lane 1: naked pGFP+Acryl
LC PEI+Acryl- T904, Lane 4: LC PEI+unmodified T904, (b) Agarose gels prepared 
without EtBr; Lane 5 and 7: 
without EtBr; For lane 5 and 6, 20µl of 30% w/v 
T904 solution was added. The image of lane 7 and 8 is a visible light photograph of 
lane 5 and 6   
 
7.3.2.  The effect of the hydrogel
Figure 7.3 shows the effect of the presence of hydrogel degradation products on 
DNA detection by the PicoGreen assay when various concentrations of degradation 
solution were added to naked DNA and each gene complex.
varied depending on the decomplexation method. When pH12 TE buffer was used, the 
DNA amount significantly decreased with an increase in the amount of degradation 
products. For 120mg/ml STP solution, samples in the presence of degradat
except for naked DNA group changed the DNA amounts by less than 14% in comparison 
with hydrogel-free samples. 
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-T904, Lane 2: naked pGFP+unmodified T904, Lane 3: 
Acryl-T904 with EtBr, Lane 6 and 8: unmodified
either Acryl-T904 or unmodified 
 degradation products on PicoGreen assay











Figure 7.3. The effect of concentration of the hydrogel degradation products on 
DNA detection by PicoGreen assay; (a) Decomplexation by use of pH12 TE and (b) 
120mg/ml STP treatment for decomplexation, p<0.05, * and # represent significant 
difference in comparison with 0% w/v degradation product and 1% w/v 
degradation product, respectively 
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7.3.3. Interaction of hydrogel degradation product with released DNA 
Increasing amounts of DNA were recovered as the pH of unmodified T904 
solution was reduced Figure 7.4. The self-aggregation strongly occurred at 37°C at 30% 
w/v T904, which reduced the DNA amount to 74% (±5.25) in pH6.5 in comparison with 
the control group in pH7.4 PBS. After dilution in 2.5ml PBS (pH7.4) at 37°C, pH effect 
significantly disappeared, while micelle formation with DNA still existed. Only 72.64% 
to 77.66% of the initial DNA amount was detected. This result was consistent with the 
effect caused by hydrogel degradation products in Figure 7.3. 
 
Figure 7.4. Interaction of unmodified T904 macromers (100µl, 30% w/v in 50mM 
PBS) with DNA, p<0.05, letters and * represent significant difference between 
groups and in comparison with pH7.4 PBS group, respectively 
 
7.3.4. Plasmid DNA incorporation efficiency 
The measurement of the initial DNA amount within T904 hydrogels was shown in 
Figure 7.5. The measured DNA amount decreased after hydrogel crosslinking. In the 
naked DNA case, the measured DNA amounts in the presence of 2% w/v hydrogel 
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degradation products were 74.83% (±0.57) over the initial DNA amounts. (Figure 7.3(b)) 
In addition, the detected DNA amount in the presence of unmodified T904 and dilution in 
pH7.4 PBS in Figure 7.4 was 74.47% (±7.95) in the pH7.2 group. When naked DNA 
actually underwent hydrogel crosslinking process and then was released from a hydrogel, 
the recovered amount was 53.30% (±0.68) in Method I and 63.25% (±1.16) in Method II 
of the initial loaded amount under a neutral condition (pH7.4), whereas addition of STP 
solution lowered DNA detection more. (Figure 7.5) Total DNA recovery was 
significantly better in the hydrogel group prepared by Method II than the group prepared 
by Method I (except for pH12 TE treatment). The complexation with PEI also 
significantly influenced DNA release or detection. When STP was used for 
decomplexation, the measured initial DNA amounts of LC PEI-T904 hydrogel prepared 
by both Method I and II decreased significantly in comparison with DNA-T904 hydrogel, 
resulting in 24.71% (±0.54) in Method I and 37% (±1.83) in Method II. pH12 TE 
treatment exhibited the worst DNA recovery, 14.02% (±3.00) in Method I and 13.56% 
(±4.30) in Method II. 
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Figure 7.5. Initial DNA amount loaded within T904 based hydrogel; p<0.05, letters 
represents significant difference between groups, Method I: DNA or LC PEI was 
resuspended in DTT solution, Method II: DNA or LC PEI was resuspended in 
Acryl-T904 solution 
 
7.3.5. In vitro release of plasmid DNA 
Figure 7.6 shows the release profiles for the different hydrogel preparation and 
decomplexation methods. Overall, the release profile f DNA from hydrogels prepared 
by Method I showed consistent release over time and closely matched the hydrogel 
degradation profile. In the case of Method II, there was a small initial burst detected on 
day 1, likely due to a small amount of unincorporated DNA, and substantial burst release 
at the last point measured prior to reverse gelation and hydrogel dissolution. As shown in 
Figure 7.6, 120mg/ml STP solution exhibited more eff ctive as a decomplexation agent 
than pH12 TE buffer and was less influenced by hydrogel degradation products. The 
results in Figure 7.6 (b) show the increased DNA amounts detected for both loading 
Methods, resulting in 32.57% (±1.08) recovery in Method I and 40.95% recovery (±2.28) 
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in Method II. In spite of a change in the DNA amount detected, the choice of 





Figure 7.6. In vitro release of DNA from LC PEI-T904 hydrogels; DNA 
decomplexation (a) by pH12 TE treatment and (b) by 120mg/ml STP treatment, 
Method I: LC PEI was resuspended in DTT solution, Method II: LC PEI was 
resuspended in Acryl-T904 solution  
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7.3.6. Modification of hydrogels with adhesive ligands 
Both fibronectin and acrylated peptide (GRGDS) were inv stigated to induce cell 
attachment and proliferation. When fibronectin was used, cell behavior was inconsistent, 
independent of the hydrogel preparation methods. Most of the time, cells tended to form 
clumps and partially survived on the hydrogel. Their growth was very slow and the 
morphology of fibroblasts was more in rounded form, different from their longitudinal 
shape. Figure 7.7 (a) and (b) show a selected portion of a hydrogel where fibroblasts were 
attached after 4 days in culture. Unfortunately, the rest of the hydrogel surface was 
unable to support cell growth. In contrast, acrylated peptide improved cell attachment and 
proliferation consistently, resulting in uniform cell adhesion and growth on the hydrogel 
surface. (Figure 7.7 (c) and (d)) Fibroblasts on the peptide-T904 hydrogel grew relatively 




(a)     (b) 
  
 (c)     (d) 
Figure 7.7. NIH 3T3 proliferation on the LC PEI-T904 hydrogels with various cell 
adhesive molecules; 4 days in culture on (a, b) fibronectin-modified hydrogels and (c, 
d) acrylated peptide-modified hydrogels, figures on the left are hydrogel prepared 
by Method I and figures on the right are hydrogel prepared by Method II (Scale 
bars = 100µm) 
 
7.3.7. Cell transfection through hydrogel compositions 
This study investigated the transfection of fibroblasts in direct contact with thin 
hydrogel films. Lyophilized complexes were prepared either by mixing 16µg pDNA in 
70µl with 10% w/v sucrose (7mg) or by mixing 16µg pDNA in 560µl with 10% w/v 
sucrose (56mg). Both gene complexes exhibited fibroblast transfection without 
significant difference in performance between prepaation methods when using 
conventional bolus injection in serum-free medium (data not shown). However, the 
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groups prepared by the method that increased the complex volume with increased sucrose 
amount within the hydrogel started exhibiting cell transfection 1day after  cell seeding on 
samples maintained in buffer for 1 day (data not shwn).  In addition, esterase accelerated 
hydrogel degradation, resulting in transfection at earlier time points of hydrogel 
degradation in comparison with the groups without esterase in the culture media. Figure 
7.8 and 7.9 show cell transfection around hydrogels at 1day and 3days of hydrogel 
degradation, caused by release of gene complex from hydrogels in the esterase-containing 
media. Both hydrogel groups prepared by Method I and II with gene complexes with 
increased volume exhibited sustained gene expression up to 6 days in culture. However, 
the transfection efficiency was very low with less than 1% of adherent cells exhibiting 
GFP fluorescence.  
 
Figure 7.8. Transfection of NIH 3T3 fibroblasts 
presence of 10% BGS and esterase
T904-based hydrogel prepared
degradation. Gene complex 
fluorescent images on the left column and only fluorescent images on the right 
column. Asterisk and arrows indicate a hydrogel and transfected cells, respectively. 





at 48 hour post-transfection in
 (15units/ml) via gene complex released from 
 by Method I; (a) 1day and (b) 3days hydrogel 











Figure 7.9. Transfection of NIH 3T3 fibroblasts at 48 hour post-transfection in the 
presence of 10% BGS and esterase (15units/ml) via gene complex released from 
T904-based hydrogel prepared by Method II; (a) 1day and (b) 3days hydrogel 
degradation. Gene complex with increased volume was used. Phase contrast and 
fluorescent images on the left column and only fluorescent images on the right 
column. Asterisk and arrows indicate a hydrogel and transfected cells, respectively. 
(4x magnification, Scale bars = 100µm)  
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7.4. Discussions 
The incorporated LC PEI was released from the T904-based hydrogel and DNA 
dissociated from those complexes was primarily in the supercoiled forms, whereas total 
amount seemed decreased. (Figure 7.1) A decrease in DNA amount can be caused by 
lyophilization process as shown in Figure 4.6 in Chapter 4 rather than Michael-type 
addition polymerization. Neither hydrogel component solution damaged LC PEI or 
pGFP. In the previous studies, the photoencapsulated DNA was severely damaged by UV 
light, resulting in loss of supercoiled conformation and potentially decrease in 
transfection efficacy. [118, 119] Removal of free radicals within the system via Michael-
type addition improved DNA protection. In this study, the electrophoretic behavior or 
T904 was evaluated. The unusual traces moving toward c thode was not related to DNA 
binding to T904 molecules. Instead, T904 itself hasthe own electrophoretic property, 
possibly positively charged, which forced polymers to move to the negatively charged 
pole.  (Figure 7.2) Also, T904 (or acrylated) was detectable under the UV and with bare 
eyes without dye such as EtBr.  
As mentioned before, the majority of degradation products are theoretically 
Tetronic® polymers or T904 in this case, it is possible for T904 to form micelles at high 
pH like pH12 and high temperature (> room temperature, 37°C) and trap DNA or gene 
complexes within those micelles. This event interfer d with the interaction between 
PicoGreen reagent and dsDNA, resulting in poor effici ncy of the PicoGreen assay. 
(Figure 7.3) STP solution was able to reduce the pH effect on T904 macromers. (Figure 
7.3 (b)) However, micelle interference still remained in the presence of hydrogel 
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degradation products, due to the pH of the STP solution (pH8.2-8.3). To make sure that 
reduction in the detected DNA amount was caused by T904 micellization, the pH effect 
on T904 was further studied. Ideally, protonated amines in low pH lead to columbic 
repulsion and reduce aggregation. [195] However, if negatively charged DNA binds to 
these protonated amines electrostatically, repulsion between polymers can be reduced and 
the micelle formation can be increased. Decreasing pH could help DNA binding as well 
as micellization, resulting in a decrease in DNA detection by the PicoGreen assay. 
However, as shown in Figure 7.4, higher pH induced more loss of detection efficiency, 
that is, the micellization driven by pH was more dominant event rather than electrostatic 
binding. The following dilution of these samples (100µl) in higher volume (2.5ml) 
reduced pH-driven columbic repulsion and confirmed that the micelle formation of 
Acryl-T904 polymers with DNA was only reason to reduce the efficiency of PicoGreen 
assay-based DNA detection. And furthermore, the effct of Acryl-T904 polymers on 
DNA or gene complexes released from degradable hydrogels was investigated. (Figure 
7.5) Again, a basic environment caused by use of both STP and pH12 TE facilitated 
polymer micelle formation and interfered with the PicoGreen assay. Comparing the DNA 
amount after STP treatment, the release of complexes was significantly lower than that 
obtained for plasmid alone in both methods. It seemed that LC PEI incorporated into the 
hydrogels was primarily retained within the hydrogel. In vitro release data also showed 
the similar tendency to reduced DNA amount, approximately 33% and 41% of for 
Method I and II, respectively. (Figure 7.6) Similarly, Wieland and others reported the 
reduced release of DNA when PEI-DNA complexes were incorporated into PEG-HA 
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based hydrogels. In their case, for example, only 14% of the initial DNA was measured in 
one type of hydrogels that exhibited 80% release of the initial DNA. The reduction in the 
DNA amount can be induced by nonspecific interaction between PEI and hydrogel 
polymer. One possible reason can be the reaction of primary or secondary amines in PEI 
with polymer groups such as vinyl groups in Acryl-T904. Those amines can undergo 
Michael-type addition with acrylate groups. In fact, several studies used this 
polymerization process to improve PEI function as gene delivery vector by conjugating 
with various acrylated polymers including PEG diacrylates, PCL diacrylates, etc. [208-
210] Unlike Michael-type addition between thiol and acrylate groups within the hydrogel 
network, their crosslinking process required higher t mperature than 37°C, organic 
solvent or a certain catalyst. So, those studies cannot fully explain the happening in our 
system. However, when LC-PEI was resuspended in Acryl-T904 solution (Method II), 
the DNA release was almost detained until the hydrogel was completely degraded and 
released gene complexes in a burst manner. In contrast to Method II, LC-PEI 
resuspended in DTT solution first had less chance of xposure to acrylate groups in 
Acryl-T904. The hydrogel prepared in Method I allowed DNA release in the more linear 
feature. It is necessary to conduct further experimnt in order to understand the 
interaction of PEI with acrylated hydrogel polymers. On the other hand, Tetronic® 
polymers have been investigated as gene delivery systems due to micellar formulations 
based on their amphiphilic structural property. [190, 196, 211, 212] If the unfavorable 
reaction between amines in PEI and acrylates in Acryl-T904 is removed by incorporating 
only plasmid DNA, Tetronic® based hydrogels via Michael-type addition will provide 
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DNA protection as well as the structural and release stability unlike easily reversible, 
thermally generated gel. The previous studies indicated that the in vivo application of 
naked DNA loaded-Tetronic® molecules as gene delivery increased several fold the 
transfection efficiency and the production of recombinant proteins, which suggested that 
the co-existent hydrogel degradation product may help to stabilize gene complexes 
released from our gene delivery system and to improve transfection efficiency. 
For reverse gene delivery or surface-mediated DNA delivery, providing cell-
friendly environment at the substrate is the crucial factor. In this study, fibronectin and 
acrylated peptide was incorporated with T904 based hydrogel. (Figure 7.7) Fibronectin is 
an adhesive glycoprotein and one of popular adhesive proteins to mediate cellular 
adhesion to the matrix. As one of approach of substrate-mediate delivery system, 
manipulating the surface properties of a substrate is he critical factor to impact cellular 
response and gene delivery. The adsorption of adhesive proteins including ECM proteins 
has been used as a simple approach to increase the positive interaction of both DNA/gene 
complex and cells onto the material surface, resulting in an increase in gene expression 
levels and gene-expressing cell numbers. Shea group investigated the mechanism and 
optimal conditions of various serum (e.g. BSA, FBS, fibronectin) and ECM proteins (e.g. 
fibronectin, collagen, laminin) to enhance transgene expression in substrate-mediate 
delivery via lipoplexes (lipofectamin) or polyplexes (PEI). [23, 130, 137, 138] Based on 
their results, fibronectin mediated the highest leve s of transgene expression, whereas the 
protein identity did not influence substrate binding. [23, 130] It was expected that 
incorporation of fibronectin with the current Tetronic® based hydrogels might improve 
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cell adhesion as well as potential support for gene int rnalization. However, the 
fibronectin effect on cell attachment was very incosistent at each try. This event can be 
explained by pH-dependent conformational states of fibronectin. [213-215] A 
conformational change occur when solution pH deviats from physiological range of pH, 
for example, unfolded form of fibronectin at pH 2 or 11. In our cases, although pH did 
not exceed neutral condition, each sample might have slightly different pH so that caused 
a change in the fibronectin conformation. In spite of using microorganisms, Ito and 
colleagues indicated that subtle pH changes such as that from 6.8 to 7.6 caused a 
conformational change in fibronectin. The same phase in fibronectin possibly happened 
in our study. In contrast, peptide-T904 based hydrogels exhibited the uniform fibroblasts 
attachment at the overall hydrogel surface. While mild evidence of cell death was 
observed in fibroblasts cultured on the hydrogel surface, the promoted cell adhesion and 
spreading on the hydrogel were seen. Several studie showed the same data that 
incorporated peptide into nonadhesive PEG-based hydrogels dramatically reduced their 
protein repellant properties and increased the number of attached cells, correlated with a 
strong cell spreading. [176, 216-218] Acrylated RGD peptide (or acryoly PEG-RGD) 
seemed to be more affected by their concentration for the application and MW of PEG 
spacer rather than pH that there has not been yet an  study related to pH. 
Finally, transfection of NIH 3T3 fibroblasts in direct contact with thin hydrogel 
films in the presence of serum was investigated. It appeared that groups containing 
increased amounts of sucrose within the hydrogel exhibited transfection at early time 
point of hydrogel degradation during the course of this study. The large amount of 
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sucrose within hydrogel (56mg sucrose/100µl hydrogel) appeared to change the hydrogel 
crosslinking rate, especially Method I (data not shown). The effect of the sucrose amount 
on the hydrogel crosslinking rate might cause a change in hydrogel network or 
crosslinking density, resulting in the different transfection performance due to a change 
in degradation kinetics. In fact, increasing the sucrose amount reduced the pH, which 
might have caused a pH change in the final hydrogel solution after resuspending 
lyophilized gene complexes. Alternatively, the inclusion of a large amount of sucrose 
may have produced defects in the network structure, increasing the effective network 
mesh size, and allowing accelerated vector release. E terase was expected to promote 
hydrogel degradation as described in the previous studies. [219-221] Although the effect 
of esterase on the hydrogel degradation kinetics wa not investigated in this study, it 
seemed that esterase might enhance the hydrogel degradation and the subsequent gene 
complex release, resulting in the cell transfection at early time points (Day 1 and 3 
hydrogel degradation) in comparison with the condition without esterase. In the case of 
hydrogels with the small amount of sucrose (7mg sucrose/100µl hydrogel), however, the 
effect of esterase was not as beneficial as when it was used for hydrogel with the large 
amount of sucrose within the designed time period in this study. As shown in Figure 7.6, 
the DNA amount released from hydrogel was lower than 2% of the initial loaded DNA 
within 7days of hydrogel degradation in the case of 120mg/ml STP decomplexation. The 
release kinetics was also very low until the end point f hydrogel degradation; perhaps 
the poor transfection in the group with the small amount of sucrose was due to an 
insufficient supply of DNA for cell transfection. The problem observed in this study was 
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the poor cell adherence to the hydrogels, which caused only cell transfection around the 
hydrogel, not at the hydrogel in the direct contact mode. Although acrylated RGD-
peptide improved cell attachment and proliferation on the hydrogel surface as shown in 
Figure 7.7, its effect seemed to be dulled by the incorporation of lyophilized gene 
complexes. Further study is required to explain the cause of a change in peptide activity 
within hydrogels. 
7.5. Conclusions 
 This study has shown that DNA in an active, supercoiled form can be released 
from degradable hydrogels prepared by Michael-type addition. Due to the unique 
properties of Tetronic® or T904 in this case, unique conditions were requred to analyze 
released DNA, reducing the interaction of polymer with released DNA via micelle 
formation. Unspecified reactions occurred between PEI complex and acrylated polymer, 
which detained gene complex release and subsequently induced a decrease in total 
amount of DNA released. Although peptide-T904 based hy rogels exhibited uniform 
fibroblast attachment at the overall hydrogel surface, lyophilized PEI-pGFP complexes 
affected peptide activity, resulting in the poor cell adherence to the hydrogel and the 
subsequent poor transfection. However, the sustained gene expression was observed 
around the hydrogel, which contained the large amount f sucrose, in the presence of 
both serum and esterase during the designed time period in this study. Above all, the 
suggested approach in this study is unique in its ability to facilitate the simultaneous gene 
expression and support of transfected cell growth. Combination strategies combining 
these controlled, substrate-based gene delivery system and topographical support by the 
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grooved fibers will provide a large step to mimic the multifaceted nature of complex 
tissue regeneration.  
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CHAPTER EIGHT 
CONCLUSIONS AND RECOMMENDATIONS 
 
8.1. Conclusions 
The major objective of this dissertation was to develop hydrolytically degradable 
hydrogels incorporating nonviral vectors and providing, controlled vector release based 
on hydrogel polymer properties. Furthermore, combining this system with the 
topographical guidance as the combinatorial strategy was suggested to increase the 
potential of these hydrogel compositions to mimic the multifaceted nature of complex 
tissue regeneration. As seen in the reverse transfection as a pilot study, the result of the 
dramatic increase in transfection in the presence of serum suggested that hydrogel-based 
delivery of nonviral vectors may concentrate vectors near the surface of adherent cells in 
a similar manner and also achieve improved transfection efficiency. Relative to substrate-
mediated reverse transfection approaches, it is expected that encapsulation of vectors 
within a hydrogel matrix may provide improved vector stability and avoid an initial burst 
release. This research project was conducted in three main sections: optimal formulation 
of gene complex able to be condensed throughout hydrogel-based gene delivery system, 
development and characterization of hydrogel matrix capable of controlled release as 
well as geometrically stable under physiological condition, and evaluation of effective 
gene delivery in a controlled manner based on a population of cells in proximity to 
biodegradable hydrogel.  
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To design gene delivery system incorporating gene complex, lyophilization 
process was required to concentrate a sufficient amount of DNA within the hydrogel 
delivery system. To protect gene complex from in-process damage during lyophilization, 
the effect of different cryoprotectant agents was evaluated. In these preliminary studies, 
all X-tremeGene (XG) formulations and N/P 7.5 PEI complex lyophilized with 10% 
sucrose exhibited similar transfection efficiencies following lyophilization. Because XG 
is a proprietary material of undisclosed composition, N/P 7.5 PEI was selected for the 
entire study. At the same time, identifying the most effective decomplexation method was 
fundamental for the current study to measure the amount of released nonviral-DNA 
complexes from hydrogels. In comparison of various solutions to dissociate DNA from 
complexes, 120 mg/ml STP treatment was found to provide the highest level of DNA 
recovery and detection.  
One important component associated with matrix-based system is the 
maintenance of cell viability and proliferation, whic  is a critical factor to accomplish 
local DNA delivery to a population of cells proximal to the material surface. Although 
both linear poly(ethylene glycol)(PEG)-based hydrogels and Tetronic®-based hydrogels 
appeared noncytotoxic, hydrogels do not contain any bioactivity. Therefore, it is essential 
to modify those hydrogels with cell adhesive molecus. Addition of RGD peptide into 
the both linear PEG-based and Tetronic®-based hydrogel networks provided ligands for 
cell adhesion. 
In the case of substrate-mediated gene delivery, the nature of DNA 
immobilization method hindered sustained gene delivery, resulting in either uncontrolled 
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initial burst release due to non-specific DNA adsorpti n to the surface or suppressed 
DNA release due to strong binding with substrate. In contrast, both linear PEG-based and 
Tetronic®-based hydrogels achieved significant variation in degradation rate and 
exhibited potential as a controlled release system. Crosslinkable, hydrolytically 
degradable PEG-based macromers were successfully prepared with high conversion 
efficiency by a novel two-step synthetic route using difunctional chemical intermediaries. 
Through variation in the alkyl chain length of the chemical intermediary, significant 
variation in degradation rate was achieved without significantly altering the gel physical 
properties. The sustained release profile of immunoglobulin G (IgG) suggested the 
feasibility of these PEG-based hydrogels for gene delivery system in spite of different 
nature of IgG from DNA. However, the delamination of these PEG-based hydrogels as 
fiber coatings in the aqueous environment was limited for their application in 
combinatorial system investigated in this dissertation. Also, free radicals generated 
during photopolymerization should be taken into account.  
On the other hand, Tetronic® polymers have the distinct properties from PEG 
polymers due to their polymeric structure, two amine groups in the center and four-armed 
amphiphilic chains, which result in the self-aggregation depending on environmental 
conditions such as temperature and pH. Tetronic®-based hydrogels prepared via 
Michael-type addition showed its ability to release DNA in an active, supercoiled form 
with a profile closely correlated to hydrogel degradation kinetics as well as significantly 
improved, geometrical stability when coated on polymer fibers. However, this release 
profile was dependent on the hydrogel type and preparation method with gene complex. 
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Hydrogels with higher Tetronic® 1107 (T1107) content or lower Tetronic® 904 (T904) 
content underwent more swelling and quicker degradation, which will shorten the period 
of DNA release (at least 18days). T904-based hydrogel used in this study exhibited the 
least change in its size and prolonged degradation kinetics. When lyophilized PEI-DNA 
complex was resuspended in dithiothreitol (DTT) soluti n, DNA release was more 
sustained than one resuspended in T904 solution. It was concluded that there were 
nonspecific interactions between PEI complex and acryl ted polymer, which delayed 
gene complex release and subsequently induced a decreas  in total amount of DNA 
released. In addition, the self-aggregation properties of Tetronic® polymers influenced 
not only hydrogel network structure but also the gene complex behavior. The hydrogel 
degradation products interfered with the DNA detection assay (PicoGreen assay), 
resulting in a decrease in the measured amount of DNA. In vitro DNA detection may be 
problematic with the presence of degradation product, mainly Tetronic® polymer itself. 
However, several studies indicated that the in vivo application of naked DNA loaded-
Tetronic® molecules as gene delivery increased several fold the transfection efficiency 
and the production of recombinant proteins, which suggested that the co-existent 
hydrogel degradation product may help to stabilize gene complexes released from our 
gene delivery system and to improve transfection effici ncy at least in in vivo models. 
Although there was some positive transfection in the presence of serum for the group 
with increased amount of sucrose, in vitro transfection was very limited and its efficiency 
was lower than 1%. Low transfection efficiency in vitro might be due to the non-linear 
degradation kinetics of Acryl-T904 hydrogels, which caused the delayed DNA release at 
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early time point of hydrogel degradation. Again, i  vivo application of the current gene 
delivery system based on the Tetronic®-based hydrogels may enhance the degradation 
rate, resulting from hydrolysis and enzymatic degradation caused by the cellular 
environment. Increased degradation kinetics of the hydrogel will enhance the DNA 
release rate, possibly resulting in an increase in transfection efficiency. 
8.2. Recommendations 
The key challenges identified in these studies were 1) non-linear vector release 
kinetics and 2) limited in vitro transfection. There are several potential solutions t  these 
problems. A likely factor contributing the delayed release of vectors from T904-based 
hydrogels is the relatively large size of the gene complexes (~100nm). Therefore, 
significant degradation was required in order for the mesh size to sufficiently expand to 
allow vector release. One approach to overcoming this problem is the creation of blends 
of Acryl-T904 and acrylated T904 modified with the chloroacetyl chloride chemistry 
described in Chapter 5. The presence of an additional ester bond in this second product 
will likely accelerate degradation and various blends are expected to exhibit degradation 
profiles with increased linearity and concurrent improvements in vector release. A similar 
principle has been demonstrated by Anseth’s group using photopolymerized PEG-
diacrylates prepared with oligo-alpha hydroxyl acid sequences of varying composition, 
degree of polymerization, and hence susceptibility to hydrolytic degradation. [118, 119] 
Within the context of the present work, the effect of Tetronic® polymers or 
degradation products on the transfection is yet unknown in this study. They could hinder 
gene delivery by forming micelles to retain gene complex and/or by covalent links to 
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PEIs. It was noticed the possibility of the nonspecific interaction between PEI and 
Tetronic® polymers according to in vitro release data. If only considering of this side 
reaction between two molecules, replacing PEI with o er nonviral vectors with less 
amine contents can be a simple approach. Cationic lipid-based vectors can be alternative. 
However, it was known that positively charged surface of both polyplex and lipoplex 
limits their transfection efficacy in vivo. 
An alternative approach would be the use of Tetronic®-based hydrogels for the 
delivery of naked plasmid DNA. Although almost universally ineffective in vitro, several 
groups have continued to pursue naked DNA delivery in vivo and demonstrated effective 
transfection in several tissues. [196, 222] Recent work on noncationic vectors has also 
suggested that amphiphilic block copolymers, although they cannot condense DNA in the 
manner of PEI, can promote transfection and gene expression, although the mechanisms 
responsible remain largely unknown. In addition, Tetronic®-DNA complexes showed 
promising results including gene transfer in skeletal and heart muscle in vivo. [211] 
Therefore, there is the possibility that Tetronic® degradation products help gene delivery 
by protecting DNA from environmental barriers via hydrophilic chains as well as 
association with cell membrane via hydrophobic chains. Several groups have shown that 
naked DNA can be released by diffusion from hydrogels that severely restrict the release 
of gene complexes. [19, 115, 128] So, using only naked DNA with Tetronic®-based 
hydrogels may be another approach to avoid the nonspecific interaction with cationic 
polymers used for gene complexes and increase transfection efficiency in vivo. Using 
T904-based hydrogels, released naked DNA may spontaneously associate with T904 
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degradation products to take advantage of this effect, which will provide more controlled 
gene delivery due to removal of the potential covalent binding to polymers. Also, it was 
noticed that lyophilization process damaged DNA in some degree even in the presence of 
a cryoprotectant; PEI-mediated complex with sucrose in this study. Adjusting DNA 
concentration during purification process may remove lyophilization process and in-situ 
process damage on DNA. In addition, i  vitro transfection in the presence of serum was 
resulted with very limited transfection for a short time. Further studies addressing the 
long-term DNA release and the subsequent transfection efficiency are required. However, 
several studies showed that the efficacy of transfection was different between i vivo and 
in vitro applications. Since Tetronic®-based hydrogels exhibited the delayed degradation 
properties, in vivo application may increase the degradation rates caued by hydrolysis as 
well as enzymatic degradation (e.g., esterase releas d from cells).  
As combinatorial strategy, hydrogel-based gene delivery should be combined with 
the CCP fiber as a topographical support. Although initial geometric stability of T904-
based hydrogel was observed, hydrogel stability will change over time with hydrogel 
degradation, so long-term monitoring of hydrogel coating state should be followed. 
However, when target cells adhere to the coating surface, the degradation rate will be 
changed or increased, which can contribute two ways; i) to stimulate gene release from 
hydrogel as well as transfection of cells, and ii) hydrogel escape/dissociation from the 
fiber. However, the second phase may not be problematic depending on the cell density 
on the surface. It will be dependent on the cell affinity to the surface in vitro and in vivo 
and cell clearance by inflammatory and immune cells in the body. To this end, multiple 
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therapeutic gene delivery through various hydrogel coating on the fiber will be feasible. 
Each fiber can be coated with distinct degradation profile of hydrogels carrying different 
biomolecules, which will satisfy the complexity of tissue regeneration such as spinal cord. 
For the clinical application, the proper sterilizaton and packaging techniques should be 
investigated. For sterilization, terminal sterilizat on is more active method to destroy 
viable microorganisms than aseptic processing, and c  be done by various procedures 
including steam sterilization, ethylene oxide (EtO) sterilization, hydrogen peroxide (H2O2) 
sterilization, gamma radiation, and autoclave. [223, 224] However, each procedure has its 
own advantages and disadvantages and will affect th properties of hydrogels as well as 
the stability of gene complexes. Also, the reproducibility of sterilization is important. 
Therefore, it is essential to examine the effects of terilization process on the properties 
of polymeric materials including morphological struct re, thermal behavior, swelling and 
degradation behavior, as well as DNA release profile. The choice of packaging 
techniques will play an important role in the success of hydrogel-based gene delivery 
system in this study as merchandise as well as appeal to clinicians. Due to the 
lyophilization of gene complexes and the geometrical st bility of T904-based hydrogels 
after swelling at 37°C, the dry product can be commercialized and can be directly 
implanted to the targeting site such as the lesion at the spinal cord. At this point, the main 
concern will be the proper time point to use the developed gene delivery system in this 
study. For example, the phase of damage varies over tim  in the spinal cord injury, which 
requires the different protein factors at each time point. Again, combining the multiple 
therapeutic genes through distinct degradation profile  hydrogel coatings on the fibers 
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should be followed for each application. However, suturing the end points to the host 
tissue is still required during implantation, which may cause further damage to the lesion 
and host tissue. Therefore, the study of an alternaive to suturing will be required.  
As an unexpected outgrowth of this project, Tetronic®-based hydrogels were 
noted to have interesting and potentially useful mechanical properties including the 
ability to withstand substantially higher levels ofdeformation than observed for 
hydrogels crosslinked by free radical polymerization (see Appendix D). When applied to 
tissue surfaces, these materials are able to achieve bonding strengths at least as high as 
conventional hydrogel-based sealants such as PEG-diacrylates and fibrin glue. Therefore, 
Tetronic®-based hydrogels may be useful in tissue adhesive/sealant applications with the 
capability for modulating the wound healing process through the gene delivery strategies 
developed in this dissertation. Although a seemingly minor point, Tetronic®s may also 
be advantageous due to their limited swelling after crosslinking under physiological 
conditions relative to PEG-based hydrogels that swell considerably (up to 5-10 times 
initial swelling ratio) after crosslinking. To our knowledge, the effects of this swelling 





















Figure A-1: Adenine-nucleotide; one base of DNA 
A.1. Introduction 
The N/P ratio is a measure of the ionic balance of the complexes, referring to the 
number of nitrogen residues of the vector per the number of DNA phosphate groups.  
A.2. The number of phosphate in 1µg DNA  
DNA is made up of four building blocks, called nucleotides. The molecular 
weights of these four nucleotides (A,C,G,T) are notidentical, so in routine work we 
usually average the molecular weights of all four and go with 330 Daltons (Da) per 
nucleotide in DNA (=330 g/mol of individual nucleotides). MW of a nucleotide pair in 
the double strand DNA would be 660 g/mol. 
i. The number of phosphate/mol = 2/mol 

















A.3. The number of nitrogen in 1µg PEI 
Since 25kDa b-PEI was used in this study and repeating unit of PEI is 43g/mol, 


























A.4. Conversion of N/P number ratio to mass ratio of PEI to DNA 








































































Calculation of depth and width of the CCP fiber 
Data from profilometer analysis only gives the surface roughness (= shape). 
Contour processed data can be converted to 2D profile. To calculate depth and width of 
untreated or special treated fiber such as plasma treatment, hydrogel coating etc., Y 
profile in 2D profile was used. Software (Wyko vision 32) gave length of x and y axis by 
moving the plot cursor that indicated the cursor positi n and the distant difference. Width 



















Figure B-1: Calculation of depth and width of one groove at the capillary channel 






Mechanical properties of photocrosslinked, linear PEG-based hydrogels 
C.1. Mechanical analysis 
Hydrogels were photopolymerized from solutions of varying macromer 
composition and concentration as described earlier, cut into dog-bone shaped specimens 
according to ASTM D 5937, and equilibrated in distilled water overnight. Five to six 
specimens of each group were subjected to uniaxial tensile testing at a constant crosshead 
speed of 10 mm/min using an MTS Synergie 100 equipped with a 10 N load cell. In order 
to facilitate gripping of the specimens, pieces of Kimwipe were applied to the grip 
portions of the dog bones. All samples were subjected to two cycles of 20% strain and 
relaxation to ensure sample slippage did not occur, and then strained to failure. The 
Young's modulus, elongation at break and ultimate tensile strength (UTS) were 
determined for each sample. 
C.2. Results 
C.2.1. Influence of macromer concentration on mechanical properties 
The corresponding initial (Day 1) tensile properties of PEG-bis-AA hydrogels 
prepared at various concentrations are summarized in Table C-1. With increasing 
macromer concentration, the hydrogels became stiffer and less elastic, exhibiting 
significant increases in Young's modulus and ultimae tensile strength (UTS) among all 
samples and decreased elongation at break. Comparing 10% w/v and 40% w/v hydrogels, 
elongation at break was reduced by approximately half, whereas Young's modulus and 
UTS both increased by more than an order of magnitude. 
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Table C-1. Tensile properties of hydrogels polymerized from solutions containing 




(kPa) UTS (kPa) 
Elongation at Break 
(%) 
10 73.72±9.43 45.72±16.13 63.05±19.96* 
20 429.26±12.34 164.09±19.31 47.29±6.02* 
40 1041.89±40.00 262.08±8.19 31.09±3.13 
*All values were significantly different with exception of elongation at break (%) 
between 10 and 20% w/v 
 
C.2.2. Influence of macromer chemical composition on mechanical properties 
Young's modulus, UTS, and percent elongation at break of hydrogels prepared 
from the different macromers are shown in Table C-2. No significant differences in 
mechanical properties were observed among the hydrogels prepared from macromers 
based on the different chemical intermediaries. 




(kPa) UTS (kPa) 
Elongation at 
Break (%) 
PEG-bis-AA 73.72±9.43 45.72±16.13 63.05±19.96 
PEG-bis-AP 69.55±5.62 38.23±8.68 57.48±9.78 
PEG-bis-AB 72.78±2.19 37.38±4.79 58.75±9.47 
*No significant differences were observed among different hydrogel chemical 




Mechanical properties of Tetronic®-based hydrogels 
D.1. Mechanical analysis 
D.1.1. Tensile properties 
Hydrogels were polymerized from solutions of varying macromer composition of 
Acryl-T1107 and Acryl-T904 as described above, cut into dog-bone shaped specimens 
according to ASTM D5937, and equilibrated in 37°C PBS (pH7.4) overnight. Five to six 
specimens of each group were subjected to uniaxial tensile testing at a constant crosshead 
speed of 10 mm/min using an MTS Synergie 100 equipped with 10N load cell. In order 
to facilitate gripping of the specimens, pieces of Kimwipe were applied to the grip 
portions of the dog bones. All samples were subjected to two cycles of 20% strain and 
relaxation to ensure sample slippage did not occur, and then strained to failure.  The 
Young’s modulus, tensile elongation at break and ultimate tensile strength (UTS) were 
determined for each sample. 
D.1.2. Bonding strength 
The bonding strength was investigated using rat skin referring to ASTM 2255. 
The rats were humanely euthanized using a CO2 chamber. Rat skins were collected using 
sterile surgical tools, were stored in 150mM sterile NaCl and were cut into 4cm×1cm 
strips. The hydrogel solutions were applied at one e d (approximately 1cm×1cm) of one 
skin strip and another skin strip was placed over it. The polymerization was maintained at 
37°C overnight in a humidified atmosphere and then equilibrated in 37°C PBS (pH7.4) 
before testing. More than five specimens of each group were subjected to uniaxial 
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strength at a constant crosshead speed of 10 mm/min using an MTS Synergie 100 
equipped with 10N load cell. In order to facilitate gripping of the specimens, pieces of 
Kimwipe were applied to both ends of rat skins. All samples were strained until two skins 
were detached from each other.  The bonding strength were determined Test samples 
were kept at 37°C and were tested at room temperatur . 
D.2. Results 
D.2.1. Tensile properties 
The tensile properties of Tetronic®-based hydrogels were tested over the different 
temperature. (Figure D-1) With increasing Acryl-T904 content, the hydrogels saturated 
with 37°C PBS became more elastic as well as more firm, exhibiting increased Young’s 
modulus and increased strain to failure. In comparison with Tetronic®-based hydrogels, 
4-arm PEG-based hydrogels appeared easily breakable at 44% strain with low Young’s 
modulus (ca. 181.21kPa). In comparison with 37°C testing temperature, Young’s 
modulus of the specimens, which were saturated at 4°C, decreased and lowered than 4-
arm-based PEG at 37°C in the case of 100/0, but still ended to increase as an increase in 
Acryl-T904 content. However, strain to failure of all groups decreased to exhibit close to 
strain of 4-arm-based PEG at 37°C. 
Young’s modulus is a bulk property of the hydrogel and correlates with the 
hydrogel’s cohesive strength. Figure D-1 shows that increasing Acryl-T904 content 
caused an increase in Young’s modulus at both 37°C and 4°C. As explained before, the 
solution of Acryl-T904 has more functional groups reactive with thiol groups than one of 
Acryl-T1107 at the same concentration, resulting in more crosslinking density within the 
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gel networks and stronger hydrogels with higher tensil  strength (data not shown). 
Interestingly, the strain to failure of Tetronic®-based hydrogels increased with an 
increase in Acryl-T904 contents at 37°C or was higher t an 4-arm PEG. It will give the 
flexibility as the adhesives. Exclusive of hydrophobic effects, this may be due to the 
increased number of thiol linkers that form elastically active chain. [174] However, data 
from 4°C didn’t support this assumption because their strain to failure exhibited similar 
values among groups. Therefore, hydrophobic effects had a greater influence on the 
mechanical properties of hydrogels than the chemical crosslinking composition. 
D.2.2. Bonding strength 
The tissue bonding strength of all Tetronic®-based hy rogels ranged between 
approximately 10-25 kPa except for 4-arm PEG hydrogels. (Figure D-2) Bonding 
strength was significantly higher in all formulations including Acryl-T904 relative to 
homogeneous Acryl-T1107. This likely reflects reduced average macromer molecular 
weights and subsequent increased number of reactive functional groups available to react 
with the skin tissue. 
The observation from Figure D-2 is that the different composition did not appear 
to affect the adhesive’s strength significantly except for 100/0 group. However, the 
average bonding strength of each group had a tendency to increase with an increase in 
Acryl-T904 content. Consistently, hydrophobic interaction strongly affected hydrogel 
bonding strength, resulting from the very weak bonding of 4-arm PEG-based hydrogel. 
An advantage of Tetronic®-based hydrogel is a high bonding strength to soft tissues 
(skin). The adhesive strengths for Tetronic®-based hy rogels ranged from 18.3 (±1.42) 
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to 21.68 (±1.03) kPa except for 11.54 (±0.93) kPa of 100/0 group, suggesting a stronger 
adhesiveness than fibrin-based sealants and comparable with other tissue adhesives used 
in clinical and experimental procedures. 
 
Figure D-1: Tensile properties of various Tetronic®-based hydrogels, p<0.05, * 
represents significant difference between two temperatures, lett rs represent the 




Figure D-2: Bonding strength of various Tetronic®-based hydrogels, p<0.05, letters 





Reversible swelling behavior of Tetronic®-based hydrogels 
E.1. Test of reversible swelling behavior 
The reversible swelling behavior of the hydrogels at consecutive time intervals 
was measured according to the volumetric swelling ratio equation as well. All the 
hydrogel discs were prepared at 37°C according to the methods as stated above, and 
submerged in 4ml of 37°C PBS (pH 7.4). Then, the sample bottles were stored at 4°C 
room for 24 hours, followed by storing at 37°C for another 24 hours. The total incubation 
time was 98 hours with the storing temperature alternat d every 24 hours. 
E.2. Results 
The temperature-reversibility of the hydrogel or the reversible swelling-
deswelling kinetics of hydrogels is illustrated in Figure 5.6. Hydrogel samples were 
prepared in 37°C PBS (pH7.4) and then placed in the 4°C environment. The hydrogels 
increased their swelling ratio, showing the average volumetric swelling ratio of 13.2 for 
100/0 group, 11.5 for 75/25 group, 10.4 for 50/50 group and 9.3 for 0/100 group, 
respectively. When hydrogels were placed in the 37°C environment, the hydrogels 
collapsed and showed a dramatic decrease in swelling ratio.  Increasing Acryl-T904 
content induced more shrink, for example, for 0/100 group showing 62.37% decrease in 
the volumetric swelling ratio in comparison to 49.24% decrease for 100/0 group. They 
were returned to 4°C and increased their size again. The swollen networks reverted to 
relatively shrunk networks whenever the temperature increased.  
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The dynamic or reversible swelling behavior exhibited hat increasing Acryl-T904 
contents induced more contraction of gel networks. Although raw T904 did not show the 
physical gelation within the experimental temperature (up to 40°C), Acryl-T904-based 
hydrogels strongly exhibited hydrophobic aggregation f the PPO chains. After 
polymerization, Acryl-T904 molecules were fixed within the gel networks and the 
repulsions among positive amine groups were dismissed. T904 has longer PPO chains 
than PEO chains (PPO:PEO=17:15), so hydrophobic attraction among PEO chains and 
the hydrogen-bonding of water rearranged around the hydrophobic molecules drove the 
hydrophobic effect on the hydrogel networks. Therefor , the aggregation of PPO chains 
strongly impacted the water uptake of 0/100 group hydrogels, corresponding to the 
contraction of a half portion of gel networks. For Acryl-T1107-based hydrogels, even an 
increase in temperature caused hydrophobic aggregation, PEO chains of T1107 are 
roughly three times longer than PPO chains, which resulted in better water uptake than 
Acryl-T904 hydrogels. 
 
Figure E-1. The reversible swelling behavior of various Tetronic®-based hydrogels; 
100/0 (×), 75/25 (●), 50/50 (■), and 0/100 (▲). The change in temperature ranged 





1. Murray, M. and I. Fischer, Transplantation and gene therapy: combined 
approaches for repair of spinal cord injury. Neuroscientist, 2001. 7(1): p. 28-41. 
2. Park, T.G., J.H. Jeong, and S.W. Kim, Current status of polymeric gene delivery 
systems. Adv Drug Deliv Rev, 2006. 58(4): p. 467-86. 
3. Rubanyi, G.M., The future of human gene therapy. Mol Aspects Med, 2001. 22(3): 
p. 113-42. 
4. Crystal, R.G., Transfer of genes to humans: early lessons and obstacle  to success. 
Science, 1995. 270(5235): p. 404-10. 
5. Han, S., et al., Development of biomaterials for gene therapy. Mol Ther, 2000. 
2(4): p. 302-17. 
6. Kodama, K., et al., The features and shortcomings for gene delivery of current 
non-viral carriers. Curr Med Chem, 2006. 13(18): p. 2155-61. 
7. Marshall, L.H., Careful planning created the Society for Neurosciene. Science, 
2000. 290(5500): p. 2259. 
8. Abdallah, B., et al., A powerful nonviral vector for in vivo gene transfer into the 
adult mammalian brain: polyethylenimine. Hum Gene Ther, 1996. 7(16): p. 1947-
54. 
9. Gao, X., K.S. Kim, and D. Liu, Nonviral gene delivery: what we know and what 
is next. Aaps J, 2007. 9(1): p. E92-104. 
10. Jackson, D.A., S. Juranek, and H.J. Lipps, Designing nonviral vectors for efficient 
gene transfer and long-term gene expression. Mol Ther, 2006. 14(5): p. 613-26. 
11. Ledley, F.D., Nonviral gene therapy: the promise of genes as pharmaceutical 
products. Hum Gene Ther, 1995. 6(9): p. 1129-44. 
12. Nishikawa, M. and L. Huang, Nonviral vectors in the new millennium: delivery 
barriers in gene transfer. Hum Gene Ther, 2001. 2(8): p. 861-70. 
13. Sakurai, H., et al., Innate immune response induced by gene delivery vectors. Int J 
Pharm, 2008. 354(1-2): p. 9-15. 
14. Chollet, P., et al., Side-effects of a systemic injection of linear polyeth lenimine-
DNA complexes. J Gene Med, 2002. 4(1): p. 84-91. 
15. Moghimi, S.M., et al., A two-stage poly(ethylenimine)-mediated cytotoxicity: 
implications for gene transfer/therapy. Mol Ther, 2005. 11(6): p. 990-5. 
16. Gautam, A., C.L. Densmore, and J.C. Waldrep, Pulmonary cytokine responses 
associated with PEI-DNA aerosol gene therapy. Gene Ther, 2001. 8(3): p. 254-7. 
17. Segura, T. and L.D. Shea, Materials for non-viral gene delivery. Annu Rev Mater 
Res, 2001. 31: p. 25-46. 
 194
18. Bonadio, J., et al., Localized, direct plasmid gene delivery in vivo: prolonged 
therapy results in reproducible tissue regeneration. Nat Med, 1999. 5(7): p. 753-9. 
19. Shea, L.D., et al., DNA delivery from polymer matrices for tissue engineering. Nat 
Biotechnol, 1999. 17(6): p. 551-4. 
20. Robbins, P.D. and S.C. Ghivizzani, Viral vectors for gene therapy. Pharmacol 
Ther, 1998. 80(1): p. 35-47. 
21. Laporte, L.D. and L.D. Shea, Matrices and scaffolds for DNA delivery in Tissue 
engineering. Adv Drug Deliv Rev, 2007. 59(4-5): p. 292-307. 
22. Houchin-Ray, T., et al., Patterned PLG substrates for localized DNA delivery and 
directed neurite extension. Biomaterials, 2007. 28(16): p. 2603-2611. 
23. Bengali, Z., J.C. Rea, and L.D. Shea, Gene expression and internalization 
following vector adsorption to immobilized proteins: dependence on protein 
identity and density. J Gene Med, 2007. 9(8): p. 668-78. 
24. Annex, B.H. and M. Simons, Growth factor-induced therapeutic angiogenesis in 
the heart: protein therapy. Cardiovasc Res, 2005. 65(3): p. 649-55. 
25. Pannier, A.K. and L.D. Shea, Controlled release systems for DNA delivery. Mol 
Ther, 2004. 10(1): p. 19-26. 
26. Segura, T. and L.D. Shea, Surface-tethered DNA complexes for enhanced gene 
delivery. Bioconjug Chem, 2002. 13(3): p. 621-9. 
27. Cho, E., et al., A novel synthetic route for the preparation of hydrolytically 
degradable synthetic hydrogels. J Biomed Mater Res A, 2009. 0(4): p. 1073-82. 
28. Marshall, E., Gene therapy death prompts review of adenovirus vector. Science, 
1999. 286(5448): p. 2244-5. 
29. Patil, S.D., D.G. Rhodes, and D.J. Burgess, DNA-based therapeutics and DNA 
delivery systems: a comprehensive review. AAPS J, 2005. 7(1): p. E61-77. 
30. Zhang, X. and W.T. Godbey, Viral vectors for gene delivery in tissue engineering. 
Adv Drug Deliv Rev, 2006. 58(4): p. 515-34. 
31. Park, F., Lentiviral vectors: are they the future of animal transgenesis? Physiol 
Genomics, 2007. 31(2): p. 159-73. 
32. Abdellatif, A.A., et al., Gene delivery to the spinal cord: comparison between 
lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res, 
2006. 84(3): p. 553-67. 
33. Muruve, D.A., The innate immune response to adenovirus vectors. Hum Gene 
Ther, 2004. 15(12): p. 1157-66. 
34. Kennedy, P.G., Potential use of herpes simplex virus (HSV) vectors for gene 
therapy of neurological disorders. Brain, 1997. 120 ( Pt 7): p. 1245-59. 
35. Uherek, C. and W. Wels, DNA-carrier proteins for targeted gene delivery. Adv 
Drug Deliv Rev, 2000. 44(2-3): p. 153-66. 
 195
36. Wolff, J.A., et al., Direct gene transfer into mouse muscle in vivo. Science, 1990. 
247(4949 Pt 1): p. 1465-8. 
37. Amiji, M.M., Polymeric Gene Delivery Vehicles: Principles and Applications. 1 
(Sep. 29, 2004) ed. 2004: CRC press. 704. 
38. Davis, M.E., Non-viral gene delivery systems. Curr Opin Biotechnol, 2002. 13(2): 
p. 128-31. 
39. Zabner, J., et al., Cellular and molecular barriers to gene transfer by a cationic 
lipid. J Biol Chem, 1995. 270(32): p. 18997-9007. 
40. Wagner, E., Application of membrane-active peptides for nonviral gene delivery. 
Adv Drug Deliv Rev, 1999. 38(3): p. 279-289. 
41. Kichler, A., et al., Influence of membrane-active peptides on lipospermine/DNA 
complex mediated gene transfer. Bioconjug Chem, 1997. 8(2): p. 213-21. 
42. Kamata, H., et al., Amphiphilic peptides enhance the efficiency of liposome-
mediated DNA transfection. Nucleic Acids Res, 1994. 22(3): p. 536-7. 
43. Liu, G., et al., Biological properties of poly-L-lysine-DNA complexes generated 
by cooperative binding of the polycation. J Biol Chem, 2001. 276(37): p. 34379-
87. 
44. Storrie, H. and D.J. Mooney, Sustained delivery of plasmid DNA from polymeric 
scaffolds for tissue engineering. Adv Drug Deliv Rev, 2006. 58(4): p. 500-14. 
45. Maruyama, A., et al., Characterization of interpolyelectrolyte complexes b tween 
double-stranded DNA and polylysine comb-type copolymers having hydrophilic 
side chains. Bioconjug Chem, 1998. 9(2): p. 292-9. 
46. Choi, Y.H., et al., Polyethylene glycol-grafted poly-L-lysine as polymeric gene 
carrier. J Control Release, 1998. 54(1): p. 39-48. 
47. Fischer, D., et al., In vitro cytotoxicity testing of polycations: influence of polymer 
structure on cell viability and hemolysis. Biomaterials, 2003. 24(7): p. 1121-31. 
48. Kunath, K., et al., Low-molecular-weight polyethylenimine as a non-viral vector 
for DNA delivery: comparison of physicochemical properties, transfection 
efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J 
Control Release, 2003. 89(1): p. 113-25. 
49. Neu, M., D. Fischer, and T. Kissel, Recent advances in rational gene transfer 
vector design based on poly(ethylene imine) and its erivatives. J Gene Med, 
2005. 7(8): p. 992-1009. 
50. Godbey, W.T., K.K. Wu, and A.G. Mikos, Tracking the intracellular path of 
poly(ethylenimine)/DNA complexes for gene delivery. P oc Natl Acad Sci U S A, 
1999. 96(9): p. 5177-81. 
 196
51. Sonawane, N.D., F.C. Szoka, Jr., and A.S. Verkman, Chloride accumulation and 
swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J 
Biol Chem, 2003. 278(45): p. 44826-31. 
52. Thomas, M. and A.M. Klibanov, Enhancing polyethylenimine's delivery of 
plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A, 2002. 99(23): p. 
14640-5. 
53. Godbey, W.T., K.K. Wu, and A.G. Mikos, Size matters: molecular weight affects 
the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater 
Res, 1999. 45(3): p. 268-75. 
54. Ogris, M., et al., The size of DNA/transferrin-PEI complexes is an important 
factor for gene expression in cultured cells. Gene Ther, 1998. 5(10): p. 1425-33. 
55. Moret, I., et al., Stability of PEI-DNA and DOTAP-DNA complexes: effect of 
alkaline pH, heparin and serum. J Control Release, 2001. 76(1-2): p. 169-81. 
56. Segura, T., P.H. Chung, and L.D. Shea, DNA delivery from hyaluronic acid-
collagen hydrogels via a substrate-mediated approach. Biomaterials, 2005. 
26(13): p. 1575-84. 
57. Goula, D., et al., Size, diffusibility and transfection performance of linear 
PEI/DNA complexes in the mouse central nervous system. Gene Ther, 1998. 5(5): 
p. 712-7. 
58. Ahn, H.H., et al., DNA/PEI nano-particles for gene delivery of rat bone marrow 
stem cells. Colloids and surfaces A: Physicochem. Eng. Aspects, 2008. 313-314: p. 
116-120. 
59. Petersen, H., et al., Poly(ethylenimine-co-L-lactamide-co-succinamide): a 
biodegradable polyethylenimine derivative with an adv ntageous pH-dependent 
hydrolytic degradation for gene delivery. Bioconjug Chem, 2002. 13(4): p. 812-
21. 
60. Kukowska-Latallo, J.F., et al., Efficient transfer of genetic material into 
mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad 
Sci U S A, 1996. 93(10): p. 4897-902. 
61. Wiethoff, C.M. and C.R. Middaugh, Barriers to nonviral gene delivery. J Pharm 
Sci, 2003. 92(2): p. 203-17. 
62. Lukacs, G.L., et al., Size-dependent DNA mobility in cytoplasm and nucleus. J 
Biol Chem, 2000. 275(3): p. 1625-9. 
63. Watson, J.D., et al., Molecular Biology of the Gene, in Wikipedia, the free 
encyclopedia. 2004, Pearson Benjamin Cummings: CSHL Press. 
64. Bessis, N., F.J. GarciaCozar, and M.C. Boissier, Immune responses to gene 
therapy vectors: influence on vector function and effector mechanisms. Gene Ther, 
2004. 11 Suppl 1: p. S10-7. 
 197
65. Zhang, X., et al., The in vivo use of chloroquine to promote non-viral gene 
delivery to the liver via the portal vein and bile duct. The jornal of gene medicine, 
2003. 5(3): p. 209-218. 
66. Harrington, K., et al., Cells as vehicles for cancer gene therapy: the missing link 
between targeted vectors and systemic delivery? Hum Gene Ther, 2002. 13(11): p. 
1263-80. 
67. Pouton, C.W. and L.W. Seymour, Key issues in non-viral gene delivery. Adv 
Drug Deliv Rev, 2001. 46(1-3): p. 187-203. 
68. Dash, P.R., et al., Factors affecting blood clearance and in vivo distribution of 
polyelectrolyte complexes for gene delivery. Gene Ther, 1999. 6(4): p. 643-50. 
69. Zhang, J.S., F. Liu, and L. Huang, Implications of pharmacokinetic behavior of 
lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev, 2005. 57(5): p. 689-
98. 
70. Tuszynski, M.H., Gene therapy: Applications to the neurosciences and to 
neurological disease. The neuroscientist, 1998. 4(6): p. 398-407. 
71. Heyde, M., et al., Gene therapy used for tissue engineering applications. J Pharm 
Pharmacol, 2007. 59(3): p. 329-50. 
72. Clamme, J.P., J. Azoulay, and Y. Mely, Monitoring of the formation and 
dissociation of polyethylenimine/DNA complexes by two photon fluorescence 
correlation spectroscopy. Biophys J, 2003. 84(3): p. 1960-8. 
73. Finsinger, D., et al., Protective copolymers for nonviral gene vectors: synthesis, 
vector characterization and application in gene deliv ry. Gene Ther, 2000. 7(14): 
p. 1183-92. 
74. Bikram, M., et al., Long-circulating DNA-complexed biodegradable multiblock 
copolymers for gene delivery: degradation profiles and evidence of 
dysopsonization. J Control Release, 2005. 103(1): p. 221-33. 
75. Levy, R.J., et al., Localized adenovirus gene delivery using antiviral IgG 
complexation. Gene Ther, 2001. 8(9): p. 659-67. 
76. Luo, D. and W.M. Saltzman, Enhancement of transfection by physical 
concentration of DNA at the cell surface. Nat Biotechnol, 2000. 18(8): p. 893-5. 
77. Luo, D. and W.M. Saltzman, Synthetic DNA delivery systems. Nat Biotechnol, 
2000. 18(1): p. 33-7. 
78. Read, M.L., et al., A versatile reducible polycation-based system for efici nt 
delivery of a broad range of nucleic acids. Nucleic Acids Res, 2005. 33(9): p. e86. 
79. Godbey, W.T., et al., Improved packing of poly(ethylenimine)/DNA complexes 
increases transfection efficiency. Gene Ther, 1999. 6(8): p. 1380-8. 
 198
80. Fahrmeir, J., et al., Electrophoretic purification of tumor-targeted 
polyethylenimine-based polyplexes reduces toxic side effects in vivo. J Control 
Release, 2007. 122(3): p. 236-45. 
81. Tseng, W.C., F.R. Haselton, and T.D. Giorgio, Mitosis enhances transgene 
expression of plasmid delivered by cationic liposomes. Biochim Biophys Acta, 
1999. 1445(1): p. 53-64. 
82. Varga, C.M., et al., Quantitative comparison of polyethylenimine formulations 
and adenoviral vectors in terms of intracellular gene delivery processes. Gene 
Ther, 2005. 12(13): p. 1023-32. 
83. Tseng, W.C., F.R. Haselton, and T.D. Giorgio, Transfection by cationic liposomes 
using simultaneous single cell measurements of plasmid delivery and transgene 
expression. J Biol Chem, 1997. 272(41): p. 25641-7. 
84. Varga, C.M., K. Hong, and D.A. Lauffenburger, Quantitative analysis of synthetic 
gene delivery vector design properties. Mol Ther, 2001. 4(5): p. 438-46. 
85. Fernandez-Tarrio, M., et al., Pluronic and tetronic copolymers with 
polyglycolyzed oils as self-emulsifying drug delivery systems. AAPS 
PharmSciTech, 2008. 9(2): p. 471-9. 
86. De Laporte, L., J. Cruz Rea, and L.D. Shea, Design of modular non-viral gene 
therapy vectors. Biomaterials, 2006. 27(7): p. 947-54. 
87. Hoffman, A.S., Hydrogels for biomedical applications. Adv Drug Deliv Rev, 
2002. 54(1): p. 3-12. 
88. Hubbell, J.A., Biomaterials in tissue engineering. Biotechnology (N Y), 1995. 
13(6): p. 565-76. 
89. Luten, J., et al., Biodegradable polymers as non-viral carriers for plasmid DNA 
delivery. J Control Release, 2008. 126(2): p. 97-110. 
90. Jang, J.H. and L.D. Shea, Controllable delivery of non-viral DNA from porous 
scaffolds. J Control Release, 2003. 86(1): p. 157-68. 
91. Jang, J.H., C.B. Rives, and L.D. Shea, Pl smid delivery in vivo from porous 
tissue-engineering scaffolds: transgene expression and cellular transfection. Mol 
Ther, 2005. 12(3): p. 475-83. 
92. Cohen-Sacks, H., et al., Delivery and expression of pDNA embedded in collagen 
matrices. J Control Release, 2004. 95(2): p. 309-20. 
93. Mooney, D.J., et al., Novel approach to fabricate porous sponges of poly(D,L-
lactic-co-glycolic acid) without the use of organic solvents. Biomaterials, 1996. 
17(14): p. 1417-22. 
94. Harris, L.D., B.S. Kim, and D.J. Mooney, Open pore biodegradable matrices 
formed with gas foaming. J Biomed Mater Res, 1998. 42(3): p. 396-402. 
 199
95. Dang, J.M. and K.W. Leong, Natural polymers for gene delivery and tissue 
engineering. Adv Drug Deliv Rev, 2006. 58(4): p. 487-99. 
96. Fang, J., et al., Stimulation of new bone formation by direct transfer of osteogenic 
plasmid genes. Proc Natl Acad Sci U S A, 1996. 93(12): p. 5753-8. 
97. Tyrone, J.W., et al., Collagen-embedded platelet-derived growth factor DNA 
plasmid promotes wound healing in a dermal ulcer model. J Surg Res, 2000. 
93(2): p. 230-6. 
98. Doukas, J., et al., Matrix immobilization enhances the tissue repair activity of 
growth factor gene therapy vectors. Hum Gene Ther, 2001. 2(7): p. 783-98. 
99. Chandler, L.A., et al., Matrix-enabled gene transfer for cutaneous wound repair. 
Wound Repair Regen, 2000. 8(6): p. 473-9. 
100. Ochiya, T., et al., New delivery system for plasmid DNA in vivo using 
atelocollagen as a carrier material: the Minipellet. Nat Med, 1999. 5(6): p. 707-
10. 
101. Chandler, L.A., et al., FGF2-Targeted adenovirus encoding platelet-derived 
growth factor-B enhances de novo tissue formation. Mol Ther, 2000. 2(2): p. 153-
60. 
102. Berry, M., et al., Sustained effects of gene-activated matrices after CNS injury. 
Mol Cell Neurosci, 2001. 17(4): p. 706-16. 
103. Ochiya, T., et al., Biomaterials for gene delivery: atelocollagen-mediated 
controlled release of molecular medicines. Curr Gene Ther, 2001. (1): p. 31-52. 
104. Kyriakides, T.R., et al., Regulation of angiogenesis and matrix remodeling by 
localized, matrix-mediated antisense gene delivery. Mol Ther, 2001. 3(6): p. 842-
9. 
105. Fukunaka, Y., et al., Controlled release of plasmid DNA from cationized glatin 
hydrogels based on hydrogel degradation. J Control Release, 2002. 80(1-3): p. 
333-43. 
106. Kushibiki, T., et al., In vivo release and gene expression of plasmid DNA by 
hydrogels of gelatin with different cationization extents. J Control Release, 2003. 
90(2): p. 207-16. 
107. Kushibiki, T., et al., Controlled release of plasmid DNA from hydrogels prepared 
from gelatin cationized by different amine compounds. J Control Release, 2006. 
112(2): p. 249-56. 
108. Yamamoto, M. and Y. Tabata, Tissue engineering by modulated gene delivery. 
Adv Drug Deliv Rev, 2006. 58(4): p. 535-54. 
109. Guo, T., et al., Porous chitosan-gelatin scaffold containing plasmid DNA 
encoding transforming growth factor-beta1 for chondrocytes proliferation. 
Biomaterials, 2006. 27(7): p. 1095-103. 
 200
110. Megeed, Z., J. Cappello, and H. Ghandehari, Controlled release of plasmid DNA 
from a genetically engineered silk-elastinlike hydrogel. Pharm Res, 2002. 19(7): p. 
954-9. 
111. Megeed, Z., J. Cappello, and H. Ghandehari, Genetically engineered silk-
elastinlike protein polymers for controlled drug deliv ry. Adv Drug Deliv Rev, 
2002. 54(8): p. 1075-91. 
112. Megeed, Z., et al., In vitro and in vivo evaluation of recombinant silk-elastinlike 
hydrogels for cancer gene therapy. J Control Release, 2004. 94(2-3): p. 433-45. 
113. Meilander-Lin, N.J., et al., Sustained in vivo gene delivery from agarose hydrogel 
prolongs nonviral gene expression in skin. Tissue Eng, 2005. 11(3-4): p. 546-55. 
114. des Rieux, A., A. Shikanov, and L.D. Shea, Fibrin hydrogels for non-viral vector 
delivery in vitro. J Control Release, 2009. 136(2): p. 148-54. 
115. Kong, H.J., et al., Design of biodegradable hydrogel for the local and sustained 
delivery of angiogenic plasmid DNA. Pharm Res, 2008. 25(5): p. 1230-8. 
116. Sawhney, A.S., C.P. Pathak, and J.A. Hubbell, Bioerodible hydrogels based on 
photopolymerized poly(ethylene glycol)-co-poly(.alph .-hydroxy acid) diacrylate 
macromers. Macromolecules, 1993. 26(4): p. 581-587. 
117. Metters, A.T., C.N. Bowman, and K.S. Anseth, A Statistical Kinetic Model for the 
Bulk Degradation of PLA-b-PEG-b-PLA Hydrogel Networks. Journal of Physical 
Chemistry B (J. Phys. Chem. B), 2000. 1 4(30): p. 7043-7049. 
118. Quick, D.J. and K.S. Anseth, Gene delivery in tissue engineering: a photopolymer 
platform to coencapsulate cells and plasmid DNA. Pharm Res, 2003. 20(11): p. 
1730-7. 
119. Quick, D.J. and K.S. Anseth, DNA delivery from photocrosslinked PEG hydrogels: 
encapsulation efficiency, release profiles, and DNA quality. J Control Release, 
2004. 96(2): p. 341-51. 
120. Quick, D.J., K.K. Macdonald, and K.S. Anseth, Delivering DNA from 
photocrosslinked, surface eroding polyanhydrides. J Control Release, 2004. 97(2): 
p. 333-43. 
121. Wieland, J.A., T.L. Houchin-Ray, and L.D. Shea, Non-viral vector delivery from 
PEG-hyaluronic acid hydrogels. J Control Release, 2007. 120(3): p. 233-41. 
122. Chun, K.W., et al., Controlled release of plasmid DNA from photo-cross-linked 
pluronic hydrogels. Biomaterials, 2005. 26(16): p. 3319-26. 
123. Temenoff, J.S., F.K. Kasper, and A.G. Mikos, Fumarate-based macromers as 
scaffolds for tissue engineering applications, in Topics in Tissue engineering, N. 
Ashammakhi, R. Reis, and E. Chiellini, Editors. 2007. 
124. Jo, S., et al., Synthesis and Characterization of Oligo(poly(ethylene glycol) 
fumarate) Macromer. Macromolecules, 2001. 34(9): p. 2839-2844. 
 201
125. Temenoff, J.S., et al., Effect of poly(ethylene glycol) molecular weight on te sile 
and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for 
cartilage tissue engineering. Journal of Biomedical Materials Research (J Biomed 
Mater Res), 2002. 59(3): p. 429-437. 
126. Kasper, F.K., et al., Characterization of DNA release from composites of 
oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. 
Journal of Biomedical Materials Research (J Biomed Mater Res), 2006. 78A(4): p. 
823-835. 
127. Kasper, F.K., et al., In vitro release of plasmid DNA from oligo(poly(ethylene 
glycol) fumarate) hydrogels. J Control Release, 2005. 104(3): p. 521-39. 
128. Huang, Y.C., et al., Long-term in vivo gene expression via delivery of PEI-DNA 
condensates from porous polymer scaffolds. Hum Gene Ther, 2005. 16(5): p. 609-
17. 
129. De Laporte, L., et al., Plasmid releasing multiple channel bridges for transgene 
expression after spinal cord injury. Mol Ther, 2009. 17(2): p. 318-26. 
130. De Laporte, L., A.L. Yan, and L.D. Shea, Local gene delivery from ECM-coated 
poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. 
Biomaterials, 2009. 30(12): p. 2361-8. 
131. Rives, C.B., et al., Layered PLG scaffolds for in vivo plasmid delivery. 
Biomaterials, 2009. 30(3): p. 394-401. 
132. Salvay, D.M. and L.D. Shea, Inductive tissue engineering with protein and DNA-
releasing scaffolds. Mol Biosyst, 2006. 2(1): p. 36-48. 
133. Ziauddin, J. and D.M. Sabatini, Microarrays of cells expressing defined cDNAs. 
Nature, 2001. 411(6833): p. 107-10. 
134. Bengali, Z. and L.D. Shea, Gene Delivery by Immobilization to Cell-Adhesive 
Substrates. MRS Bull, 2005. 30(9): p. 659-662. 
135. Segura, T., M.J. Volk, and L.D. Shea, Substrate-mediated DNA delivery: role of 
the cationic polymer structure and extent of modification. J Control Release, 2003. 
93(1): p. 69-84. 
136. Segura, T., et al., Crosslinked hyaluronic acid hydrogels: a strategy to 
functionalize and pattern. Biomaterials, 2005. 26(4): p. 359-71. 
137. Bengali, Z., et al., Gene delivery through cell culture substrate adsorbed DNA 
complexes. Biotechnol Bioeng, 2005. 90(3): p. 290-302. 
138. Jang, J.H., et al., Surface adsorption of DNA to tissue engineering scaffolds for 
efficient gene delivery. J Biomed Mater Res A, 2006. 77(1): p. 50-8. 
139. Houchin-Ray, T., K.J. Whittlesey, and L.D. Shea, Spatially patterned gene 
delivery for localized neuron survival and neurite extension. Mol Ther, 2007. 
15(4): p. 705-12. 
 202
140. Pannier, A.K., B.C. Anderson, and L.D. Shea, Substrate-mediated delivery from 
self-assembled monolayers: effect of surface ionization, hydrophilicity, and 
patterning. Acta Biomater, 2005. 1(5): p. 511-22. 
141. Pannier, A.K., J.A. Wieland, and L.D. Shea, Surface polyethylene glycol enhances 
substrate-mediated gene delivery by nonspecifically immobilized complexes. Acta 
Biomater, 2008. 4(1): p. 26-39. 
142. Erbacher, P., et al., Transfection and physical properties of various saccharide, 
poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene 
Med, 1999. 1(3): p. 210-22. 
143. Lai, E. and J.H. van Zanten, Real time monitoring of lipoplex molar mass, size 
and density. J Control Release, 2002. 82(1): p. 149-58. 
144. Anchordoquy, T.J. and G.S. Koe, Physical stability of nonviral plasmid-based 
therapeutics. J Pharm Sci, 2000. 89(3): p. 289-96. 
145. Anchordoquy, T.J., et al., Physical stabilization of DNA-based therapeutics. Drug 
Discov Today, 2001. 6(9): p. 463-470. 
146. Lyscov, V.N. and Y. Moshkovsky, DNA cryolysis. Biochim Biophys Acta, 1969. 
190(1): p. 101-10. 
147. Anchordoquy, T.J., et al., Stability of lipid/DNA complexes during agitation ad 
freeze-thawing. J Pharm Sci, 1998. 7(9): p. 1046-51. 
148. Crowe, J.H., et al., Stabilization of dry phospholipid bilayers and proteins by 
sugars. Biochem J, 1987. 242(1): p. 1-10. 
149. Allison, S.D. and T.J. Anchordoquy, Mechanisms of protection of cationic lipid-
DNA complexes during lyophilization. J Pharm Sci, 2000. 89(5): p. 682-91. 
150. Allison, S.D., M.C. Molina, and T.J. Anchordoquy, Stabilization of lipid/DNA 
complexes during the freezing step of the lyophilizat on process: the particle 
isolation hypothesis. Biochim Biophys Acta, 2000. 1468(1-2): p. 127-38. 
151. Armstrong, T.K., L.G. Girouard, and T.J. Anchordoquy, Effects of PEGylation on 
the preservation of cationic lipid/DNA complexes during freeze-thawing and 
lyophilization. J Pharm Sci, 2002. 91(12): p. 2549-58. 
152. Crowe, J.H., B.J. Spargo, and L.M. Crowe, Preservation of dry liposomes does 
not require retention of residual water. Proc Natl Acad Sci U S A, 1987. 84(6): p. 
1537-40. 
153. Crowe, J.H., L.M. Crowe, and D. Chapman, Preservation of Membranes in 
Anhydrobiotic Organisms: The Role of Trehalose. Science, 1984. 223(4637): p. 
701-703. 
154. Koping-Hoggard, M., et al., Improved chitosan-mediated gene delivery based on 
easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene 
Ther, 2004. 11(19): p. 1441-52. 
 203
155. Ferrari, S., et al., ExGen 500 is an efficient vector for gene delivery to lung 
epithelial cells in vitro and in vivo. Gene Ther, 1997. 4(10): p. 1100-6. 
156. Boussif, O., et al., A versatile vector for gene and oligonucleotide transfer into 
cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A, 1995. 
92(16): p. 7297-301. 
157. Godbey, W.T., K.K. Wu, and A.G. Mikos, Poly(ethylenimine) and its role in gene 
delivery. J Control Release, 1999. 60(2-3): p. 149-60. 
158. Molina, M.C., S.D. Allison, and T.J. Anchordoquy, Maintenance of nonviral 
vector particle size during the freezing step of the lyophilization process is 
insufficient for preservation of activity: insight from other structural indicators. J 
Pharm Sci, 2001. 90(10): p. 1445-55. 
159. Brus, C., et al., Stabilization of oligonucleotide-polyethylenimine complexes by 
freeze-drying: physicochemical and biological characterization. J Control 
Release, 2004. 95(1): p. 119-31. 
160. Talsma, H., et al., Stabilization of gene delivery systems by freeze-drying. Int J 
Pharm, 1997. 157(2): p. 233-238. 
161. Reinisalo, M., A. Urtti, and P. Honkakoski, Freeze-drying of cationic polymer 
DNA complexes enables their long-term storage and reverse transfection of post-
mitotic cells. J Control Release, 2006. 110(2): p. 437-43. 
162. Davis, K.A. and K.S. Anseth, Controlled release from crosslinked degradable 
networks. Crit Rev Ther Drug Carrier Syst, 2002. 19(4-5): p. 385-423. 
163. Drury, J.L. and D.J. Mooney, Hydrogels for tissue engineering: scaffold design 
variables and applications. Biomaterials, 2003. 24(24): p. 4337-51. 
164. Elisseeff, J., et al., Advances in skeletal tissue engineering with hydrogels. Orthod 
Craniofac Res, 2005. 8(3): p. 150-61. 
165. Obara, K., et al., Photocrosslinkable chitosan hydrogel containing fibroblast 
growth factor-2 stimulates wound healing in healing- mpaired db/db mice. 
Biomaterials, 2003. 24(20): p. 3437-44. 
166. Taylor, S.J., J.W. McDonald, 3rd, and S.E. Sakiyama-Elbert, Controlled release 
of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release, 2004. 
98(2): p. 281-94. 
167. Sakiyama-Elbert, S.E. and J.A. Hubbell, Controlled release of nerve growth 
factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control 
Release, 2000. 69(1): p. 149-58. 
168. Wallace, D.G. and J. Rosenblatt, Collagen gel systems for sustained delivery and 
tissue engineering. Adv Drug Deliv Rev, 2003. 55(12): p. 1631-49. 
 204
169. Nuttelman, C.R., S.M. Henry, and K.S. Anseth, Synthesis and characterization of 
photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering 
scaffolds. Biomaterials, 2002. 23(17): p. 3617-26. 
170. Martens, P.J., S.J. Bryant, and K.S. Anseth, Tailoring the degradation of 
hydrogels formed from multivinyl poly(ethylene glyco ) and poly(vinyl alcohol) 
macromers for cartilage tissue engineering. Biomacromolecules, 2003. 4(2): p. 
283-92. 
171. Martens, P.J., C.N. Bowman, and K.S. Anseth, Degradable networks formed from 
multi-functional poly(vinyl alcohol) macromers: comparison of results from a 
generalized bulk-degradation model for polymer networks and experimental data. 
Polymer  (Polymer), 2004. 5(10): p. 3377-3387. 
172. Wang, D.A., et al., Synthesis and characterization of a novel degradable 
phosphate-containing hydrogel. Biomaterials, 2003. 24(22): p. 3969-80. 
173. Elbert, D.L., et al., Protein delivery from materials formed by self-selective 
conjugate addition reactions. J Control Release, 2001. 76(1-2): p. 11-25. 
174. Metters, A. and J. Hubbell, Network formation and degradation behavior of 
hydrogels formed by Michael-type addition reactions. Biomacromolecules, 2005. 
6(1): p. 290-301. 
175. Vyavahare, N.R., M.G. Kulkarni, and R.A. Mashelkar, Matrix systems for zero-
order release : facile erosion of crosslinked hydrogels. Polymer  (Polymer), 1992. 
33(3): p. 593-599 (20 ref.). 
176. Hern, D.L. and J.A. Hubbell, Incorporation of adhesion peptides into nonadhesive 
hydrogels useful for tissue resurfacing. J Biomed Mater Res, 1998. 39(2): p. 266-
76. 
177. Lin, C.C. and A.T. Metters, Enhanced protein delivery from photopolymerized 
hydrogels using a pseudospecific metal chelating ligand. Pharm Res, 2006. 23(3): 
p. 614-22. 
178. Park, K., et al., Surface modification of biodegradable electrospun na ofiber 
scaffolds and their interaction with fibroblasts. J Biomater Sci Polym Ed, 2007. 
18(4): p. 369-82. 
179. DILSIZ, N., Plasma surface modification of carbon fibers: a review. J. Adhesion 
Sci. Technol., 2000. 14(7): p. 975-987. 
180. Lee, S.D., et al., Plasma-induced grafted polymerization of acrylic acid and 
subsequent grafting of collagen onto polymer film as biomaterials. Biomaterials, 
1996. 17(16): p. 1599-608. 
181. Shaffer, C.B. and F.H. Critchfield, The absorption and excretion of the solid 
polyethylene glycols ("carbowax" compounds). J Am Pharm Assoc, 1947. 36: p. 
152-157. 
 205
182. Kutty, J.K., et al., The effect of hyaluronic acid incorporation on fibro last 
spreading and proliferation within PEG-diacrylate based semi-interpenetrating 
networks. Biomaterials, 2007. 28(33): p. 4928-38. 
183. Shah, N.M., M.D. Pool, and A.T. Metters, Influence of network structure on the 
degradation of photo-cross-linked PLA-b-PEG-b-PLA hydrogels. 
Biomacromolecules, 2006. 7(11): p. 3171-7. 
184. Schoenmakers, R.G., et al., The effect of the linker on the hydrolysis rate of drug-
linked ester bonds. J Control Release, 2004. 95(2): p. 291-300. 
185. West, J.L. and J.A. Hubbell, Photopolymerized hydrogel materials for drug-
delivery applicatioins. React Polym, 1995. 25: p. 139-147. 
186. Mason, M.N., et al., Predicting controlled-release behavior of degradable PLA-b-
PEG-b-PLA hydrogels. Macromolecules, 2001. 34: p. 4630-4635. 
187. Alvarez-Lorenzo, C., et al., Tetronic micellization, gelation and drug 
solubilization: Influence of pH and ionic strength. Eur J Pharm Biopharm, 2007. 
66(2): p. 244-52. 
188. Missirlis, D., et al., Doxorubicin encapsulation and diffusional release from 
stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci, 2006. 29(2): p. 120-9. 
189. Fernandez-Tarrio, M., C. Alvarez-Lorenzo, and A. Concheiro, Calorimetric 
approach to tetronic/water interactions. J. Ther. Anal. Calorimetry, 2007. 87: p. 
171-178. 
190. Roques, C., Y. Fromes, and E. Fattal, Hydrosoluble polymers for muscular gene 
delivery. Eur J Pharm Biopharm, 2009. 72(2): p. 378-90. 
191. Armstrong, J.K., et al., The effect of pH and concentration upon aggregation 
transitions in aqueous solutions of poloxamine T701. Int J Pharm, 2001. 229(1-2): 
p. 57-66. 
192. Habas, J.P., et al., Nanostructure in block copolymer solutions: rheology and 
small-angle neutron scattering. Phys Rev E Stat Nonlin Soft Matter Phys, 2004. 
70(6 Pt 1): p. 061802. 
193. Cellesi, F., N. Tirelli, and J.A. Hubbell, Towards a fully-synthetic substitute of 
alginate: development of a new process using thermal gel tion and chemical 
cross-linking. Biomaterials, 2004. 25(21): p. 5115-24. 
194. Perreur, C., et al., Determination of the structure of the organized phase of the 
block copolymer PEO-PPO-PEO in aqueous solutions under flow by small-angle 
neutron scattering. Phys Rev E Stat Nonlin Soft Matter Phys, 2002. 65(4 Pt 1): p. 
041802. 
195. Gonzalez-Lopez, J., et al., Self-associative behavior and drug-solubilizing ability 
of poloxamine (tetronic) block copolymers. Langmuir, 2008. 24(19): p. 10688-97. 
 206
196. Prokop, A., et al., Maximizing the in vivo efficiency of gene transfer by means of 
nonviral polymeric gene delivery vehicles. J Pharm Sci, 2002. 91(1): p. 67-76. 
197. Chiappetta, D.A., et al., Triclosan-loaded poloxamine micelles for enhanced 
topical antibacterial activity against biofilm. Eur J Pharm Biopharm, 2008. 69(2): 
p. 535-45. 
198. Jeong, B., S.W. Kim, and Y.H. Bae, Thermosensitive sol-gel reversible hydrogels. 
Adv Drug Deliv Rev, 2002. 54(1): p. 37-51. 
199. He, C., S.W. Kim, and D.S. Lee, In situ gelling stimuli-sensitive block copolymer 
hydrogels for drug delivery. J Control Release, 2008. 127(3): p. 189-207. 
200. Cellesi, F. and N. Tirelli, A new process for cell microencapsulation and other 
biomaterial applications: Thermal gelation and chemical cross-linking in 
"tandem". J Mater Sci Mater Med, 2005. 16(6): p. 559-65. 
201. Cellesi, F., et al., Towards a fully synthetic substitute of alginate: optimization of 
a thermal gelation/chemical cross-linking scheme ("tandem" gelation) for the 
production of beads and liquid-core capsules. Biotechnol Bioeng, 2004. 88(6): p. 
740-9. 
202. Chiappetta, D.A. and A. Sosnik, Poly(ethylene oxide)-poly(propylene oxide) block 
copolymer micelles as drug delivery agents: improved hydrosolubility, stability 
and bioavailability of drugs. Eur J Pharm Biopharm, 2007. 66(3): p. 303-17. 
203. Oh, K.T., T.K. Bronich, and A.V. Kabanov, Micellar formulations for drug 
delivery based on mixtures of hydrophobic and hydrophilic Pluronic block 
copolymers. J Control Release, 2004. 94(2-3): p. 411-22. 
204. Alexandridis, P., et al., Surface activity of poly(ethylene oxide)-block-
poly(propylene oxide)-block-poly(ethylene oxide) copolymers. Langmuir, 1994. 
10: p. 2604-2612. 
205. Lutolf, M.P., et al., Systematic modulation of Michael-type reactivity of thiols 
through the use of charged amino acids. Bioconjug Chem, 2001. 12(6): p. 1051-6. 
206. Solovieva, M.E., et al., Vitamin B12b enhances the cytotoxicity of dithiothreitol. 
Free Radic Biol Med, 2008. 44(10): p. 1846-56. 
207. Wallace, D.G., et al., A tissue sealant based on reactive multifunctional 
polyethylene glycol. J Biomed Mater Res, 2001. 58(5): p. 545-55. 
208. Arote, R., et al., A biodegradable poly(ester amine) based on polycaprol ctone 
and polyethylenimine as a gene carrier. Biomaterials, 2007. 28(4): p. 735-44. 
209. Park, M.R., et al., Highly efficient gene transfer with degradable poly(ester amine) 
based on poly(ethylene glycol) diacrylate and polyeth l nimine in vitro and in 
vivo. J Gene Med, 2008. 10(2): p. 198-207. 
 207
210. Forrest, M.L., J.T. Koerber, and D.W. Pack, A degradable polyethylenimine 
derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem, 
2003. 14(5): p. 934-40. 
211. Pitard, B., et al., Negatively charged self-assembling DNA/poloxamine 
nanospheres for in vivo gene transfer. Nucleic Acids Res, 2004. 32(20): p. e159. 
212. Richard, P., et al., Amphiphilic block copolymers promote gene delivery in vivo to 
pathological skeletal muscles. Hum Gene Ther, 2005. 16(11): p. 1318-24. 
213. Tooney, N.M., et al., Solution and surface effects on plasma fibronectin structure. 
J Cell Biol, 1983. 97(6): p. 1686-92. 
214. Benecky, M.J., et al., Ionic-strength- and pH-dependent conformational states of 
human plasma fibronectin. Biochemistry, 1991. 30(17): p. 4298-306. 
215. Williams, E.C., et al., Conformational states of fibronectin. Effects of pH, ionic 
strength, and collagen binding. J Biol Chem, 1982. 257(24): p. 14973-8. 
216. Shu, X.Z., et al., Attachment and spreading of fibroblasts on an RGD peptide-
modified injectable hyaluronan hydrogel. J Biomed Mater Res A, 2004. 68(2): p. 
365-75. 
217. Groll, J., et al., A novel star PEG-derived surface coating for specific ell 
adhesion. J Biomed Mater Res A, 2005. 74(4): p. 607-17. 
218. Burdick, J.A. and K.S. Anseth, Photoencapsulation of osteoblasts in injectable 
RGD-modified PEG hydrogels for bone tissue engineerg. Biomaterials, 2002. 
23(22): p. 4315-23. 
219. Xu, H., et al., Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified 
with cleavable PEG-lipid derivatives. J Control Release, 2008. 130(3): p. 238-45. 
220. Pitarresi, G., et al., A new biodegradable and biocompatible hydrogel with 
polyaminoacid structure. Int J Pharm, 2007. 335(1-2): p. 130-7. 
221. Tsai, M.F., et al., Characterization of hydrogels prepared from copolymerization 
of the different degrees of methacrylate-grafted chondroitin sulfate macromers 
and acrylic acid. J Biomed Mater Res A, 2008. 4(3): p. 727-39. 
222. Moghimi, S.M. and A.C. Hunter, Poloxamers and poloxamines in nanoparticle 
engineering and experimental medicine. Trends Biotechnol, 2000. 18(10): p. 412-
20. 
223. Kanjickal, D., et al., Effects of sterilization on poly(ethylene glycol) hydrogels. J 
Biomed Mater Res A, 2008. 7(3): p. 608-17. 
224. Eljarrat-Binstock, E., et al., Preparation, characterization, and sterilization of 
hydrogel sponges for iontophoretic drug-delivery use. Polymers for advanced 
technologies, 2007. 18(9): p. 720-730. 
 
 
